500R89002           "!IJL
           United States                                   ECAO-CIN-G074
           Environmental Protection                              September, 1989
                                                      K
'PA       Research  and
           Development
           HEALTH AND ENVIRONMENTAL EFFECTS DOCUMENT
           FOR 1.3-DICHLOROPROPENE
           Prepared for
          OFFICE OF SOLID WASTE AND
          EMERGENCY RESPONSE
           Prepared by

           Environmental  Criteria and  Assessment Office
           Office of Health and  Environmental Assessment
           U.S. Environmental Protection  Agency
           Cincinnati,  OH  45266
                      DRAFT: DO NOT CITE OR QUOTE
                              NOTICE

       This document 1s a preliminary draft.  It has not been formally released
    by the U.S. Environmental Protection Agency and should not at this stage be
    construed to represent Agency policy.  It 1s being circulated for comments
    on Us technical accuracy and policy Implications.

-------
                                  DISCLAIMER

    This report  1s  an external draft  for  review purposes only  and  does not
constitute  Agency  policy.   Mention of  trade names  or  commercial  products
does not constitute endorsement or recommendation for use.
                                      11

-------
                                    PREFACE


    Health and  Environmental  Effects Documents (HEEOs) are  prepared  for the
Office of Solid  Waste  and Emergency Response  (OSUER).  This document series
Is Intended to support  listings  under  the  Resource Conservation and Recovery
Act (RCRA) as  well as  to  provide health-related limits and goals  for emer-
gency and  remedial actions  under the Comprehensive  Environmental  Response,
Compensation  and  Liability  Act  (CERCLA).   Both  published literature  and
Information obtained for  Agency  Program Office  files are evaluated  as  they
pertain to potential human health,  aquatic  life  and environmental  effects of
hazardous waste  constituents.   The  literature searched for  In  this document
and  the  dates  searched are  Included In  "Appendix:  Literature  Searched."
Literature search  material  1s  current up  to 8 months previous  to  the final
draft date  listed  on  the front  cover.   Final  dr.aft document  dates  (front
cover} reflect the date the document Is sent to the Program Officer  (OSWER).

    Several  quantitative  estimates  are  presented  provided  sufficient  data
are  available.   For  systemic   toxicants,   these   Include:  Reference  doses
(RfDs) for chronic  and  subchronlc exposures  for  both the  Inhalation and oral
exposures.   The  subchronlc  or  partial  lifetime  RfD, Is  an estimate of  an
exposure  level  which would  not  be expected  to  cause adverse  effects  when
exposure occurs  during  a  limited time  Interval  I.e., for an Interval which
does  not  constitute a  significant   portion  of the  llfespan.  This  type  of
exposure estimate  has  not been  extensively used,  or rigorously defined  as
previous risk assessment efforts  have  focused  primarily on lifetime exposure
scenarios.   Animal  data  used  for  subchronlc estimates  generally  reflect
exposure durations of   30-90  days.   The  general  methodology for  estimating
subchronlc RfDs  1s  the  same  as  traditionally employed for  chronic  estimates,
except that subchronlc  data are utilized  when available.

    In the case  of suspected carcinogens,  RfDs are  not estimated.   Instead,
a  carcinogenic  potency  factor,  or  q-j*   (U.S.  EPA,  1980a)  Is  provided.
These potency  estimates  are  derived for  both  oral and Inhalation  exposures
where possible.  In addition, unit  risk  estimates  for air  and drinking water
are presented based on  Inhalation and oral  data,  respectively.

    Reportable quantities  (RQs)  based  on both chronic toxlclty and cardno-
genlclty  are  derived.   The  RQ  Is  used   to  determine  the quantity of  a
hazardous substance for which  notification 1s  required   In the event  of  a
release  as   specified   under   the  Comprehensive   Environmental   Response,
Compensation  and Liability  Act   {CERCLA).    These  two RQs  (chronic  toxldty
and carc1nogen1c1ty)  represent  two of  six  scores developed (the  remaining
four  reflect  1gn1tab1l1ty, reactivity, aquatic toxlclty,  and acute  mammalian
toxlclty).   Chemical-specific  RQs  reflect  the lowest of  these six  primary
criteria.  The  methodology  for  chronic  toxlclty  and cancer  based RQs  are
defined 1n U.S. EPA, 1984 and 1986a, respectively.
                                      111

-------
                               EXECUTIVE SUMMARY

    1,3-D1chloropropene  Is  a  colorless  liquid with  the  odor of  chloroform
(Wlndholz,  1983).    It   occurs  In  els- and  trans-TsomeMc   forms.    The
cls-lsomer has  a slightly  higher  vapor  pressure  than  the trans-lsomer  (43
versus 34  mm  Hg), but the  water  solubilities  are similar (2700-2800 ppm at
20°C)  (DHUng,  1977).  Current  production  figures  for  1,3-dlchloropropene
are  not  available.   According  to the public  portion of  the  U.S. EPA TSCA
Production File  for  1977,  two U.S.  manufacturers  (Dow  and  Shell  Chemical)
produced a combined  total  of 10-60 million pounds  In 1977 (U.S. EPA, 1977).
1,3-Olchloropropene   has  been  produced  as  a  by-product   of  allyl chloride
production  In  conjunction  with  other  by-products,  such  as 3,3-dlchloro-
propene  and   l,2-d1chloropropene  (KMJgsheld  and  van  der  Gen,   1986;
DeBened1ct1s,    1979).    By-product  mixtures   of   l,3-d1chloropropene   and
1,2-dlchloropropane  have  been  marketed  as a  fumlgant under  the  trade name
D-D  by  Shell  Chemical  Co.   (Worthing  and  Walker,  1987;  Yang,  1986).
l,3-D1chloropropene  Is used  as  a  soil  fumlgant and nematldde (Worthing  and
Walker,   1987).    Several    different  commercial   formulations    containing
1,3-d1chloropropene   have   been  marketed  as   a   fumlgant.    Telone   II*
(currently marketed  by Dow Chemical) Is widely used  In agriculture as a soil
fumlgant  for  parasitic  plant  nematodes   (Yang,  1986; SRI,  1986).  Current
Telone !!• formulations  contain  98%  1,3-d1chloropropene   (Albrecht, 1987a),
although original formulations  contained only 92%  (Yang, 1986).
    Degradation  of  l,3-d1chloropropene  1n the  ambient  atmosphere results
primarily  by  reaction with photochemically  generated  HO* (Tuazon  et  al.,
1984).   Based  upon experimentally  determined  rate  constants  (Tuazon et al.,
1984),  the half-lives  for the  reaction of  els- and  trans-1,3-d1chloropropene
                                      1v

-------
with HO-  In air  are  ~2.1 and  1.2 days,  respectively.   l,3-D1chloropropene
has  been  detected  1n  rainwater  (Mazurek and  Slmonettl,  1986),  Indicating
that physical removal by  wet  deposition  can  occur.   Hydrolysis and volatili-
zation  are  Important environmental  fate  processes  1n water.   The  rate  of
hydrolysis  has  been  found to be Independent of  pH  at  pHs 5, 7  and  9 and to
be  essentially  Identical  for   the   c1s-  and  trans-lsomers.   The  measured
hydrolysis  half-lives  at 10,  20  and  30°C were  51,  11.3  and  3.1  days,
respectively, with  3-chloroallyl  alcohol  Identified as a hydrolysis product
(McCall,  1987).   Volatilization half-lives  of  3.8-4.2 and 46-50  hours  have
been estimated  for  a  model river (1  m deep} and a  model  environmental pond,
respectively  (Thomas,  1982;  U.S.  EPA,  1986b).   The  fate of  1,3-d1chloro-
propene In  soil  has  been studied extensively.   It  hydrolyzes  In wet soil to
yield els-  and  trans-3-chloroallyl alcohol  (Castro.and Belser,  1966; Roberts
and Stoydln, 1976).   Since the  rate  of hydrolysis Is  strongly dependent upon
temperature, the  Importance  of  hydrolysis  In soil will depend  upon  moisture
content and  temperature.   In warm,  moist  soil,  hydrolysis  may  be  one of the
dominant  degradation   processes.    1,3-Dlchloropropene   Is  susceptible  to
degradation  by  soil  microorganisms  (Krljgsheld  and  van der  Gen,  1986).
Adapted microbes  appear capable of  degrading l,3-d1chloropropene at  signifi-
cant rates  (Tabak et  al.,  1981; van  der  Pas  and Lelstra,  1987).  Volatiliza-
tion  Is  an  Important  physical removal  process for  1,3-d1chloropropene  In
soil.   The  volatilization  rate of  l,3-d1chloropropene  that  Is  applied  to
soil as a fumlgant can vary greatly with application  methods,  temperature,
moisture  content,  soil  porosity  and  soil   organic   content  (Albrecht  and
Chenchln,  1985).   Volatilization  losses  from  soil may  exceed  50%  of  the
amount  applied   (Roberts  and  Stoydln,   1976)  or   range  from  only  5-10X

-------
(Munnecke and  Van Gundy,  1979).   Dissolved 1,3-dlchloropropene  1s  suscept-
ible  to  significant  leaching In  soil  (Kenaga, 1980).  Although  leaching In
wet   soil   can  occur,  concurrent  hydrolysis   and   blodegradatlon  should
attenuate the  amounts of  1,3-dlchloropropene that  may reach  groundwaters.
Vapor phase  1,3-dlchloropropene  1s more strongly  adsorbed to soil  than  the
dissolved chemical (Munnecke and  Van Gundy,  1979). The overall  half-lives of
l,3-d1chloroprolene  In soil  have been observed  to vary from 3-69 days  (van
der Pas and Lelstra,  1987; Lelstra, 1970;. Albrecht; 1987a).
    l,3-D1chloropropene  has  been  Identified  In   a  very  limited number  of
drinking  waters.   It  has been  qualitatively detected  In  New  Orleans,  LA
drinking water collected  1n August 1974  (Dowty et  al., 1975; Shackelford and
Keith,  1976).    Monitoring studies  conducted  In Denver,  CO  and  In  nine
municipalities along  the Great  Lakes  failed  to  detect any  trace  of 1,3-dl-
chloropropene  (Rogers  et  al.,   1987;  Otson,  1987).   Extensive  groundwater
monitoring  for  agricultural  chemicals In  California   (Including  areas  where
Telone and  D-D  had been  applied for years)  has  detected  1,3-dlchloropropene
In only  three  of thousands of  samples analyzed  (Cohen, 1986; Maddy et  al.,
1982).   1,3-Dlchloropropene  has  been detected  In  leachate from municipal
waste landfills  and  sewage treatment  plants  (Sabel  and Clark, 1984;  Lao et
al.,  1982).   It has  been suggested  that chlorlnatlon  of  water  can  lead to
the   formation   of   1,3-dlchloropropene   and  that   the   Identification   of
1,3-dlchloropropene  In  various  water  samples may  be due  to  chlorlnatlon
treatment (Krljgsheld  and  van  der Gen, 1986).  Examination  of 231 different
ready-to-eat foods (collected during the U.S.  Food and Drug  Administration's
Market  Basket  Survey) for  22 fumlgants  and  Industrial  residues failed  to
detect any 1,3-dlchloropropene at a detection  limit of -1  ppb  (Daft, 1988).
                                      v1

-------
The  major  source  of  1,3-d1chloropropene  release  to  the  atmosphere  Is
probably volatile losses  from  soil  following soil application as  a  fumlgant
(KMjgsheld and van der Gen, 1986).  Albrecht  (1987b)  studied  the  Inhalation
exposure of  1,3-d1chloropropene 1n workers  Involved  1n applying  Telone  !!•
to pineapple fields In Hawaii and found exposures  to be predominantly <1  ppm.
    Data  are  available  on  the  acute  toxlclty  of  l,3-d1chloropropene  to
several  species  of Invertebrates and  vertebrates.   As  shown  In  Table  4-1,
96-hour  IC50  values   reveal  a similar, range  of  sensitivity, among   six
freshwater  fish   species  native  to U.S.  waters   (Applegate et  a!., 1957;
Buccafusco  et  al., 1981;  Hermens   et  al.,  1985;   Johnson  and  Flnley, 1980;
LeBlanc,  1984;  Schneider, 1979;  U.S.  EPA,  1978).   A  seventh  species,   the
walleye,  S.  vltreum  vltreum.   showed  markedly greater  sensitivity, with  a
96-hour  LC5Q of  1.08  ppm.   The water  flea,  j). magna.  (Leblanc, 1980, 1984;
U.S.  EPA,  1978)   showed a  sensitivity  comparable with  that of the  blueglll
sunflsh, L. macrochlrus.  the least  sensitive of the freshwater fish species
tested  (Buccafusco  et al.,  1981;  LeBlanc,  1984;  U.S.  EPA, 1978).   1,3-dl-
chloropropene 1s  more  acutely  toxic to the saltwater Invertebrate,  M. bahla
(LeBlanc, 1984;  U.S.  EPA,  1978), than  to  the freshwater species, D.  magna.
The sheepshead minnow, C.  vaMeqatus.  a saltwater fish. Is  highly sensitive
to 1,3-dlchloropropene (mean  96-hour LC,Q =  1.76 ppm)  (LeBlanc,  1984).
    Chronic toxlclty  tests of  1,3-dlchloropropene to the fathead  minnow,  P.
promelas, and  mysld  shrimp, H_._ bahla.  revealed  NOECs  of  0.18  ppm  and  4.2
ppm, respectively (U.S. EPA,  1978).
    Data  regarding the  toxlclty  of  1,3-dlchloropropene   to  aquatic flora
follow a  similar  pattern  to  that for aquatic  fauna.  The saltwater  alga,  S.
costatum. has  a  mean  96-hour   EC™  of  1.01  ppm  (LeBlanc,  1984;  U.S.  EPA,
1978);  the  freshwater alga,  S. caprlcornutum. has a  mean 96-hour  EC™  of

-------
4.95 ppra  (LeBlanc,  1984;  U.S. EPA, 1978).  Data  on  effects of 1,3-dlchloro-
propene on  bacteria  Indicate that Aerobacter  sp..  and  Pseudomonas  sj>.  are
more  resistant  to  the compound  than  are  higher  aquatic species  reported
above.
    Studies  on  the  bloconcentratlon/bloaccuroulatlon  potential  of  l,3-d1-
chloropropene 1n  aquatic  fauna and flora  were  not  located In the  available
literature, but  BCFs  of 7  (based  on  water  solubility) and 1  (based  on KQW)
were predicted for this compound by Kenaga (1980).-
    Data   support   1,3-dlchloropropene's  effectiveness   as   a   nematodde
(Ablvardl, 1970; Blackmon and  Husen,  1974; Costante  et al., 1987;  Kotcon and
Lorla, 1987) and Us  toxlclty  to  the  earthworm,  Lumbrlcus  terrestrls. and to
Dlpter and Coleopter larvae (Edwards and Re1ch1e, 1969).
    Data  regarding  the effectiveness  of  1,3-dlchloropropene   for control  of
soil  microorganisms  are  equivocal.    Nathur  et  al.  (1980) noted  Increased
numbers of fungi, bacteria  and actlnomycetes after  treating field  plots with
the chemical,  but Cook et  al. (1987)  noted 95-10074 elimination of  a  popu-
lation of Pythlum spp. with 1,3-dlchloropropene.
    The  lack  of  pertinent data  regarding effects  of  exposure of  aquatic
fauna  and flora to 1,3-dlchloropropene prevented the development  of fresh-
water or saltwater criteria.
    Approximately 80% of   the  administered dose  of 1,3-dlchloropropene  was
absorbed  Into  the  body following  Inhalation   or oral  exposure (Stott  and
Kastl, 1986; Hutson et  al., 1971).  As the Inhaled  concentration  of  1,3-dl-
chloropropene Increased, the absorption did not  Increase  linearly  because of
an exposure  level-related  decrease In  respiratory ventllatory frequency  and
to saturation of  the  metabolism of 1,3-dlchloropropene  (see Section  5.1.).

-------
1,3-D1chloropropene was  rapidly  eliminated from  the  body, primarily  1n  the
urine as  N-acetyl-S-(3-chloroprop-2-enyl)  cystelne, following  Inhalation  or
oral exposure (Hutson et al., 1971; CUmle  et  al.,  1979;  D1etz et al., 1965;
Stott  and  Kastl,  1986;  Fisher   and  Kllgore,  1988b).   1,3-D1chloropropene
elimination 1s  due  to an efficient glutathlone-dependent  blotransformatlon:
l,3-d1chloropropene conjugates with glutathlone,  enters the mercapturlc acid
pathway  and  Is  excreted In  the  urine  as  N-acetyl-S-(3-chloroprop-2-enyl)
cystelne (Cllmle et al., 1979; Fisher  and Kllgore,O988a).
    Differences In disposition exist  between the  els-  and  the  trans-lsomers.
Greater concentrations  of  the trans-lsomer were  found In the  blood of rats
after  Inhalation  exposure  to approximately equal  concentrations of the  two
Isomers  (Stott  and Kastl,  1986),  and greater  amounts of the  ds- than  the
trans-lsomer  were  found  1n   the  urine,  while  much greater amounts  of  the
trans-lsomer  were  excreted  as  CCL  In  the  expired breath  (Hutson  et al.,
1971).
    Distinct  differences exist  In the  elimination  of  l,3-d1chloropropene
between  rats   and  mice.   Following  oral   dosing  with 14C-l,3-d1chloropro-
pene, more  of  the  administered  dose  of  radioactivity was  excreted   In  the
urine and  expired  air of mice than of rats (D1etz  et al., 1985).  The rate
of  urinary excretion  of  the mercapturlc  acid  of l,3-d1chloropropene  was
comparable between rats  (Fisher  and Kllgore,  1988b) and humans  (Osterloh  et
al., 1984).
    The  LC5Q  for   l,3-d1chloropropene  In  rats  and  mice  was  4530   mg/m3
(H1ne et  al., 1953).   Information  regarding  subchronlc and chronic Inhala-
tion of 1,3-dlchloropropene suggests  that damage  to the nasal  mucosa of rats
and mice and  damage to  the urinary bladders of mice may result from exposure
(Stott  et  al., 1988;   Torkelson  and  Rowe,   1981; Lomax  et  al.,  1989).
                                      1x

-------
Evidence of  damage  to the liver  and  kidneys  was also found  (Parker  et  at.,
1982; Torkelson and Rowe, 1981).
    Oral LD5_  values In  rats  ranged  from 140-740  mg/kg and. In  mice,  from
300-640 mg/kg  {Torkelson and  Rowe,  1981;  Mine et  al.f 1953; Toyoshlma  et
al.,  1978a,b).   Subchronlc   studies   suggested  Increases  1n  the  relative
weight  of  the  kidneys   1n  rats   treated  orally  with  l,3-d1chloropropene
(Torkelson and  Rowe, 1981).   Chronic  oral  studies  suggest that  hyperplasla
of  the  fore stomach  and  of  the  urinary-bladders of  rats  and mice  resulted
from exposure (NTP,  1985).
    The only  data available regarding  the carclnogenldty of  1,3-dlchloro-
propene 1n humans are  three  reported  cases of hematologlc malignancies  that
may have been the result  of acute  exposure  to 1,3-d1chloropropene (Markovltz
and Crosby, 1984).   There 1s sufficient  evidence that  1,3-dlchloropropene  Is
a  carcinogen  1n  orally  exposed  animals.   NTP   (1985)  found  Increased
Incidences of squamous-cell paplllomas and carcinomas  of the  forestomach and
neoplastlc nodules or carcinomas  of the liver In male  rats treated  chronic-
ally  with  1,3-dlchloropropene by  gavage.   Mice   similarly  treated  showed
Increased  Incidences of  forestomach tumors,  lung adenomas or  carcinomas and
transitional cell carcinomas of the urinary bladder.   There 1s weak  evidence
that  1,3-dlchloropropene  1s  carcinogenic  In  animals exposed  by  Inhalation.
Lomax et al. (1989)  found an Increase  1n the  Incidence of  benign  lung tumors
(bronchloloalveolar   adenomas)   In  male  mice   treated  chronically   with
1,3-dlchloropropene,  but  no evidence  of  any  Increase 1n neoplasms In either
male  or  female  rats  or  In  female mice  following  Inhalation.   1,3-Dlchloro-
propene has been  found  to be  mutagenlc  In various  strains of  S.  typhlmurlum
(NTP,  1985;  Stolzenberg  and   H1ne,  1980; Haworth  et  al.,  1983).   1,3-01-
chloropropene  has also  been   found  to  be  positive  for  sex-linked  lethal

-------
mutations,  but negative  for  reciprocal  translocatlons  1n  D.  melanoqaster
                                              i
{NTP, 1985).   l,3-D1chloropropene  does  not  appear to be a reproductive  or  a
developmental toxicant.
    The only  available data  regarding  the  carclnogenlclty  of  l,3-d1chloro-
propene In  humans  are  three reported cases  of hematologlc malignancies  that
may have  resulted  from acute exposure to 1,3-dlchloropropene  (MarkowHz  and
Crosby, 1984).   The available animal  data  Indicate  evidence that  1,3-dl-
chloropropene  Is carcinogenic  by  the oral  route of exposure  (NTP,  1985)  and
may  be carcinogenic  following  Inhalation  exposure  (Lomax   et  a!.,  1989).
Mutagenlclty  studies  Indicate  that  1,3-dlchloropropene  1s  mutagenlc   to
various  strains  of  S.  typhlmuMum  (NTP,  1985;   Haworth   et   al.,  1983;
Stolzenberg  and  Hlne,  1980).    According  to  U.S.  EPA  (1986c)  guidance,
1,3-dlchloropropene can  be  placed In Group 82  - probable human  carcinogen.
An  Inhalation  q *  of  l.SxlO"1  (mg/kg/day)"1  1s   derived  based   on   an
Increased   Incidence  of bronchloloalveolar  adenomas  1n  male  mice exposed  to
60 ppm for 2 years (Lomax et al.,  1989).
    An  oral   q *   of   l.SxltT1   (mg/kg/day)"1   Is   derived  based  on   the
combined  Incidences of tumors In  the  forestomach and liver  and  pheochromo-
cytoma In  the adrenals  of male rats (NTP, 1985).
    A subchronlc  Inhalation RfD  of  0.01 mg/m"  1s calculated by  adjusting  a
NOEL of 10  ppm from the  Stott  et  al. (1988)  study for Intermittent  exposure,
multiplying by the RGDR and dividing by an  uncertainty  factor  of  100  (10  for
Interspedes extrapolation and 10  to  protect the  most  sensitive  Individual).
    The subchronlc  Inhalation RfD of  0.01  mg/ma Is  adopted as  the chronic
Inhalation RfO because the  chronic LOAEL In mice  (20  ppm)  Is higher  than  the
NOEL of 10 ppm In  rats 1n  the  subchronlc  study used  as  the basis for  the
subchronlc RfD.
                                      xl

-------
    A  subchronlc  oral  RfD  of  3xlO~9  mg/kg/day  Is  calculated  taking the
NOEL of  3  mg/kg/day from the T11  et  al.  (1973)  study, adjusting for  Inter-
mittent exposure  to 2.6 mg/kg/day and  dividing  by an uncertainty factor of
1000 (10  for  Interspedes extrapolation,  10  to protect  the most sensitive
Individuals and an  additional modifying factor  of  10 for the deficient data
base).   A  chronic oral RfD  of  3xlO~4  mg/kg/day  Is  calculated  by adjusting
the NOEL  of  3 mg/kg/day  from the T11  et  al.  (1973)  study  for  Intermittent
exposure  and  dividing  by an uncertainly  factor-of  10,000  (10  for  Inter-
species extrapolation, 10 to protect  the most  sensitive Individuals, 10 for
the use  of a  subchronlc  study and an  additional  modifying  factor of 10 for
the  deficient data base).  This oral  RfD of  3x10"4  mg/kg/day has  been
verified  (U.S.  EPA, 1987b).  An  RQ  of 100 Is  calculated  on  the  basis  of
chronic toxldty and an RQ of 100  1s  calculated based  on cardnogenlclty.
                                     xll

-------
                               TABLE  OF  CONTENTS
                                                                        Page

1.   INTRODUCTION	    1-1

     1.1.   STRUCTURE AND CAS NUMBER	    1-1
     1.2.   PHYSICAL AND CHEMICAL PROPERTIES	    1-1
     1.3.   PRODUCTION DATA	    1-3
     1.4.   USE DATA	    1-3
     1.5.   SUMMARY	    1-4

2.   ENVIRONMENTAL FATE AND TRANSPORT	    2-1

     2.1.   AIR	    2-1
                                                  •
     2.2.   WATER	7	    2-1

            2.2.1.   Hydrolysis	    2-1
            2.2.2.   Photolysis	    2-2
            2.2.3.'  Mlcroblal Degradation	    2-2
            2.2.4.   Volatilization	    2-2
            2.2.5.   Adsorption	    2-2

     2.3.   SOIL	    2-3

            2.3.1.   Chemical Degradation	    2-3
            2.3.2.   Mlcroblal Degradation	    2-3
            2.3.3.   Volatilization	    2-4
            2.3.4.   Adsorption/Leaching	    2-4
            2.3.5.   Persistence	    2-5

     2.4.   SUMMARY	    2-5

3.   EXPOSURE	    3-1

     3.1.   HATER	    3-1
     3.2.   FOOD	    3-2
     3.3.   INHALATION	    3-2
     3.4.   DERMAL	    3-3
     3.5.   SUMMARY	    3-3

4.   ENVIRONMENTAL TOXICOLOGY	     4-1

     4.1.   AQUATIC TOXICOLOGY	    4-1

            4.1.1.   Acute Toxic Effects on Fauna	    4-1
            4.1.2.   Chronic Effects on Fauna	    4-1
            4.1.3.   Effects on Flora	    4-4
            4.1.4.   Effects on Bacteria	    4-5

     4.2.   TERRESTRIAL TOXICITY	    4-5

            4.2.1.   Effects on Fauna	    4-5
            4.2.2.   Effects on Flora	    4-5

-------
                          TABLE  OF  CONTENTS  (cent.)
                                                                        Page

     4.3.   FIELD STUDIES	    4-6
     4.4.   AQUATIC RISK ASSESSMENT	    4-7
     4.5.   SUMMARY	   4-10

5.   PHARMACOKINETICS	     5-1

     5.1.   ABSORPTION	     5-1
     5.2.   DISTRIBUTION	     5-2
     5.3.   METABOLISM	     5-3
     5.4.   EXCRETION	     5-5
     5.5.   SUMMARY	     5-9

6.   EFFECTS	7	     6-1

     6.1.   SYSTEMIC TOXICITY	     6-1

            6.1.1    Inhalation Exposure	     6-1
            6.1.2.   Oral Exposure	     6-5
            6.1.3.   Other Relevant Information	     6-8

     6.2.   CARCINOGENICITY	    6-11

            6.2.1    Inhalation	    6-11
            6.2.2.   Oral	    6-12
            6.2.3.   Other Relevant Information	    6-16

     6.3.   MUTAGENICITY	    6-17
     6.4.   DEVELOPMENTAL TOXICITY	    6-20
     6.5.   OTHER REPRODUCTIVE EFFECTS	    6-21
     6.6.   SUMMARY	    6-22

7.   EXISTING GUIDELINES AND STANDARDS	     7-1

     7.1.   HUMAN	     7-1
     7.2.   AQUATIC	     7-1

8.   RISK ASSESSMENT	     8-1

     8.1.   CARCINOGENICITY	     8-1

            8.1.1.   Inhalation	     8-1
            8.1.2.   Oral	     8-2
            8.1.3.   Other Routes	     8-3
            8.1.4.   Weight of Evidence	     8-3
            8.1.5.   Quantitative Risk Estimates	     8-4

     8.2.   SYSTEMIC TOXICITY	     8-5

            8.2.1.   Inhalation Exposure	     8-5
            8.2.2.   Oral Exposure	     8-9
                                      xlv

-------
                           TABLE  Of  CONTENTS  (cont.)
                                                                        Page

9.   REPORTABLE QUANTITIES	     9-1

     9.1.   BASED ON SYSTEHIC TOXICITY	,	     9-1
     9.2.   BASED ON CARCINOGENICITY	     9-4

10.  REFERENCES	    10-1

APPENDIX A	     A-l

APPENDIX B	     B-l

APPENDIX C	:		     C-l

APPENDIX D	     D-l
                                      xv

-------
                                LIST OF TABLES

No,                                 Title                               Page

1-1   Synonyms, CAS Numbers. Molecular Weight, Empirical Formula
      and Structure of 1,3-Dlchloropropene	      1-2

4-1   Acute Toxlclty of 1,3-Dlchloropropene to Aquatic Fauna	      4-2

5-1   Rates of Excretion of Radioactivity After Oral
      Administration of 1,3-Dlchloropropene	'..      5-7

5-2   Recoveries of Radioactivity from Rats 1n the 4 Days Following
      Oral Administration of 1,3-Dlchloropropene	      5-8
                                                  *
6-1   LDso/LCso Values for Dlchloropropene	     6-10

6-2   Incidence of BroncMoloalveolar Adenomas 1n Nice Exposed to
      1,3-Dlchloropropene for 24 Months	     6-13

6-3   Chronic Oral Exposure to Telone !!• for 2 Years	     6-14

6-4   Mutagenlclty of 1,3-Dlchloropropene	     6-18

6-5   Testlcular Weights, Sperm Counts and Percent Abnormal  Sperm
      After IntraperHoneal Injection of 1,3-Qlchloropropene	     6-23

9-1   Toxlclty Summary for 1,3-Dlchloropropene	      9-2

9-2   Oral Composite Scores for 1,3-Dlchloropropene	      9-5

9-3   1,3-Dlchloropropene:  Minimum Effective Dose (MED) and
      Reportable Quantity (RQ)	      9-6

9-4   Derivation of Potency Factor (F) for Inhalation Exposure to
      1,3-D1chloropropene	      9-8

9-5   Derivation of Potency Factor (F) for Oral Exposure to
      1,3-D1chloropropene	      9-9
                                      xv1

-------
                             LIST  OF  ABBREVIATIONS

AEL                     Adverse effects level
ALB                     Albumla
BCF                     B1oconcentrat1on factor
BOO                     Biological oxygen demand
BUN                     Blood urea nitrogen
CBI                     Confidential Business Information
cc                      Cubic centimeter
CNS                     Central nervous system
CS                      Composite score
EC5Q                    Concentration effective to 50% of recipients
EDgo                    Effective dose to 50X of recipients
F                       Potency factor
F344                    Fischer 344
GEMS                    Graphical Exposure Modeling System
GLU                     Glutamyl
GMAV                    Genus mean acute value
GMCV                    Genus mean chronic value
GPT                     Glutamlc pyruvlc transamlnase
HCT                     HematocrH
NEC                     Human equivalent concentration
HGB                     Hemoblobln
Koc                     Soil sorptlon coefficient standardized
                        with respect to organic carbon
Kow                     Octanol/water partition coefficient
LC5Q                    Concentration lethal to SOX of recipients
1059                    Dose lethal to SOX of recipients
                                     xv11

-------
                         LIST OF  ABBREVIATIONS (cont.)

LOAEL                   Lowest-observed-adverse-effect level
LOEC                    Lowest-observed-effect concentration
NOEC                    No-observed-effect concentration
NOEL                    No-observed-effect level
NPS                     Non-protein sulfhydryl
ppb                     Parts per billion
ppm                     Parts per million
RBC                     Red blood cell
RfD                     Reference dose
RGDR                    Regional gas dose ratio
RQ                      Reportable quantity
RV(j                     Dose rating value
RVe                     Effect rating value
TLV                     Threshold HmH value
THA                     Time-weighted average
WBC                     White blood cell
                                     XV111

-------
                               1.   INTRODUCTION
1.1.   STRUCTURE AND CAS NUMBER
    The  structures,  CAS Registry  numbers,  synonyms,  molecular  weights  and
empirical  formulas  of  c1s-  and trans-l,3-d1chloropropene  are  presented  In
Table 1-1  with  the c1s- and  trans-lsomer mixture.  Mixtures of the ds-  and
trans-1somers are  known by Dow Chemical Company  trade names Telone, Telone
C,  Telone  II   and  Dorlone  II (Yang,  1986; Worthing  and  Walker,  1987).
The Shell  Chemical Co.  trade  name for ^hls  mixture  Is  0-D92 (Worthing  and
Walker, 1987). The trade-named  products are not pure  1,3-dlchloropropene  but
contain other chlorinated compounds (Section 1.4).
1.2.   PHYSICAL AND CHEMICAL PROPERTIES
    1,3-Dlchloropropene  1s  a colorless  liquid with  the  odor of chloroform
(Wlndholz, 1983). The  technical product  (92%  pure)  Is a colorless  to amber-
colored  liquid  with  a pungent   odor  (Worthing  and Walker,   1987).  1,3-
Dlchloropropene  Is  soluble  In  chloroform,  ether,  benzene,  acetone,  carbon
tetrachlorlde, heptane and methanol (Dean, 1985; Worthing and Walker, 1987).
Selected  physical  properties of  els- and  trans-l,3-d1chloropropene  are  as
follows:
    Melting point:               no  data
    Boiling point:               104.3°C (c1s-)          Yang, 1986
                                112°C  (trans-)          Yang, 1986
    Specific gravity:           1.224  (c1s-)             Yang, 1986
      (20/4'C)                  1.217  (trans-)          Yang, 1986
    Water solubility:
      at 20°C                   2700 ppm (ds-)          Dllllng, 1977
                                2800 ppm (trans-)        Dllllng, 1977
    Vapor pressure:
      at 25'C                   43  mm  Hg (els-)          Ollllng, 1977
                                34  mm  Hg (trans-)        DUlIng, 1977
5968H                                1-1                             07/25/89

-------
                                                                       TABLE 1-1
                                             Synonyms,  CAS Numbers,  Molecular Weight,  Empirical  Formula and
                                                            Structure of 1,3-Dichloropropene
                Chemical
                (Synonyms)"
   CAS
  Number
Molecular
 Weight
Empirical
 Formula
Structure
    ci s-1,1-Oichloropropene
            l-propene,  1,3-dichloro-, (Z)-
            cis-l,3-dichloropropyle»e
10061-01-5
 110.98
                                                        H, Cl,
                      CL       CHt-CL
    trans-1.3-Dichloropropene
            l-propene,  1,3-dichloro-,  (£)-
            trans-1,3-dichloropropylene
10061-02-6
 110.98
 , H, Cl,
                                                                                                                             CL
                                                                              CH*CH
                                                                                    CH,-CL
     1,3-Dichtoropropene (mixture)
            l-propene,  1,3-dichloro-
            1,3-dichloropropylene
            1,3-dichloropropene, E.Z
            alpha-chloroallyl chloride
            gaimia-chloroallyl chloride
            alpha, gamma-chloroallyl chloride
i
ro
 542-75-6
 110.98
C3 H,
                                                                          CL-CH=CH-CHf-CL
    "SANSS,  1989
    5969H
                                                                                         05/09/69

-------
    Log Kow:                1.603 (estimated by         U.S. EPA, 1987a
                                   GEMS)
    Conversion factor:      1 mg/m3 = 0.217 ppm
      (air at 20°C)         1 ppm = 4.614 mg/m3

1,3-Dlchloropropene hydrolyzes  In  water to form  3-chloroallyl  alcohol.   The
hydrolysis  half-life  Is  Independent  of   pH  and  Is  =11.3  days  at  20°C
(McCall. 1987).
1.3.   PRODUCTION DATA
    Current  production   figures  for  1,3-dlchloropropene  are not  available.
According  to the public  portion of  the  U.S.  EPA  TSCA Production  File  for
1977  (U.S.  EPA,  1977),  Dow Chemical  Co.  (Freeport,  TX) manufactured  10-50
million  pounds,  Shell  Chemical  Co.  manufactured  1-10  million pounds  and
Columbia Organic Chemicals  manufactured <1000  pounds 1n  1977.   Dow Chemical
(Freeport, TX) 1s listed as  the  sole current producer  of 1,3-dlchloropropene
(SRI, 1988).
    l,3-D1chloropropene  has  been produced  as  a by.-product  of ally! chloride
production  (Krljgsheld and  van  der  Gen, 1986), which Is  accomplished  by  the
direct  chlorlnatlon  of  propylene   (DeBenedlctls,  1979).   Other  by-products
formed  Include  3,3-dlchloropropene  and  1,2-dlchloropropane  (DeBenedlctls,
1979).   By-product  mixtures  of  l,3-d1chloropropene and  1,2-dlchloropropane
have been marketed as  a  fumlgant under the trade name  D-D  by Shell Chemical
Co. (Worthing and Walker, 1987;  Yang, 1986).
1.4.   USE DATA
    l,3-D1chloropropene  Is  used  as  a  soil  fumlgant and nematIcicle  (Worthing
and  Walker,  1987).   Several  different commercial  formulations  containing
1,3-d1chloropropene   have    been  marketed  as   a   fumlgant.   Telone   II
(marketed by  Dow Chemical)  Is widely  used  In  agriculture as a  soil fumlgant
5968H                                1-3                            07/25/89

-------
for  parasitic  plant   nematodes   (Yang,  1986).   Originally,  Telone   II
contained  *92X 1,3-dlchloropropene,  2% 1,2-dUhloropropane  and  5%  other
chlorinated propenes  and  hexenes  with  a IX addition  of eplchlorohydrln  as
stabilizer  (Yang,   1986).   Currently,   Telone   II*   1s  marketed  as   98%
1,3-d1chloropropene with no eplchlorohydrln addition (Albrecht,  1987a).   The
fumlgant  D-D  (marketed  by Shell  Chemical)  contained  roughly 50-80%  1,3-dl-
chloropropene and  20-40%  1,2-d1chloropropane with  several  percent of  other
chlorinated  compounds  (Krljgsheld  and^van  der-Gen,  1986;   Yang,   1986).
Fumlgants  marketed  under   trade names  Telone C,  Terr-0-C1de and  Terr-0-Gas
contained  either   Telone  II   or  D-D  with  additions  of  the   pesticide
chloroplcrln (Yang, 1986).
1.5.   SUMMARY
    1,3-D1chloropropene  Is  a  colorless  liquid  with the odor  of  chloroform
(Hlndholz,  1983).    It  occurs   1n   ds-  and   trans-lsomerlc  forms.   The
cls-lsomer has  a  slightly higher  vapor pressure than  the  trans-lsomer  (43
versus 34  mm  Hg),  but  the water  solubilities  are similar (2700-2800  ppm  at
20°C)  (Dining,  1977).   Current  production  figures for  1,3-d1chloropropene
are  not  available.  According  to  the  public  portion  of the U.S.  EPA TSCA
Production File for  1977,  two  U.S.  manufacturers  (Dow  and  Shell  Chemical)
produced a combined  total  of  10-60  million pounds  In 1977 (U.S. EPA,  1977).
1,3-D1chloropropene  has  been  produced   as  a  by-product of  allyl chloride
production  1n  conjunction  with  other   by-products,  such  as   3,3-d1chloro-
propene   and   1,2-dlchloropropane  (Krljgsheld   and   van  der   Gen,   1986;
DeBened1ct1s,    1979).    By-product   mixtures   of  1,3-dlchloropropene   and
1,2-dlchloropropane  have been  marketed  as  a  fumlgant  under  the trade name
D-D  by  Shell  Chemical  Co.   (Worthing  and  Walker,  1987;  Yang,   1986).
5968H                                1-4                            07/25/89

-------
1,3-Dichloropropene is used  as  a soil  fumigant and  nematlclde  (Northing  and
Nalker,  1987).    Several   different   commercial    formulations   containing
1,3-dichloropropene   have   been   marketed   as   a  fumigant.   Telone   II®
(currently marketed by Dow Chemical) 1s widely used  1n agriculture as  a  soil
fumigant for  parasitic  plant  nematodes  (Yang,  1986;  SRI,  1986).   Current
Telone   II®   formulations    contain   981   1,3-dichloropropene   (Albrecht,
1987a), although original formulations  contained only 92% (Yang. 1986).
5968H                                1-5                            06/21/89

-------
                     2.  ENVIRONMENTAL FATE AND TRANSPORT
2.1.   AIR
    1,3-Dlchloropropene 1s  degraded  In the atmosphere primarily  by  reaction
with  photocheroically  generated  HO*.   Reaction  with  ozone  will  contribute
to  Its  destruction  at a  much  slower  rate  than  reaction  with HO*.   Rate
constants  for  the  reaction of  ds-  and  trans-l,3-d1chloropropene with  HO*
have  been   experimentally  determined   to   be  7.7xlO~1JZ  and   13.0xlO~12
cm3/molecule-sec,  respectively,  at  22'C.  Assuming  an  average  atmospheric
HO-   concentration   of  5xl05   molecules/cm3,  the   respective  els-   and
trans-  half-lives  can  be   calculated  to   be  2.1 days  and  1.2 days.   Rate
constants for  the  reaction of els- and trans-l,3-d1chloropropene with  ozone
have  been   experimentally   determined   to   be   l.SxIO"19   and  6.7xlO~19
cm3/molecule-sec,  respectively,  at  22°C.  Assuming  an  average  atmospheric
ozone  concentration   of   7X1011  molecules/cm3,  the  respective  c1s-   and
trans- half-lives  can  be calculated  to be 67.4 days and 17.1  days.   Formyl
chloride and chloroacetaldehyde  have  been  Identified as  reaction  products  of
1,3-dlchloropropene  with   both   HO*   and  ozone  (Tuazon  et   a!.,   1984).
Reaction  with  ozone  also  yields  chloroacetlc  acid  formic  add,  hydrogen
chloride, carbon dioxide and carbon monoxide.
    Concentrations  of  10 and  2  ng/9. of  ds-  and  trans-1,3-dlchloropropene,
respectively, were  detected In rainwater   collected  1n  Portland, OR  In  1982
(Hazurek  and  S1monett1,   1986).  This  Indicates that   physical  removal  of
1,3-dlchloropropene from the atmosphere by wet deposition can occur.
2.2.   WATER
2.2.1.   Hydrolysis.   McCall   (1987)  studied   the  hydrolysis  of  "C-radlo-
labeled  1,3-dlchloropropene In sterile buffered water  at 10,  20 and  30°C.
The  rate of hydrolysis  was  Independent  of  pH  at  pHs  5,  7 and  9  and  was


6225H                                2-1                           07/25/89

-------
essentially  Identical   for   the  els-  and   trans-lsomers.    The  measured
hydrolysis  half-lives at  10,  20  and  30°C   were  51.  11.3  and  3.1  days.
respectively.  3-Chloroallyl  alcohol was Identified as a hydrolysis product.
2.2.2.   Photolysis.  Direct  photolysis Is  not an  Important  environmental
fate process with respect to  1,3-dlchloropropene (Mabey et al., 1981).
2.2.3.   Mlcroblal  Degradation.   Tabak  et  al.  (1981)  used a  static-culture
flask-screening procedure  utilizing  BOD dilution water  and  settled  domestic
wastewater  as  mlcroblal  Inoculum to deiermlne  that  1,3-dlchloropropene  1s
significantly biodegradable  with  gradual mlcroblal adaptation.  After  a  28-
day  Incubat.lon  period,  81-89% of Input 1,3-dlchloropropene  {5-10 mg/l)  was
blodegraded.
2.2.4.   Volatilization.    The Henry's   Law  constant  for  els- and   trans-
1,3-dlchloropropene  have  been  measured  experimentally  to   be  0.0012  and
0.0008  atm-ma/mol  at  20°C,  respectively  (Lelstra,  1970).   Henry's  Law
constants of  this magnitude   Indicate that volatilization from environmental
waters 1s probably  significant  (Thomas, 1982).  Using a  model  river  estima-
tion  method  (Thomas, 1982), the   volatilization  half-lives  of  els-  and
trans-l,3-d1chloropropene from a  river  1 meter  deep flowing  1 m/sec  with  a
wind  velocity  of  3  m/sec  can   be  estimated  to  be  =3.8  and  4.2  hours,
respectively.  The  volatilization half-lives  from  a  model environmental pond
can  be estimated  to be  =46  and 50 hours  (U.S.  EPA,  1986b).  Based  upon
these estimates,  volatilization from water Is  expected to be a major  process
for the removal of 1,3-dlchloropropene from the aquatic environment.
2.2.5.   Adsorption.   Experimental   data  pertaining  to  the  adsorption  of
1,3-dlchloropropene  to   aquatic   sediments  were  not  located;  however,  the
water   solubilities  of   2700-2800  ppm   (Dllllng,   1977)    suggest   that
partitioning from the water column to sediment may not be Important.


6225H                                2-2                            07/25/89

-------
2.3.   SOIL
    The fate  of 1,3-dichloropropene  In  soil  has  been extensively  studied.
The Important fate processes In soil  are briefly discussed below.
2.3.1.   Chemical Degradation.  The  els-  and  trans-1somers of  1,3-dichloro-
propene have  been observed  to hydrolyze In  wet soil  to form  corresponding
els- and trans-3-chloroal1yl alcohol  under  laboratory  conditions  (Castro and
Belser, 1966).   The  rate  of hydrolysis was observed  to Increase as the soil
content of aqueous  solutions  was  Increased.  -Other  studies  conducted  under
laboratory and  outdoor  conditions  have found  the 3-chloroallyl  alcohol  to be
the major  degradation  product of  1,3-dichloropropene  (Roberts  and  Stoydln,
1976).  Degradation  of  3-chloroallyl  alcohol  in soil  occurs  primarily  by
microbial   transformation  (McCall,  1987).   As  noted   in  Section 2.2.1,  the
hydrolysis   rate   of   1,3-dichloropropene   .Is   strongly   dependent   upon
temperature.   Therefore,  the  importance  of hydrolysis in  soil  will  depend
upon  moisture  content  and  temperature.   In warm  moist  soils,  hydrolysis
should be  relatively rapid  and a  dominant  removal  process;  however,  in dry
or cold soils, the importance of hydrolysis will be diminished.
2.3.2.   Microbial Degradation.  Although  1,3-dichloropropene 1s susceptible
to  degradation  by soil microorganisms (Krijgsheld and van  der Gen,  1986),
the relative  importance of  biodegradation  in  soil  has not  been  determined
with  certainty.   Experiments  specific   to   1,3-dichloropropene  involving
degradation in nonsterile soil versus  control  experiments  In  sterilized soil
are not available.  Results  of 1,3-dichloropropene transformation experiments
In  flower-bulb   fields  have  suggested that  microbes  In  fields  previously
exposed to the   compound  become  adapted to 1,3-dichloropropene  and are able
to  rapidly degrade   it  at low  input  concentrations   (12  ppm).   Half of the
compound degraded in <5 days (van  der Pas and  Leistra,  1987).
6225H                                2-3                            06/21/89

-------
2.3.3.   Volatilization.   Volatilization  Is  an  Important  physical  removal
process for  1,3-dlchloropropene  In soil.  The  amount  of 1,3-dlchloropropene
applied  to  soil   as  a  fumlgant  that  volatilizes  can vary  greatly  with
application  methods,  temperature,  moisture  content,  soil porosity  and  soil
organic content  (Albrecht  and Chenchln, 1985).   In experiments  performed In
Jars  to  trap  escaping  vapor,  a  major portion  of  the  1,3-dlchloropropene
applied to a soil  was observed to  evaporate  unchanged  from  the soil and  some
degradation  of   1,3-dlchloropropene   In, soil   was  detected   (Roberts   and
Stoydln,  1976).   It has also  been  reported  that commercial  applications  at a
depth  of  0.3  m  In  a  warm,  moist,  sandy  loam  soil  result  1n  evaporative
losses  of   only  5-10  percent  (Munnecke and  Van  Gundy, 1979;  Thomas  and
McKenry,  1974).
2.3.4.   Adsorption/Leaching.   1,3-D1chloropropene  can  occur  1n soil  as a
gas and as  an  aqueous  solution.   The adsorption characteristics of  each of
these  phases  Is   different.   Experimental  K    values  for  the  els-   and
trans-1somers  of  1,3-dlchloropropene  In aqueous solution are  reported to be
23-26  (Kenaga, 1980).   These KQC values  Indicate high mobility   In  soil
{Swann et  al., 1983}  and a  significant potential  for  leaching.   Although
leaching In  wet  soil   can  occur,   concurrent  hydrolysis and  blodegradatlon
should attenuate  the  amounts of  1,3-dlchloropropene  that may reach  ground-
waters.   Extensive  groundwater   monitoring  conducted  1n   California  have
demonstrated  that  field-applied  1,3-dlchloropropene   Is  not  significantly
contaminating well waters  (Maddy  et al., 1982;  Cohen, 1986).
    Vapor-phase 1,3-dlchloropropene  Is more strongly  adsorbed to  soil  than
the   dissolved  chemical   (Munnecke  and  Van   Gundy,   1979).    Vapor-phase
adsorption  has  been found to depend partially  upon organic content  of  the
soil  and  temperature.   Adsorption  Isotherms  Indicate   Increasing  adsorption
with  Increasing  organic  content.    Adsorption   at  2°C  1s   =3  times  higher
6225H                                2-4                            07/25/89

-------
than  adsorption  at  20"C.   Adsorption  Isotherms measured  for humous  sand,
peaty  sand   and   peat   Indicate  vapor-phase   Koc   values   of   ^450-750
(Lelstra, 1970).
2.3.5.   Persistence.  The  persistence of  1,3-dlchloropropene  In  soil  has
been measured by  a  number  of Investigators,  van der  Pas  and  Lelstra (1987)
observed half-lives  of 3-4  days  1n fields  used for  planting  flower-bulbs
with  only  very  small  amounts  remaining  after  periods £49  days.   Lelstra
(1970) reported  slower degradation-rates  of-0.035/day  (half-life  of  19.8
days)  In a  loam  soil and 0.01/day  (half-life  of 69 days) In-  sandy  and peat
soils.  Albrecht  (1987a) reported half-lives  of 3-25 days  at  20°C for  ds-
and  trans-l,3-d1chloropropene.    Twelve  weeks  after  radlolabeled  els-  and
trans-1,3-d1chloropropene was  applied  to soils  and stored  1n sealed  jars,
19%  of the  cls-isomer and  18%  of the  trans-i.somer  remained in a  sandy loam
soil while 10% of the  cis-1somer and  22% of  the trans-1 somer  remained  In  a
•edlum loam soil  (Roberts and Stoydin,  1976).
    As noted  previously,  the  removal  of  1,3-dlchloropropene  from soil  can
occur  from  hydrolysis, microbial degradation and volatilization.   Since the
rate  of  these processes can vary  significantly with  soil  conditions,  the
wide   range   of   reported   persistence   half-lives  demonstrates   that  the
persistence of 1,3-d1chloropropene 1n soil depends upon local  conditions.
2.4.   SUMMARY
     Degradation  of  1,3-dlchloropropene  in  the  ambient  atmosphere  results
primarily  by reaction  with  photochemically  generated  HO  (Tuazon  et al.,
1984).   Based upon  experimentally determined  rate constants (Tuazon  et al.,
1984), the half-lives  for  the reaction of ds- and trans-1,3-dlchloropropene
with  H0« In  air  are  «2.1  and  1.2   days,  respectively.   1,3-Dlchloropro-
pene   has   been   detected   In  rainwater   (Mazurek  and  Slmonetti,  1986),
6225H                                2-5                            06/21/89

-------
Indicating  that  physical  removal  by wet  deposition can  occur.   Hydrolysis
                                              •
and volatilization are  Important environmental  fate  processes  In  water.  The
rate of  hydrolysis has  been found  to be Independent of pH at  pHs  5,  7 and 9
and  to  be  essentially  Identical   for  the  els-  and  trans-1somers.   The
measured  hydrolysis  half-lives at  10,   20  and  30°C  were 51,  11.3  and  3.1
days,  respectively,  with  3-chloroallyl  alcohol  Identified  as a  hydrolysis
product  (McCall.  1987).    Volatilization  half-lives  of   3.8-4.2  and  46-50
hours have  been  estimated for a model river  (1  m 
-------
should  attenuate the amounts  of 1.3-
-------
                                 3.  EXPOSURE
3.1.   WATER
    1,3-Olchloropropene  has  been  Identified  In  a  very  limited  number  of
drinking  waters.   It  has  been  qualitatively  detected  In  New  Orleans,  LA
drinking water collected  1n  August 1974  (Dowty  et al.,  1975; Shackelford and
Keith, 1976).   Analysis  of  15 drinking  water samples from  Denver  collected
between  October   1,  1985  and March  31,  1986  did  not  detect  any els-  or
trans-1,3-d1chloropropene  at or  above detection  Tirolts  of  0.13  ppb (Rogers
et  al.,  1987).   1,3-Dlchloropropene  was  not  detected  (detection  limit  0.1
ppb)  In.42  raw and 42  finished  drinking  water samples  collected between July
1982  and  May  1983  from  nine municipalities along  the  Great  lakes (Otson,
1987).
    Trans-1,3-d1chloropropene  has  been   qualitatively  Identified   In  river
water  from  the Genesee  River and Mine  Creek,  which flow Into  Lake Ontario
(Great Lakes  Water  Quality  Board,  1983).   Extensive groundwater monitoring
for  agricultural  chemicals  In  California has  detected  cls-1,3-dlchloropro-
pene  1n  only  two groundwater samples  and trans-1,3-dlchloropropene In only
one  groundwater  sample  (Cohen,  1986).   By  comparison,  dlbromochloropropane
(another  soil  fumlgant)  was detected   1n   2522  groundwater  samples.   In
municipal wells  In  areas  of  California  where Telone or D-D  was  applied  for
>15   years   (54   wells,   65-1200  ft  deep),   1,3-dlchloropropene   was  not
detectable  In  any sample  at the quantification  limit  of  0.1 ppb  (Maddy  et
al.,  1982). c1s-l,3-01ch1oropropene  has  been  detected  In   municipal  solid
waste  leachate from  Wisconsin  (18  ppb)  and  In a contaminated  ground  water
adjacent to a  munlclple  landfill In  Minnesota  (Sabel and  Clark.  1984).  The
preliminary  findings  of  the U.S. EPA  Nationwide Urban  Runoff  Program  re-
ported the  detection of  1,3-dlchloropropene  (1-2 ppb)  1n stormwater  runoff


6226H                                3-1                             07/25/89

-------
from   Eugene,   OR  (Cole   et   al.,   1984).    Concentrations  of   1-8   ppb
trans-dlchloropropene have  been  Identified In raw  sewage  and effluents  from
sewage treatment plants (Lao et al., 1982).
    It  has  been  suggested that  chlorlnatlon  of  water   can  lead  to  the
formation  of  l,3-d1chloropropene  and  that  the  observed  presence of  1,3-
dlchloropropene  1n some drinking water  samples  after  treatment  may be due to
chlorlnatlon.    As  an  example,   the   effluent  from  municipal   wastewater
treatment  plants was  found to contain  hJgher amounts  of l,3-d1chloropropene
than the Influent wastewater (KMJgsheld and Van der Gen. 1986).
3.2.   FOOD
    Daft (1988)  examined  231  different ready-to-eat  foods  (collected  during
the  U.S.  Food  and   Drug   Administration's  Market  Basket  Survey)  for  22
fumlgants  and  Industrial  residues.  1,3-Dlchloropropene was  not  detected  In
concentrations >1 ppb 1n any of the food samples.
3.3.   INHALATION
    Atmospheric  monitoring data  for   1,3-dlchloropropene  are  limited.  1,3-
Dlchloropropene  was detected  In  2 of  11  air samples collected In  the  Baton
                                                  3
Rouge,  LA  area  at levels  of  a  trace  to  10  ng/m  (0.0022  ppb)  (PelUzzarl
et  al.,  1979).   A mean  dlchloropropene  level  (Isomers  not  specified)  of
0.071 ppb  was  detected  In  14 air  samples  collected at source dominated  areas
In Texas and  Louisiana;  source  dominated areas are areas  where the compound
Is produced  or used.  Dlchloropropene  was  not detected  (detection  limit  not
reported)  In  seven remote  air  samples  from the Grand  Canyon (Brodzlnsky and
S1nght 1982).
    Albrecht  (1987b)  studied  the  Inhalation exposure  of l,3-d1chloropropene
In  workers   Involved   In   applying   Telone  II    to  pineapple   fields   In
Hawaii. Exposures were predominantly found to be <1 ppm.
6226H                                3-2                            07/25/89

-------
    1,3-Dichloropropene is a  volatile  compound  and after soil  application as
a fumlgant, a fraction  of the compound will  volatilize  and escape  into  the
atmosphere (Krljgsheld  and van  der  Gen,  1986).  This  1s probably  the major
source of release to the atmosphere.
3.4.   DERMAL
    Pertinent  monitoring  data   regarding   the   dermal   exposure  of  1,3-
dichloropropene  were  not  located  in the  available  literature  cited  in
Appendix  A.  Dermal  exposure  1s  possible  to' workers  involved  in  fumlgant
applications of 1,3-dichloropropene.
3.5.   SUMMARY
    1,3-Dichloropropene  has   been identified  In  a  very  limited  number  of
drinking  waters.    It  has been  qualitatively detected  In  New  Orleans,  LA
drinking water collected  In August 1974 (Dowty et al.,  1975; Shackelford and
Keith,  1976).   Monitoring  studies conducted  in  Denver,   CO,  and  in  nine
municipalities along the  Great  Lakes, failed to detect  any  trace of  1,3-
dlchloropropene (Rogers  et al.,  1987;  Otson, 1987).   Extensive  groundwater
monitoring for  agricultural   chemicals  in  California (including  areas where
Telone and D-D had been applied for years)  has  detected 1,3-d1chloropropene
in  only  3  of thousands  of  samples  analyzed  (Cohen,   1986;  Maddy et  al.,
1982).   1,3-Dichloropropene   has  been  detected   in  leachate from  municipal
waste  landfills  and sewage treatment  plants (Sabel  and Clark,  1984;  Lao et
al.,  1982).   It  has been  suggested  that  chlorination of  water  can lead to
the   formation   of  1,3-dichloropropene  and  that   the  Identification  of
1,3-dichlofopropene  In  various  water  samples  may  be  due  to  chlorination
treatment  (Krljgsheld and  van der Gen, 1986).   Examination  of  231  different
ready-to-eat  foods  (collected  during  the  United  States  Food  and  Drug
Administration's  Market  Basket  Survey)   for 22 fumigants and  industrial
6226H                                3-3                            06/21/89

-------
residues  failed  to detect  any l,3-d1chloroprppene at  a detection  limit  of
«1  ppb (Daft,  1988).   The  major  source  of  1,3-dlchloropropene  release  to
the  atmosphere   Is  probably   volatile   losses   from  soil   following  soil
application  as a  fumlgant  (Krljgsheld  and  van  der  Gen,  1986).   Albrecht
(1987b)  studied  the  Inhalation exposure  of  1,3-d1chloropropene  In  workers
Involved  1n applying  Telone  II   to  pineapple  fields  1n  Hawaii and  found
exposures to be predominantly <1 ppm.
6226H                                3-4                            07/25/89

-------
                         4.  ENVIRONMENTAL TOXICOLOGY
4.1.   AQUATIC TOXICOLOGY
4.1.1.   Acute Toxic Effects on  Fauna.   Toxic effects from acute  exposure  to
l,3-d1chloropropene are  summarized  1n  Table 4-1  for  several  freshwater  and
saltwater  species  of   Invertebrates and  vertebrates.   Host  of  the  acute
toxldty  data   show   similar   sensitivity  between   the   blueglll,   Lepj>mU
macrochlrus.  and  the  water  flea,  Daphnla  magna. with  LC5_s  of 6.15  mg/a
(U.S.  EPA,  1978)  and  6.20 mg/i  (LeBlanc,   1980,- 1984;  Buccafusco  et  al.,
1981).   The  one  exception  1s  a  very  low  value  (LC5Q =  0.09  mg/8.  In  j).
magna)  reported  by Johnson  and  Flnley  (1980).   The  most  sensitive  resident
species  of  fish  was  the  walleye,  StVzostedlon  vltreum  (LC5Q = 1.08  mg/l
(Johnson  and   Flnley,   1980).    Comparable   data  on   the   guppy,   Poecllla
retlculata.   were  not   located,   but  the  14-day  LC--  value  of   4.57  mg/l
(Hermens et al.,  1985) was,  as would be  expected,  lower  than  the shorter-term
acute  values  for species  stated  above.   It  appears  that  l,3-d1chloropropene
Is more  toxic to saltwater  than  to  freshwater  Invertebrates,  and  that  mysld
shrimp,  Hys1dops1s  bahla.  with  an  LC,n  of  0.79   mg/l,  (U.S.EPA,   1978;
          	  	               ijU
LeBlanc, 1984),  are affected by  lower   concentrations of  1,3-d1chloropropene
than  are sheepshead  minnows,  CyprlngdQn varlegatus  (1.77-1.80  mg/l,  U.S.
EPA, 1978;  He Urdu Her et al., 1981).
4.1.2.   Chronic Effects on Fauna.
    4.1.2.1.     TOXICITY -- Chronic toxldty data have  been  reported for  the
fathead minnow, Plmephales promelas. and mysld  shrimp, Hysldopsls  bahlj  (U.S.
EPA,  1978).   An  embryolarval test of  the  toxldty of 1,3-dlchloropropene  to
fathead  minnows  revealed   a NOEC  of   180  yg/l  and a LOEC  of  330  yg/l.
Chronic  toxldty  data  on  saltwater  fauna  are  limited to a  life-cycle  study
6227H                                4-1                              07/25/89

-------
                                                Acute Toxicity of 1,3-Dichloropropene to Aquatic Fauna
Species
F reshwater fauna
Daphp j a magna
Q. magna
b. magna
Pimeohales
promelas
lepomi s
macrochirus
L- macrochirus
"^ t'etroinvzon
«"»> mar i mis
Sal mo gairdneri
Microotertis
sal mo ides
vitreum v i treum
Poecilla
Ld_us idu&
melanotus*
Common Name

water flea
water flea
water flea
fathead
minnow
bluegill
bluegill
1 anprey
(larvae)
rainbow trout
larqemonth
bass
walleye
guppy
golden orfe
Test Type

NR
static acute
static acute
static acute
NR
static acute
NR
static acute
static acute
static acute
static, renewal
static acute
Du ra t i on/Endpo i n t

48-hour EC ;,„
48-hour ECr.0
48-hour EC so
96-hour LCio
96-hour LC^o
96-hour LC50
24 hours
96-hour LCi0
96-hour LCso
96-hour LCSO
14-day LC50
96-hour LCSO
Concentration,
(95% Confidence Limits)
(tng/e)

6.15 (4.33-8.99)
6.20 (4.3-9.0)
0.09 (0.063-0.13)
4.10 (3.29-4.47)
6.06 (5.14-6.82)
6.10 (5.1-6.8)
NR
5.90
3.65 (3.52-3.78)
1.08 (0.99-1.18)
4.57 (NR)
0.9 (0.8-1.1)
Temperature

NR
22±1
NR
NR
NR
22±1
NR
NR
NR
NR
NR
20
No Effect Level
(mg/e)

0.41
0.41
NR
NR
<3.6
Nft
5.0
NR
NR
NR
NR
0.63
Reference

U.S. EPA. 1978;
LeBlanc. 1984
LeBlanc, 1980
Johnson and
Finley, 1980
Johnson and
Finley, 1980
U.S. EPA, 1978;
LeBlanc, 1984
Buccafusco et
al., 1981
Applegate et
al., 1957
Schneider, 1979
Johnson and
Finley. 1980
Johnson and
Finley. 1980
Hermens et al . ,
1985
Reiff, 1978
6149H
06/26/89

-------
                                                                         4-T (cont.)
Species
Mixed group of
Ni tropis,
atherinoide.s.
and
P. oromelas
Saltwater fauna
Mysidopsis
bahia
Cyprinodon
varieoatus
£. Varieqatus
Common Name
emerald shiner
fathead minnow

mysid shrimp
sheepshead
mi nnow
sheepshead
minnow
Test Type
NR
NR

static acute
static acute
static acute
Duration/Endpoint
3-day 100% lethality
3-day 0% lethality

96-hour LC5(>
96-hour LC.,0
96-hour LCio
Concentration
(95% Confidence Limits)
(mg/tf)
NR

0.79 (0.62-0.98)
1.77 (0.71-4.49)
1.80 (0.7-4.5)
Temperature
CO
NR

NR
NR
25-31
No Effect Level Reference
(mq/e)
NR Scott and
Wolf. 1962

0.37 U.S. EPA, 1978;
LeBlanc, 1984
<1.22 U.S. EPA, 1978;
LeBlanc. 1984
1.2 Heitmuller et
al.. 1981
"Not a resident of U.S.  waters
 NR - Not reported
6149H
06/26/89

-------
mysld  shrimp,  Hysldopsls  bahla.  1n  which  a  NOEC  of  2200 yg/l  and  a  LOEC
of 4200 ug/l were reported (U.S. EPA, 1978).
    The  effects   of   the  pesticide.  Shell -DD,  on  rhythmic  adductor  muscle
activity  of the  freshwater  mussel, Anodonta  cygnea.  were  Investigated  by
Varanka  (1979).    Shell-DD,  which  contains  two  active  Ingredients  (1,3-
dlchloropropene  and   1,2-dlchloropropane),  caused   50%  Inhibition  of   the
tryptamlne-lnduced  activity  at  a  concentration  of  2xlO~2   mi  test  com-
pound/a. water.   The concentration of 1,3^1 chloropropene was not reported.
    4.1.2.2.   B1oaccumulat1on/B1oconcentrat1on  --  Pertinent  data  regarding
the  bloaccumulatlon/bloconcentratlon  potential   of  1,3-dlchloropropene   In
aquatic fauna were not located In the available  literature cited  In Appendix
A.  Predicted  bloconcentratlon  factors  of 7 (based on  water solubility)  and
1   (based   on   octanol/water   partition   coefficients)  calculated   for
1,3-dlchloropropene by  Kenaga  (1980) suggest  that  this  compound will  not  be
accumulated by aquatic organisms.
4.1.3.   Effects  on Flora.
    4.1.3.1.   TOXICITY -- Toxlclty  of  1 ,3-dlchloropropene to  aquatic plants
has been reported  for one freshwater alga and  one  saltwater alga.   A 96-hour
EC5Q  of  4950  jig/8.   was   determined   for  Selenastrum   caprlcornutum  (U.S.
EPA,  1978;  LeBlanc,   1984).   In  this  same  species,  a  96-hour   EC5Q  (reduced
cell division) of 4960 pg/i was reported In the same study.
    The  saltwater  alga,  Skeletonema  CQitaJum.  has a  96-hour  EC5Q  of  1000
      when   treated   with  1,3-dlchloropropene  (U.S.  EPA,   1978;   LeBlanc,
1984).   The  96-hour  EC5Q  for   cell  division  1n  this  same  species   was
reported as 1040 vq/l by the U.S. EPA (1978).
6227H                                4-4                             07/25/89

-------
    4.1,3.2.    BIOCONCENTRATION  --  Pertinent  data  on  the  bloconcentratlon
potential  of  1,3-dichloropropene  In  aquatic  flora were  not located  1n  the
available  literature cited in Appendix A.
4.1.4.   Effects   on  Bacteria.   Scott  and  Wolf  (1962)   examined   the  anti-
bacterial  activity  of  1,3-dichloropropene 1n  dilute  aqueous  solutions  and
found that  40% aqueous solutions  lost much of  their  antimicrobial  activity
when stored  at room temperature for 90  days.   The same products  In  the solid
state  were   stable  at   storage   temperatures   of   <40°C  for   >90   days.
Concentrations of 0.50% 1,3-dlchloropropene  killed  samples of Aerobacter  sj>.
1n  21  hours,  and  1.07.  concentrations killed  Pseudomonas  s_£.  In  21  hours.
These  lethal  concentrations  are  considerably  higher than  those  that  are
lethal to higher  aquatic species.
4.2.   TERRESTRIAL TOXICOLOGY
4.2.1.   Effects  on Fauna.   Abivardi  (1970)  tested the nematocidal  effects of
solutions  of  two  commercial  nematicides,   1,3-D  and  Telone  (content  of
1,3-dichloropropene  not  reported)  under  controlled   laboratory  conditions.
Half-cc samples  of  400,   800 and  1200  ppm  active  material   in   water  and
containing  50   active  larvae  of   Pratylenchus   hamatus   and  Tylenchulus
semipenetrans  were added   to spot  plates  covered  for   24  hours  and  then
examined.  Mortality was- 100%.
4.2.2.    Effects on  Flora.   Toxlclty of  the  commercial   product,  1,3-D (98%
1,3-dichloropropene)  to mlcrosclerotia of the fungus, Verticil 11 urn dahliae.
was tested by Ben-Yephet et  al.  (1981)  in  sealed containers  of  air and soil.
A  concentration   of  20  \>.q/m£  1.3-0  1n   air  killed  100%  of  the  mlcro-
sclerotia after   30  hours   Incubation,  and  100  yg/g  1,3-D  Induced  total
lethality of the  organism 1n  soil Incubated for 3 days.

6227H                                4-5                             06/21/89

-------
4.3.   FIELD STUDIES
    Edwards and  Relchle  (1969)  applied the  soil  fumlgant,  dlchloropropene,
D-D  (concentration  of  dlchloropropene  not  reported)  In  an  Ui  sVtu  field
experiment on  soil  systems.  Approximately  170 cc/m2  of  D-D was applied  to
a plot of  soil  with an Injection gun; the soil was  then covered with  plastic
sheeting  for  2 weeks.   D-D fumigation  eliminated  the earthworm,  Lumbrlcus
terrestMs. and  reduced the mlcroarthropod  population  (Dlpter and  Coleopter
larvae)  by  98.3%.   Costante  et  al. _(1987)  Injected   Telope  C-17   (74%
1,3-dlchloropropene and  16.5% chloroplcMn)  Into  soil  at  374 8,/hectare and
noted  significantly reduced populations  of  Pratylenchus  penetrans  after  50
and  156  days  posttreatment.    Another  report describing  the   nematlcldal
activity  of  DO, a  commercial  pesticide  containing  1,3-dlchloropropene, was
located, but the percentage of active  Ingredient was not quantified  (Blackmon
and Musen, 1974).
    Kotcon and  Lor la  (1987) applied  a fumlgant containing 94% 1,3-dlchloro-
propene at  0,  94,   117  or  140  l  of  formulated compound/hectare  to plots  in
two  commercial  potato  fields  and noted significant  reduction of nematodes,
Pratylenchus crenatus. within 2  weeks  at all levels of treatment.   Mortality
was <96% with application of 140 l/ha.
    Hathur  et  al.   (1980)  tested  two  commercial  products  that   contain
1,3-dlchloropropene,  Telone  II   and  Telone  C17,  on organic  field  plots  of
carrots  and  noted  Increased numbers  of  fungi,   bacteria  and acUnomycetes
between 0  and  28  days.  The concentration  of  1,3-dlchloropropene applied  to
these plots was not reported,  however.
    Cook  et  al.  (1987) tested  the  funglcldal  properties  of  1,3-dlchloropro-
pene combined  with  17% chloroplcrln  In wheat  field plots  and noted  95-100%
6227H                                4-6                             07/25/89

-------
elimination of  Inoculum  (population  of  Pythlum spp.  at start of test was >300
propagules/gram of soil).
4.4.   AQUATIC RISK ASSESSMENT
    The  lack  of pertinent data  regarding  the effects of  exposure of aquatic
fauna  and  flora  to  1,3-dlchloropropene  precluded  the  development  of  a
freshwater  criterion  (U.S.   EPA/OWRS,  1986)  (Figure 4-1).   Available  data
Indicate  that  acute  toxic effects can  occur at concentrations  >1.08 mg/l In
freshwater,  and  that  chronic  effects ..can   occur  at  concentrations  >0.33
mg/l.    Additional   data  required  for  the  development   of   a  freshwater
criterion  Includes  the results of acute  assays  with  benthlc  crustaceans, an
Insect,  a  nonarthropod and nonchordate species and  an Insect  or species from
a  phylum  not  previously  represented.   The  development  of  a  freshwater
criterion also  requires  data  from chronic toxldty  tests  with  two species of
fauna and at least one bloconcentratlon study.
    The  lack  of pertinent data  regarding  the effects of  exposure of aquatic
fauna  and  flora  to  l,3-d1chloropropene  precluded  the  development  of  a
saltwater  criterion  (U.S.  EPA/OWRS,   1986)   (Figure  4-2).   Available  data
Indicate  that  acute  toxic effects  can occur at  concentrations  >0.79  mg/i,
and  chronic  toxic  effects  at  concentrations  >4.20  mg/s..   Additional  data
required for the  development  of a saltwater criterion Include  the results of
acute  assays  with  one  chordate  species   a  nonarthropod  and  nonchordate
species,  two additional nonchordate species,  and  one  other  species of marine
fauna.   The  development  of   a  saltwater  criterion  also  requires data  from
chronic  toxlclty  tests   with  two   species  of  fauna   and   at   least  one
bloconcentratlon study.
6227H                                4-7                             07/25/89

-------
Farni ly
#1
Chordate (Salrnonid-f ish)
Chord ate (warrnwater fish)
#3
Chordate 
-------
Fami ly
#1
Chordate
#£
Chordate
#3
riori— flrthropod/— Chordate
Crustacean (Mysid/Panaeid)
#5
non— Chordate
#6
non-Chordate
#7
non-Chordat e
#8
other
#9
algae
#10
Vascular plant
TEST TYPE
GMflV GMCV*
1 . 76» Nfl
Nfl Nfl
Nfl Nfl
0.79- £. SO*
Nfl Nfl
Nfl Nfl
Nfl Nfl
Nfl Nfl
XXXXXXXXXXXX
XXXXXXXXXXXX l.O«
XXXXXXXXXXXX
XXXXXXXXXXXX Nfl

BCF«
Nfl
Nfl
Nfl
Nfl
Nfl
Nfl
Nfl
Nft
Nfl
Nfl
 •NA-Not available; "mean 96-hour LC,0 for sheepshead minnow, Cyprln-
odon varleqatus: e96-nour LC50 for mysld shrimp, Mysldopsls bahla;
 TTfe-cycle  NOEC  for   mysld  shrimp,   M.  bahla:  e96-houf~EC50  for  the
 alga, Skeletonema costatum. based on chlorophyl a content.

                                 FIGURE  4-2.

Organization Chart  For  Listing GMAVs,  GMCVs  And BCFs Required To  Derive
Numerical  Hater  Quality Criteria  By The Method  Of U.S.  EPA/OWRS  (1986)  To
Protect Saltwater Aquatic Life From Exposure To 1,3-D1chloropropene
6227H
                                     4-9
06/26/89

-------
4.5.   SUMMARY
    Data  are  available  on  the  acute  toxlcUy  of  1,3-dlchloropropene  to
several  species  of Invertebrates  and  vertebrates.  As  shown 1n  Table  4-1,
96-hour  LC5Q  values   reveal   a   similar  range  of  sensitivity  among   six
freshwater  fish  species  native  to U.S.  waters  (Applegate  et  al.,  1957;
Buccafusco  et  al., 1981;  Hermens  et  al.,  1985;  Johnson  and Flnley,  1980;
LeBlanc,  1984;  Schneider,  1979;  U.S.  EPA,  1978).  A  seventh species,  the
walleye,  j>. yltreum  vltreum.  showed  markedly  greater  sensitivity,  with  a
96-hour  LC50  of 1.08  ppm.  The  water  flea,  EL magna. (Leblanc,  1980,  1984;
U.S.  EPA,  1978)  showed  a  sensitivity  comparable  with  that of the  blueglll
sunflsh, L. macrochlrus.  the  least sensitive  of the freshwater fish  species
tested  {Buccafusco, 1981;  LeBlanc, 1984; U.S.  EPA,  1978).   1,3-dlchloropro-
pene  Is more acutely  toxic  to  the saltwater Invertebrate,  M.  bah la (LeBlanc,
1984;  U.S.  EPA,   1978),  than  to  the  freshwater  species,   D.  magna.   The
sheepshead  minnow,  £.  varlegatus. a saltwater  fish,  1s  highly sensitive  to
1,3-dlchloropropene (mean 96-hour LC™  =  1.76  ppm)  (LeBlanc,  1984).
    Chronic toxlclty  tests  of  1,3-dlchloropropene  to the  fathead  minnow,  £.
promelas.  and  mysld  shrimp,  H_.. bahla.  revealed  NOECs  of  0.18  ppm and  4.2
ppm, respectively (U.S. EPA, 1978).
    Data  regarding the  toxlclty  of  1,3-dlchloropropene  to  aquatic  flora
follow a  similar  pattern to that for aquatic  fauna.  The  saltwater  alga,  S.
costatum.  has  a  mean  96-hour EC50  of  1.01  ppm  (LeBlanc,  1984; U.S.  EPA.
1978);  the freshwater alga,  S.   caprlcornutum.  has a mean  96-hour EC5Q  of
4.95  ppm  (LeBlanc,  1984; U.S.  EPA, 1978).  Data on  effects  of 1,3-dlchloro-
propene  on bacteria  Indicate  that Aerobacter  s_£. and  Pseudomonas sj>.  are
more  resistant to  the  compound  than  are  higher  aquatic species  reported
above.
6227H                                4-10                            07/25/89

-------
    Studies on the bloconcentratlon/bloaccumulatlon  potential  of  1,3-dlchlo-
ropropene  1n  aquatic  fauna  and  flora  were  not  located  In  the  available
literature, but  BCFs  of 7  (based on  water  solubility)  and 1  (based on  KQW)
were predicted for this compound by  Kenaga (1980).
    Data   support   1,3-dlchloropropene1s  effectiveness   as   a   nematodde
(Ablvardl, 1970;  Blackmon and Musen,  1974; Costante  et  a!.,  1987,  Kotcon and
Lorla, 1987) and Us  toxldty to the  earthworm, Lumbrlcus  terrestrls. and to
Dlpter and Coleopter  larvae (Edwards andJtelchle,  1969).
    Data  regarding  the effectiveness of  1,3-dlchloropropene  for  control  of
soil  microorganisms  are  equivocal.   Nathur  et  al.  (1980)  noted  Increased
numbers of fungi, bacteria and actlnomycetes after treating field plots  with
the  chemical,  but   Cook   et  al.   (1987)  noted  95-100%  elimination  of a
population of  Pythlum spp. with  1,3-dlchloropropene.
    The  lack  of  pertinent data  regarding  effects  of  exposure  of aquatic
fauna  and  flora   to  1,3-dlchloropropene   prevented  the  development   of
freshwater or  saltwater criteria.
6227H                                4-11                             07/25/89

-------
                             5.  PHARHACOKINETICS
5.1.   ABSORPTION
    The   absorption   of   1,3-dlchloropropene   during  head-only   Inhalation
exposure  to  30,  90,  300 or 900  ppm  (49.3% ds- and 42.8% trans-l,3-d1chloro-
propene  and  =8 minor  contaminants)  for 3  hours  was determined In male F344
rats  (Stott   and  Kastl,  1986).   The  average  amounts of  1,3-d1chloropropene
absorbed  by  the  rats  exposed to 30, 90,  300  and 900 ppm were  =14  mg/kg (82%
of  the available  vapors  absorbed),  29 -mg/kg  (65% absorbed),  85  mg/kg (66%
absorbed) and  171 mg/kg (62% absorbed),  respectively.  -The rate of  absorption
1s  calculated  to  be  144,  307,  880 and  1810 nmol/mln for  the 30, 90,  300  and
900  ppm  exposure levels,  respectively.   The  nonllnearlty In absorption rate
and  absorbed  dose  with  Increasing concentration   may  have been  due  to  a
concentration-related  decrease  1n  the  respiratory  ventHatory frequency  In
rats  exposed  to  >90 ppm and to  the  saturation of  metabolism of the  compound
1n  rats   exposed  to  >300  ppm.  As  determined  1n   Isolated   upper  and  lower
respiratory  tracts  from rats  exposed  to 90  or 150 ppm, absorption  occurred
mainly through  the  lower  respiratory tract  (calculated  to  be =73  and 79% of
the  total  amount  absorbed at  90 and  150 ppm,  respectively).  A small amount
was  also  absorbed by the  nasal  mucosa.   Blood levels of  1,3-dlchloropropene
suggested that 1,3-dlchloropropene  1n  the  blood  reached  a  steady  state with
both  the  els- and trans-1somers  within  60 minutes  of exposure  at  30 and  90
ppm and within 2 hours at  300 ppm and within =3 hours at 900  ppm.
    Hutson et  al.  (1971)  treated Carworth Farm E rats by gavage with  c1s- or
trans-l,3-d1chloro(2l4C)propene  In  arachls  oil  at doses  of  =11.2  or   12
mg/kg,  respectively.   After  24  hours,  =80-84%  of  the  administered radio-
activity  from  either  Isomer   was  excreted   In   the  urine   or   as  14CO?,
Indicating that >80% of the dose was absorbed  by  the gastrointestinal  tract.
6228H                                5-1                               7/25/89

-------
Similar results were obtained by  Cllmle  et  al.  (1979)  In rats and by D1etz et
al.  (1985)  (Sections 5.3  and  5.4).  Absorption  through the skin  of rabbits
occurred when  1,3-dlchloropropene was applied  In  propylene  glycol solution or
when  evaporation  was  retarded  with  a  cuff  (Torkelson  and  Oyen,  1977;
Torkelson and Rowe, 1981).
5.2.   DISTRIBUTION
    The  relationship  between  Inhaled  1,3-dlchloropropene  and  the  tissue
levels  of  reduced  glutathlone,   which  Indicates i,3-dlchloropropene metabo-
lism,  was  assessed  (Fisher  and  Kllgore,  1988a; Fisher,  1988).  The  gluta-
thlone content  was measured 1n the heart,  kidney,  liver,  lung,  nasal  mucosa
and  testes  of  male  Sprague-Dawley  rats  exposed  to 0,  1.8,  4.5, 33,  306.1,
771.8,   954.6   or   1716   ppm  Telone   II    (94%  1,3-dlchloropropene   with
approximately   equal   concentrations  of   the  els- and   trans-lsomers   and
epoxldlzed soybean oil as  the stabilizing agent)  for  1  hour.   The decrease 1n
glutathlone  was  exposure-related.   At  the 4.5  ppm  level,  a   decrease  was
observed In the nasal mucosa.  Liver  glutathlone  was  depleted In an exposure-
related  manner  at  levels  >306  ppm.  At  exposures  <955  ppm, the content  of
lung  glutathlone   remained  relatively  constant  at  =75%  of  control  levels.
Only  at  1716 ppm  did  the glutathlone  content  significantly decrease  In  the
heart, liver and  testes.   No 1,3-dlchloropropene  was  detected In the blood of
animals  2  hours  after  exposure  to  <955  ppm.   These  data  Indicate that  a
substantial  portion  of the  Inhaled  1,3-dlchloropropene  Is metabolized to  a
glutathlone conjugate In  the  nasal  mucosa and  1s subsequently  transported  to
the blood.
    D1etz  et  al.   (1985)  measured  the NFS  (the majority  of  which  1s  gluta-
thlone}  content of  tissues  and  covalent  binding  to  macromolecules of  the
forestomach, glandular stomach,  liver,  kidney and urinary  bladder of rodents


6228H                                5-2                              7/25/89

-------
treated wHh  l,3-d1chloropropene.   Hale F344  rats  and male B6C3F1  mice were
fed  a single  oral  dose  of  14C-l,3-d1chloropropene.   For  the NFS  studies,
the  doses  were  0,  1, 5, 25, 50 or  100  mg/kg;  for  binding studies,  doses were
0, 1,  50  or 100 mg/kg.   Significant  depletion of NPS  levels  occurred  In the
forestomach of  rats  and mice  at >25  mg/kg,  with a depletion  range  of  17-51%
of control  values.  NPS  levels In   the  glandular  stomach  and  liver  were also
depleted  In a  dose-dependent manner  but at  a  less  severe  level.   Limited
macromolecular  binding  was  noted In  the. liver, kidneys  and urinary  bladder,
and  was greatest at  doses  that caused the most depletion  of tissue NPS  In the
forestomach  and  glandular  stomach.    These   results   also  Indicate  that  a
substantial conjugation  occurs In  the  stomach after  oral  dosing and  before
distribution to other tissues.
     Dletz   et   al.   (1985)   fed  a   single  oral  dose  of  1   or   50   mg/kg
14C-ds,trans-l,3-d1chloropropene  to  male F344 rats   and 1  or  100 mg/kg  to
male  B6C3F1 mice.   Urine, feces and  expired  air were  collected for  48  hours
after dosing, and  the rats were  then  sacrificed.   The  tissues  and  the carcass
were  analyzed   for  remaining  radioactivity.   Only 2-6%  of the  administered
dose  remained  In  the carcasses of  both species 48 hours after  dosing.   Host
of  the  radioactivity  was   excreted  1n  the   urine,   feces  and  expired  air
(Section 5.4).  Similarly, Hutson et  al.  (1971) found  <5X of  the administered
oral   dose  of 11.2 or  12  mg/kg 1,3-d1chloro(214C)propene  1n  the gut,  feces
and  skin and carcass 4 days after dosing.
5.3.    METABOLISM
    Hutson  et  al.   (1971)   administered  =11.2  or    12  mg/kg  of  els- or
trans-l,3-d1chloro(214C)propene, respectively,  to  rats  by  gavage  and  found
differences  In  metabolism  between  the  Isomers  (see  Section  5.1).   In  the
first 24 hours, 80-90% of  the  radioactivity dose  was  eliminated.  Most of the

6228H                                5-3                              7/25/89

-------
radioactivity  was  excreted  In the  urine;  80.7%  of  the  radioactivity  from
ds-l,3-d1chloropropene   and   56. 5X   from   trans-l,3-d1chloropropene   was
recovered  from  urine  within  the  first  24  hours.   The  amount  of  14C02
excreted was  different for the two  Isomers;  3.9 and  23.6%  of the dose  from
the  14C-c1s-   and   trans-lsomers,  respectively,   were  excreted  as   ^CO^
within  4  days.   A small amount of l,3-d1chloropropene was  exhaled  unchanged
    When  rates  of  degradation  of  the  trans-lsomer  and  the cH-1somer  were
compared  J[n  vitro,  the  ds-1somer  degraded  4-5   times   faster   than   the
trans-lsomer, with  absolute  rates of 4.9  and  1.0 nmol/mlnute/mg cytosol  for
els- and trans-lsomers, respectively (Cllmle et a!.,  1979).
    Two female  Wlstar  rats were  given  a  single oral dose of  cls-1 ,3-dlchlo-
ro(214C}propene of  20  mg/kg  body weight  In corn  oil  (Cllmle et a!.,  1979).
Eighty-two to 84%  of  the radioactivity appeared In  the urine within  24 hours
after  treatment.   Host  of the  urinary radioactivity  (92%) was  present  as
N-acetyl-S-[c1s-3-chloroprop-2-enyl]  cystelne   (ds- dlchloropropene   mercap-
turlc add or 3C-NAC),  as determined by comparative chromatography procedures.
    When cls-dlchloropropene  (O.lmH) was Incubated at  37°C  in vitro  with  rat
liver   supernatant   (3.55   mg  protein/ml)  containing   glutathlone   S-alkyl
transferase  and added  glutathlone  (5  mM), no  substrate remained  after  10
minutes  (Cllmle et  al.,  1979).   When glutathlone  was  omitted, 72% of  the
substrate  was  recovered.   Therefore,  It  appears  that  the  rapid   urinary
elimination  of   radioactivity  from rats  given  cls-1 ,3-d1chloro(14C)propene
Is due  to  an  efficient  glutathlone-dependent b1otransformat1on.  The  compound
conjugates  with glutathlone,  enters  the   mercapturlc  acid  pathway  and  Is
excreted  In  the urine  as  N-acetyl-S-(3-chloroprop-2-enyl ) cystelne,  3C-NAC.
6228H                                5-4                              7/25/89

-------
Studies done by Fisher  (Fisher,  1988;  Fisher  and Kllgore,  1988a) (see Section
5.2)  Indicated  that, following  Inhalation  exposure, a  substantial  amount of
l,3-d1chloropropene  was  metabolized to  the less  toxic  glutathlone conjugate
1n  the  nasal mucosa, was transported to  the  bloodstream and was subsequently
degraded to the mercapturlc acid form and excreted 1n the urine.
5.4.   EXCRETION
    In a previously  described  study  (see  Section 5.1),  Stott and Kastl (1986)
determined  that,  following  Inhalation in  rats  of  30,  90, 300  or  900  ppm
1,3-dlchloropropene, both  the  els- and trans-1somers were  rapidly  eliminated
from  the  blood  1n a blphaslc  manner  1n  rats  exposed to <300 ppm.   The  rapid
elimination phase had a half-life of 3-6 minutes, and  the  slower  elimination
phase  had  a   half-life  of  33-43  minutes.   In  rats   exposed  to  900  ppm,
1,3-dlchloropropene  was  also  eliminated  blphaslcally,  but   the  Initial  phase
was longer, with a half-life of 14-27 minutes.
    Fisher  and  Kllgore  (1988b)  determined   the  relationship  between  the
concentration  of   Inhaled   1,3-dlchloropropene   (Telone II   -94%  1,3-dl-
chloropropene  In  approximately  equal  concentrations of  the els- and  trans-
Isomers, stabilized  by  epoxldlzed soybean  oil)  and  the urinary excretion of
the mercapturlc acid of ds-l,3-d1chloropropene  In  male  Sprague-Dawley  rats.
The rats  were  exposed  for  <1  hour to 0,  284,  398  or  789  ppm and  urine  was
collected for <24 hours  after  exposure.   The  quantity  of the mercapturlc acid
found In the urine was  concentration-dependent  from  0-284 ppm,  but  the amount
did not  Increase  at the  398 or 789 ppm  exposure levels.   It  was  postulated
that  the nonllnearlty at  the higher concentrations may  be a result  of changes
1n  the   absorption  of   1,3-dlchloropropene,   which   are   due  to  altered
respiration rates  at the  higher levels.   Stott  and Kastl   (1986)  found that
absorption  of  1,3-dlchloropropene  was  not linear  with Increasing  exposure


6228H                                 5-5                               7/25/89

-------
concentrations  because  of decrease  In  the respiratory  ventilation frequency
that   are   exposure-related,   and   to  the   saturation  of   metabolism  of
1,3-dlchloropropene  (see  Section  5.1).   Osterloh et al.  (1984)  monitored the
quantity of  the mercaptuHc  add  found 1n  the 24-hour  urine  collections  of
agricultural workers  exposed to 1,3-dlchloropropene  (=0.4 ppm  for  3 hours).
A  linear  relationship was found between exposure  to  1,3-dlchloropropene (the
product of airborne concentrations and  duration  of  exposure)  and excretion  of
the  metabolite, 3C-NAC  (see Section  5.J3.).    The. amount  of  the  metabolite
excreted  1n  the urine  by the  rats  (exposed  to a  high concentration  for  a
short  period  of time)  In the  Fisher  and  Kllgore (1988b)  study  (2-59  jimol
3C-NAC/24 hours) was  similar to the  amount  excreted by  agricultural  workers
(exposed to a  low  concentration for a  longer  period of  time) In the Osterloh
et al. (1984) study (4-36 ymol 3C-NAC/24 hours).
    In  the  previously described study  by Hutson  et  al.  (1971)  {see Section
5.1),  the excretion  by  rats  of radioactivity  as a  percentage of the adminis-
tered  oral   dose   of  11.2 mg/kg  or  12  mg/kg  of  ds- or  trans-1,3~d1chlo-
ro(214C)propene, respectively,  was determined for urine,  feces and  expired
air.   Measurements were  taken at  24-hour Intervals over  a  4-day period.   The
animals were sacrificed  after the  fourth day  following  the  administration  of
the  labeled compounds,   and  radioactivity  remaining   In  the  carcasses  was
measured.  Excretion data are summarized In Tables  5-1  and 5-2.  As seen from
Table  5-1,  most of  the  radioactivity  was excreted  In  the  urine; =80% and
55X of administered  dose  of  els- and  trans-1,3-dlchloropropene, respectively,
was eliminated during the first 24  hours.
    When oral   doses  of  14C-c1s  or  trans-1,3-dlchloropropene  were given  to
male  F344  rats (1 or  50 mg/kg) and  to male  B6C3F1  mice  (1 or 100  mg/kg),
urinary excretion was the major route of elimination after 48 hours (Dletz  et


6228H                                5-6                              7/25/89

-------
                                                         T&RI F *_1
                                       Rates  of Excretion of Radioactivity After Oral
                                           Administration of  1,3-D1chloropropene
U1

-J
Excretion of Radioactivity (1 of administered dose) In 24-Hour
Periods (hour after administration)"
Compound



cls-1 ,3-D1ch1oropropene
trans-1 ,

3-Dtchloropropene

cls-1 ,3-D1chloropropene
trans-1 ,
3-D1ch1oropropene
Sex

M
F
M
f

M
F
M
F
0-24

81.3+2.76
80.3+5.34
54.6+1.92
58.7+1.08

2.0+0.38
1.4+0.43
1.3+0.37
1.9+0.24
24-48
Urine
1.9+0.21
1.2+0.29
0.6+0.06
1.1+0.16
Feces
0.8+0.28
0.2+0.04
0.2+0.11
0.2+0.10
48-72

0.6+0.14
0.4+0.23
0.3+0.04
0.5+0.13

0.3+0.14
0.1+0.03
0.4+0.15
0.2+0.10
72-96

0.3+0.06
0.4+0.23
O.M+0.02
0.2+0.09

• 0.2+0.08
0.1+0.05
0.1+0.05
0.1+0.02
Total
(0- to 96-hour)

84.1+2.94
82.3+5.18
55.6+1.90
60.5+1.00
•
3.3+0.53
1.8+0.42
2.0+0.28
2.4+0.26
         "Source: Hutson  et al.,  1971

         "The  values given are  the means  +  SEM for  groups  of  six  rats


         6138H
06/26/89

-------
                                                                         TABLE 5-2
                                               Recoveries of Radioactivity from Rats in the 4 Days Following
                                                         Oral Administration of 1,3-Dichloropropene
Compound Sex
i is-l ,3-Dichloropropene H
F
( rdiis-1 ,3-Oichloropropene H
L/l F
»
Recovery of
Urine
84.0*2.94
82.3*5.18
55-6*1.90
60.4*1.00
Radioactivity 1% of Administered Dose in 4 Davsb
Feces
3.3*0.53
1.8*0.42
2.1*0.28
2.3*0.26
Gut
0.1*0.01
0.1*0.02
0.2*0.10
0.1*0.01
Skin
0.5*0.09
0.5*0.07
0.6*0.07
0.5*0.13
Carcass
0.8*0.06
0.5*0.02
1.1*0.11
0.9*0.11
Exhaled Air
Carbon
Dioxide0
5.3 (3)
2.4 <3)
22.7 (3)
24.4 (3)
Other
Volatile
Radio-
activity6
NR
1.4 (2)
NR
•3.5 (2)
Total Radioactivity Recovered
(% of Administered Dose)
Less
Volatile
Radio-
activity
88.7*4.27
85.2*4.27
59.6*2.57
64.2*1.01
Including
Volatile
Rad i o-
activity
NR
89.0
NR
92.1
 'Source: Hutson et al..  1971
 txtept where indicated  otherwise,  values given are the means * SEN for groups  of six  rats.
'Values given are means  for the numbers of animals indicated in parentheses.
HK =: Not reported
6139H
06/20/89

-------
al., 1985}.   In  rats,  51-61% of the dose was excreted  In  the  urine;  In  mice,
63-79%.  Approximately  18 and  6X,  respectively,  of  the  administered  radio-
activity was  excreted  In feces  and as  expired  14C02  In rats,  and 15  and
14%, respectively,  In  mice.   After  48  hours,  only 2-6% of the  original  dose
remained  In  the carcasses.   Major  metabolites  were   the  mercapturlc  acid
conjugate  and the  sulfoxlde  or sulfone  derivative of  N-acetyl-S-{3-ch1oro-
prop-2-enyl) cystelne.
5.5.  SUMMARY
    Approximately 80%  of  the  administered  dose  of  1,3-dlchloropropene  was
absorbed  Into the  body  following  Inhalation  or  oral exposure  (Stott  and
Kastl,  1986;  Hutson et al.,  1971).   As the Inhaled concentration of  1,3-dl-
chloropropene Increased,  the  absorption did not Increase  linearly because  of
exposure level-related decreases  In respiratory ventllatory frequency and  to
saturation  of  the   metabolism  of   1,3-dlchloropropene  (see   Section   5.1).
1,3-Olchloropropene  was  rapidly eliminated  from the body,  primarily In  the
urine  as  N-acetyl-S-(3-chloroprop-2-enyl)  cystelne,  following  Inhalation  or
oral exposure {Hutson  et  al., 1971; CUmle et al., 1979;  D1etz  et al.,  1985;
                                                 1988b .   1,3-Olchloropropene
                                                         t  blotransformatlon:
                                                         the mercapturlc  add
                                                          3-chloroprop-2-enyl)

                                                         d  the trans-lsomers.
                                                         n the blood of  rats
                                                         itratlons  of the  two
                                                         >f the  els- than  the
                                                         ater   amounts  of  the
                                                                      7/25/89

-------
trans-isomer  were  excreted  as  C02  tn  the  expired  breath  (Hutson  et  al.,
1971).
    Distinct  differences   exist  In  the  elimination  of  1,3-d1chloropropene
between rats  and mice.   Following  oral dosing  with '4C-l,3-d1chloropropene,
more of the administered  dose of  radioactivity was excreted In the  urine and
expired air  of mice than of rats  (Dietz et  al., 1985).  The rate of urinary
excretion  of  the   mercapturlc  acid  of  1,3-dlchloropropene  was  comparable
between rats (Fisher and Kllgore,  1988b) and  humans (Osterloh et al., 1984).
6228H                                5-10                             6/20/89

-------
                                  6.   EFFECTS
6.1.   SYSTEMIC TOXICITY
                                           4
6.1.1.   Inhalation Exposure.
    6.1.1.1.   SUBCHRONIC — Stott et al.  (1988)  exposed male and female F344
rats  and  B6C3F1  mice (10/sex/exposure level)  to  0,  10, 30,  90  or  150 ppm of
technical  grade  1,3-dlchloropropene  (48.6%  cls-1,3-dlchloropropene,  42.3%
1,3-dlchloropropene,  2.4%  1,2-d1chloropropane and  1.2%  eplchlorohydrln  and
mixed  Isomers  of  chlorohexane,   chloroliexene and   trlchloropropene)  for  6
hours/day, 5  days/week  for  13 weeks.  The animals  were observed for clinical
signs of  toxlclty  and body  weight changes.   Hematologlcal, clinical chemistry
and  urlnalysls  determinations were  conducted  at the end of  the  study.   All
surviving  animals   underwent   gross  necropsy.    Comprehensive  hlstologlcal
examination was  limited  to  high-dose and control  animals and  those  animals
that  died  before  scheduled   sacrifice.    Selected   tissues  were  examined
ilstologlcally  In  the  other  groups.    Significantly  decreased body  weight
'3aIn  was  observed  1n  both  sexes  of   rats  and  mice  treated  at >90  ppm.
Degenerative  changes or  hyperplasla In  the  nasal   mucosa  were observed  In
almost all  animals  of  both  sexes of  rats  and  mice  exposed to >90  ppm and In
;i/10  male rats  exposed  to  30  ppm.   Respiratory  metaplasia of the  damaged
portions  of  the olfactory  region of the  mucosa  was  found   1n  both  sexes of
mice  In  the high  exposure group.   This  effect  Involved the replacement of the
damaged   sensory   olfactory   epithelium  with   normal-appearing,   ciliated,
respiratory-type epithelium.   Hyperplasla  of the  urinary bladder transitional
epithelium  was  found 1n  most  female  mice  exposed to 90 or ISO ppm  of  the
vapor,  but  not In  male mice or  In  rats.    No treatment-related effects  were
observed  1n male  rats  exposed  to  10 ppm  1,3-dlchloropropene  and  In female
rats  or male and female mice exposed to 30 ppm of the vapor.

6229H                                6-1                             07/25/89

-------
    Coate et al.  (1979)  exposed  groups  of  10 male and 10 female F344 rats and
10 male  and 10 female  CD-I  mice to  0,  12,  32 or  93 ppm of  Telone  II  (47%
ds- and  45% trans-1,3-dlchloropropene, 8%  related  compounds)  for  7  hours/
day, 5 days/week  for 13  weeks.   Both  sexes of rats and female mice exposed to
the  highest  concentration  (93  ppm)  had  reduced  body  weight  gain.   No
treatment-related hlstopathologlcal effects  were  noted  In the lungs,  kidneys,
liver,  heart,   brain,  gonads  or nasal  turblnates  of  rats  or  mice.   Other
tissues were not examined microscopically..
    Parker  et  al. (1982) exposed groups  of  28 male and  28  female CD-I  mice
and F344  rats  to  0,  5,  15  or 50 ppm of the D-D mixture (2S% c1s-l,3-dlchloro-
propene,  27X trans-dlchloropropene, 29X 1,2-dlchloropropane)  for  6 hours/day,
5 days/week  for 6 or 12 weeks.   No clinical signs  of toxldty or  effects  on
body  weight   changes,   hematology  (HGB,  HCT,   R8C,  WBC   and   differential
leukocyte count), serum  chemistry (BUN, GLU,  ALB,  and GPT),  urlnalysls, gross
pathology,  hlstopathology,  organ weights  and  organ-to-body  weight ratios  of
brain, heart,  testes or  ovaries  and adrenals were observed  following  12 weeks
of  exposure.   Increased mean  I1ver-to-body weight  ratios  of  male  rats  and
Increased mean  kidney-to-body  weight  ratios of  female  rats  were  seen  at  the
50 ppm  exposure level  at 12 weeks.   In male  and female mice exposed  to  the
highest concentration for 12 weeks,  a slight  to  moderate diffuse  hepatocytlc
enlargement was seen 1n  12/21  treated  males.  4/18 control males,  6/18 treated
females and  1/18  control females.  No  compound-related-effects  were seen  at
lower concentration levels.
    Torkelson  and Oyen  (1977)  described  a  preliminary  Dow  Chemical  Company
study that  exposed  rats (5/sex/group) and guinea pigs (3-5/sex/group)  to  50
ppm  l,3-d1chloropropene  (composition   not   specified)  for  19   seven-hour
exposures over  a  period of   28 days or  to  11 ppm  for 27  seven-hour  exposures

6229H                                6-2                             07/25/89

-------
over  a period  of 39  days.   In  both  experiments,  marked  liver and  kidney
changes, Including necrosis, were observed.
    Torkelson  and Oyen   {1977}  repeatedly  exposed  rats  (9-11  animals/sex/
exposure level),  guinea  pigs (7-12 animals/sex/group),  rabbits  (1-4 animals/
sex/group)   and dogs  (1-2  animals/sex/group)  by  Inhalation  to  1  or  3  ppm
1,3-dlchloropropene   (46%   c1s-    and   53%   trans-1,3-dlchloropropene,   1%
eplchlorohydrln)  for 7  hours/day,  5  days/week  for  6 months.   In  addition to
the rats exposed  for  7  hours/day,  groups of five male  rats  were  exposed  at 3
ppm  for 4,  2,  1 or  0.5  hours/day,  5  days/week  for 6  months.   Controls
consisted  of  animals exposed  to normal  laboratory  environments and  animals
exposed  In sealed chambers  to air  only.   Following  the  last exposure,  the
animals  were   sacrificed   and   the   following   tissues   and  organs   were
hlstologlcally examined:  lung, heart,  liver, kidney, spleen,  testes, ovaries,
adrenals,  pancreas,   lymph  nodes,   Intestines,  stomachs,  brains,  thyroids,
thymus,  peripheral  nerves,  skeletal  muscles,  bladders and  gall  bladders.
Hematologlcal   tests   were   also    performed   (hemocrlt,   hemoglobin   and
differential WBC  counts).   Additional groups of rats  were allowed  a  3-month
recovery period before sacrifice.  No effects on any organs  were  found 1n any
species at  either concentration  except for  a  slight,   cloudy  swelling  1n the
renal epithelium  of male  rats  exposed  to  3 ppm 1,3-dlchloropropene for 4 or 7
hours/day.   Following the  3-month recovery  period, the  cloudy  swelling was no
longer apparent.
    Reduced  body   weights  and  degeneration and  hyperplasla  of  respiratory
epithelium  were  reported  In  male  and  female F344  rats  exposed   to  Telone
II    (94%   1,3-dlchloropropene,   nearly  equally  divided   between   the   two
Isomers) at 90   ppm,  6  hours/day,  5  or   6  days/week  1n  a  multlgeneratlon
6229H                                6-3                             07/25/89

-------
reproduction  study   (Breslln  et  al.,   1987),   discussed  more   fully   1n
Section 6.5.
    6.1.1.2.   CHRONIC  --  The  chronic  toxldty  of  Inhaled  technical  grade
l,3-d1chloropropene was  determined 1n  F344  rats  and B6C3F1  mice  (Lomax  et
al., 1989).  Groups of 50 male  and  50  female rats  were exposed to 0, 5, 20 or
60  ppm  (0,  22.7,  90.8 or  272  mg/m3)   1,3-dlchloropropene  (49.5%  ds-  and
42.654  trans-l,3-d1chloropropene,  0.754 1,2-d1chloropropane  and 254  epoxldlzed
soybean  oil)  6  hours/day,  5  days/week  tor <2 years.  Ancillary  groups  of  10
rats and mice/sex/exposure  level  were  similarly exposed for  6  and  12 months.
Clinical  laboratory  determinations  (hematologlcal  and  clinical   chemistry
parameters), along  with extensive  gross  and hlstologlcal  examinations, were
determined  at  the scheduled  sacrifice  Intervals  of  6,  12  or 24 months.   No
clinical signs  of toxldty  and no significant differences  In survival were
observed.   Mean  body  weights of  both male and  female rats exposed  to  60  ppm
l,3-d1chloropropene  were  significantly   decreased   (5%)   as  compared with
controls on test  days  6-425  In males  and  6-327   1n  females (a  = 0.05  by
Dunnett's  test).   The  terminal  weights  of  the treated  rats, however, were
similar  to  those  of  control  animals.   The mean body weights  of both male  and
female  mice  exposed  to  60  ppm  l,3-d1chloropropene  were  lower  In  some
Instances than those of controls  during the  study  (3-954  1n  males  and 2-1154 In
females).   The  terminal weights of  the   male  mice  exposed  to  60  ppm were
significantly lower  than those  of  the control mice  (a  -  0.05  by  Dunnett's
test).   No  statistical  differences  were  found   between   the  terminal body
weights  of  treated  female  mice  and  those of controls.  No treatment-related
effects were observed 1n hematologlcal,  biochemical  or urlnalysls  parameters.
    Gross  pathological   examination of   all  rats   In  the  study  showed   no
apparent exposure-related effects following  exposure to  1,3- dlchloropropene.

6229H                                6-4                             07/25/89

-------
Hlstopathologlcal examination,  however,  revealed  exposure-related  effects In
the nasal  tissues of  male and female  rats  exposed to 60 ppm 1,3-dlchloropro-
pene  for  24 months.   These  changes  were  characterized  by  unilateral  or
bilateral  decreased  thickness  of  the olfactory  epithelium  that  1s  due to
degenerative  changes,  erosions   of  the  olfactory   epithelium  and  flbrosls
beneath  the  olfactory  epithelium.    No  lesions  were  observed  at  the 6- or
12-month sacrifices.
    Hlstopathologlcal   examination   of J.he  mice • revealed  exposure-related
morphological  changes  1n  the  urinary  bladder  and  nasal  tissue.   Urinary
bladder  hyperplasla,   characterized  by  diffuse,  uniform  thickening  of  the
transitional epithelium,  was observed  In  both sexes  of mice with  duratlon-
and concentration-related Increased   frequency  and  severity.  The  Incidence
of this  lesion  was  significantly Increased In males  at 60  ppm  and In females
at 20  and  60 ppm at  24,  but not at  6 or  12 months  of exposure.   The effect
was much more pronounced  In  the  female mice than  In  male mice.   Both the male
and female mice also  had compound-related microscopic changes  In  the nasal
tissues  characterized  by  hypertrophy and  hyperplasla  of  the  respiratory
epithelium   or   degeneration  of   the  olfactory   epithelium.    Significant
Increases  1n the Incidence  of hyperplasla of  the  respiratory  epithelium were
found  1n female mice  exposed to 20 and 60  ppm for 24  months  and  In  male mice
exposed  to  60   ppm  for  24 months.   The  Incidence of  degeneration  of  the
olfactory  epithelium  was  measured  significantly  1n  mice of both  sexes at 60
ppm after  24 months.   An additional  exposure-related  change was  the hyper-
plasla and hyperkeratlnlzatlon In the forestomach  of 8/50 male  mice following
exposure to 60 ppm for  24 months.
6229H                                6-5                             07/25/89

-------
6.1.2.   Oral Exposure.
    6.1.2.1.   SUBCHRONIC  --  Solutions  of  Telone II*  (78.5X  1,3-d1chloro-
propene) In propylene glycol were administered  by  gavage  at  doses  of 0, 1,  3,
10  or  30  mg/kg/day  to 10  rats (strain  unspec1f1ed)/sex/dose level  for  6
days/week  for  13 weeks  (T11  et al., 1973).   No significant effects on  body
weight,  food  consumption,  hematology,  clinical   chemistry,   urlnalysls  or
hlstopathology  were  noted  at   any  dose level.   A statistically  significant
higher  relative kidney weight,  however, was  found  -1n  males  treated with 10  or
30 mg/kg/day and In females at 30 mg/kg/day.
    As  reported  In abstracts of  Russian studies, the  effects of 1,3-dlchloro-
propene  on  trypsln,  trypsln Inhibitor, amylase  and llpase activities  In the
serum  of albino rats  was  Investigated by  Strusevlch and Ekshtat  (1974) and
Strusevlch and  Sadovnlk  (1975).  The  rats were  fed dally  doses  of  0.1,  0.5  or
2.5 mg/kg/day  !,3-d1chloropropene  for  6  months.  Trypsln activity  Increased
and trypsln  Inhibitor  activity  of  the blood decreased during the  6  months  of
treatment.   Blood   Upase  activity  Increased   and  amylase   activity  was
unaffected.   No additional  details  of  the  studies were  reported  In  the
abstracts.
                       •
    6.1.2.2.   CHRONIC  —  Groups of  52 male  and   52  female F344  rats  were
given  doses  of  0,  25  or  50 mg/kg/day  Telone  II   (89% els- and  trans-1,3-
dlchloropropene,  2.5%  1,2-dlchloropropane,  1.5%   trlchloropropene  and  1.0%
epIchlorohydMn)  1n  corn  oil  by  gavage  3  days/week  for  104 weeks  (NTP,
1985).   In the same  bloassay,  groups of  50 male  and  50 female  B6C3F1  mice
were  given doses of  0, 50  or  100  mg/kg/day  by  gavage  3  days/week for  104
weeks.   In  ancillary  studies,  groups of 28  male and  28 female  rats  and  mice
were  given  Telone  II   at   the above  doses,  and  Interim  kills  of  five
animals/sex/group were performed at  9, 16,  21,  24 or 27  months.
6229H                                6-6                             07/25/89

-------
    No  differences  tn  survival  were found  among the  groups  of rats  1n the
2-year  study;  35-42 rats/sex/group  survived  until  the end  of  the  study.  In
mice, survival  of the  control males was significantly  lower  than  either the
low or  high  dose groups.  Only 8/50  control  male mice survived until the end
of  the  experiment,  compared  with   28/50 animals 1n  the  low-dose  group and
31/50 animals  In the  high-dose  group.   Twenty-five  of the deaths  among the
male control mice occurred at  weeks  48-51 and were  attributed to myocarditis,
which was  not  treatment-related.  Survival  of  the high-dose  female mice was
significantly  less  than  that  of  the controls;  36/40 high-dose females and
46/50 female controls  survived.   Survival  In  the  low-dose group  of  female
mice was 45/50.
    The mean body weights of male rats  In  the  high-dose group (50  mg/kg/day)
were  =5%  lower  than  those  of the  control  group after 28  weeks,  while body
weights  In  the  low-dose male group  (25 mg/kg/day)  and  In  both  groups  of
treated  females  were  comparable with  controls.  There were  no significant
differences  In hematologlc and clinical  chemistry Indices  among all groups of
rats.   Basal  cell  hyperplasla of  the  forestomach  was observed  In  Increased
Incidences In  treated  male and female rats,  but these lesions were considered
preneoplastlc,  since   rats  also  had Increased  Incidences  of  paplllomas and
carcinomas of  the forestomach.  The Incidences of  edema of  the submucosa of
the  urinary  bladder   was 9/52  and  3/52 for  high-dose males  and  females,
respectively,  compared  with  0/52  for  the  control  and  low-dose  groups.
Increased  Incidences   of  nephropathy  were   observed   \t\  treated female  rats
(15/52,  control;  24/52,  low  dose and 22/52,  high dose), but not  In male rats,
as compared with controls.
6229H                                6-7                             07/25/89

-------
    The mean  body  weights  of treated mice were  Initially lower than those of
the vehicle  controls and  remained  lower  throughout  the study  (5-9%).   This
difference was  due to lack  of  randomization at the beginning  of  the experi-
ment.    No  significant  differences  In  hematologlc  or  clinical  chemistry
parameters were observed.   Dose-related  Increased  Incidences  of  epithelial
hyperplasla of  the urinary bladder  were observed  1n male  and  female treated
mice.    The Incidences  were as  follows:  0/50  for male controls,  9/50  for
low-dose males  and 18/50 for high-dose  males;  2/50- for  female controls,  15/50
for  low-dose  females  and  19/48   for   female  high-dose  groups.   Increased
Incidences of  transitional cell carcinomas  of  the urinary bladder  were also
observed  In  the treated groups  (Section 6.2.2).   High-dose  female  mice also
had  Increased  Incidences  of epithelial  hyperplasla of  the  forestomach.   A
dose-related  Increased  Incidence of  hydronephrosls occurred In  female,  but
not male, mice.  The  Incidences  were  0/50 for  controls,  2/50 for low-dose and
14/50 for the high-dose groups.
6.1.3.   Other  Relevant Information.  Torkelson  and Oyen (1977) tested  human
volunteers for  their  ability to detect the  odor  of  1,3-dlchloropropene.   At
each  concentration of  4.5 or   13.6 mg/m3 for  1-3 minutes,  7/10  Individuals
detected the odor, which was stronger at the higher concentration.
    Dermatosls  was  reported  In  three  men derma11y  exposed  to  D-D  (53%
1,3-dlchloropropene,  27.1%  1,2-dlchloropropane,  1%  eplchlorohydrln and  the
remainder,  dlchloropropene  Isomers)  while  spraying  the  fumlgant  on  their
crops  (Nater  and  Gooskens,  1976).   An  Itchy  erythematous  rash was  found  at
the site  of   exposure.  Patch  tests revealed  that,  In  one case,  an allergic
contact sensitivity to D-D existed.
    Irritation  to  eyes and  upper  respiratory mucosa  of humans occurs  after
exposure  to vapors of  dlchloropropene.   Inhalation of  vapor 1n concentrations

6229H                                6-8         .                    07/25/89

-------
>1500  ppm produces headache.  Irritation  to the mucous  membranes,  dizziness,
nausea,   vomiting,   gasping,  coughing,   substernal   pain   and   respiratory
distress,  with  slight  elevation  of  serum  enzyme  levels.   At  concentrations
<1500  ppm,  CNS  depression and moderate  Irritation of the  respiratory system
occur  (Gosselln et  al.,  1976).   Ingestlon  of l,3-d1chloropropene  produces
acute  gastrointestinal   distress,  pulmonary  congestion  and edema,  and  CNS
depression  1n humans.   Dermal exposure causes  severe skin  Irritation  with  a
marked Inflammatory response.
    LD_0  and LC5Q  values for  rats,  mice  -and  rabbits  are  listed  in  Table
6-1.   Torkelson  and   Oyen   (1977)   found  that   2700   ppm  (=12,000  mg/m3)
1,3-dlchloropropene  was  extremely  Irritating  to  the respiratory  tract  and
caused lung,  nasal,  liver and kidney Injury  In rats. Rats  survived  a 1-hour
exposure  to 1000  ppm  (=4500  mg/m3), but  death  occurred  when exposure  was
Increased  to 2  hours.   Guinea  pigs died following  a  single 7-hour  exposure to
400  ppm   (=0800 mg/m3);  rats  survived the same exposure,  but severe  Injury
and weight  loss was  evident.   Weight  loss was  recovered  after 8 days  but lung
Injury was still present.
    Torkelson and  Rowe  (1981) reported that  direct  application of two drops
of  1,3-dlchloropropene   to  the  eyes  of  rabbits  caused moderate  to  severe
Injury;  vapors   of  1,3-dlchloropropene  caused Irritation  and  lacrlmatlon.
Application of  1,3-dlchloropropene to the skin  of  rabbits,  accompanied by  the
prevention of evaporation, caused necrosis  and  edema. Carreon and  Mall (1983)
reported  that  4/10  guinea  pigs exhibited  signs  of  sensltlzatlon to  Telone
II  ,   and   Jeffrey   et   al.   (1987)    reported  edema,   erythema   and  dermal
necrosis at the site of administration of  200  mg/kg Telone II .
    Torkelson  and   Oyen   (1977)   reported   that  Telone   II ,  1n   a  12.5X
solution  In  propylene  glycol, was applied  under  a cuff to  rabbits that were

ii229H                                6-9                              07/25/89

-------
                                                    TA«     -1

                                       L05Q/LC50 Values for Dlchloropropene
Route Species
Oral rat (M)
rat (F)
rat (N)
rat (F)
rat
rat
LD50/LC5Q Value
(95% Confidence L1m1
(rag/kg)
710
470
560 (452-695)
510 (480-726)
140+25
150 (130-170)
t) Comments
Liver and kidneys grossly affected,
lung Injury 1n survivors
Animals died 1-3 days after dosing.
NC
LD5Q for all rats was 150 mg/kg;
Reference
Torkelson and
Rowe, 1981
Toyoshlma et al.,
1987a
Nine et al.. 1953
Jones and Collier,
r\j
ifi

2  *mg/m3
                mouse
300+37
                mouse (N) 640 (582-704)
                mouse (F) 640 (547-749)
LD5Q for males was 130 mg/kg;
1050 for females was between
110 and 250 mg/kg.

NC

Animals died 1-2 days after dosing.
                                                                                            1986
H1ne et al, 1953

Toyoshlma et al.,
1978b
Inhalation rat 4530*
mouse
Dermal rat >1211
mouse
rabbit 2100+260
rabbit 333 (102-610)
Cumulative high

NC
acute toxlclty


Single dose skin penetration
Dose was admlnl
was covered for
stered and the area
24 hours.
H1ne et al

Toyoshlma
1978a,b
H1ne et al
Jeffrey et
1987
., 1953

et al.,
., 1953
al.
   NC = No comment

-------
then  left  undisturbed  for  24  hours.   Absorption  occurred  by  this  route,
resulting 1n deaths with doses of  0.125  and  0.25 g/kg.  When undiluted Telone
II  was  applied In  the  same manner  to  a group  of both species  of  rabbits,
a dermal  LD-D  value of 504 mg/kg  was  obtained.   When applied to  the  eyes of
six rabbits,  four  of the  rabbits  had  severe conjunctiva!  Irritation  and two
exhibited slight  to moderate  cornea!  Injury after  24 hours  of  observation.
The effects disappeared after 8 days.
6.2.   CARCINOGENICITY
6.2.1.   Inhalation.  Harkovltz  and Crosby  (1984)  described  three reported
cases of  hematologlc  malignancies  In humans  that may  have  been  the result of
acute exposure  to 1,3-dlchloropropene.   Two  of the  cases  Involved  two  firemen
exposed  to  1,3-dlchloropropene  after  a spill   from a tank  truck.   In  nine
firemen exposed to  the  vapors,  symptoms  Included headache,  neck  pain, nausea
and  breathing  difficulty.   Eight  years  following  the  spill,  two  of  the
firemen  developed   malignant  hlstlocytlc  lymphomas and  died.  In  the  third
case, a  farmer was  exposed  to 1,3-dlchloropropene  In the  field for  30  days
and developed  redness and pain  In  the  right  ear,  the  nasal  mucosa  and the
pharynx.  The  farmer  returned to the field 1  year later  and was  exposed again
to  1,3-dlchloropropene; the  symptoms worsened.   The farmer  was diagnosed  with
acute myelomonocytlc  leukemia  and  died  of pneumonia 5 weeks  after admission
to the hospital.
    The chronic toxldty and oncogenlclty  of technical grade 1,3-dlchloropro-
pene  was  determined  In  rats and  mice  (see  Section 6.1.1.2)  (Lomax  et  al.,
1989).   Groups of  50 male  and  50 female  F344  rats and  B6C3F1  mice  were
exposed to  0,  5,  20 or 60 ppm  (0, 22.7, 90.8 or  272  mg/m3)  1,3-dlchloropro-
pene  (49.5% els- and 42.6%  trans-1,3-d1chloropropene, 0.7%  1,2-dlchloropro-
pane  and  2% epoxldlzed soybean  oil)  6 hours/day, 5 days/week for  <2  years.


6229H                                6-11                            09/28/89

-------
Ancillary  groups  of  10  rats   and  mlce/sex/exposure   level  were  similarly
exposed for 6 and 12 months.
    No  statistically significant  Increases  In  primary,  benign  or  malignant
tumor  Incidence  was  found  In  male or  female  rats when  compared with  the
controls.  The Incidence of  bronchloloalveolar  adenomas  (a  benign lung tumor)
was  significantly  Increased In male mice  exposed to 60  ppm 1,3-dlchloropro-
pene  for  24 months  (Table  6-2).   No Increase  1n  Incidence was  found  1n  the
male  mice  exposed  to  5  or  20  ppm.  -No  increase  1n primary,  benign  or
malignant  tumors  was   found In  the  treated   female  mice.   A  hyperplastlc
response  was  found  In  the urinary bladders of  both male  and  female  treated
mice  (see Section  6.1.1.2.),   but  no dose-related  tumorlgenlc  response  was
found.   A dose-related, statistically significant  decrease was  found  In  the
Incidence of liver and lymphoretlcular  tissue tumors In the  mice.
6.2.2.   Oral.  In the  previously  reported chronic  oral  bloassay (NTP,  1985),
rats  and  mice  were   treated   by  gavage   with  Telone  II ,   a  commercial
product containing 89%  els- and trans-1,3-d1chloropropene,  2.5% 1,2-dlchloro-
propane,  1.554 trlchloropropene  and  1.0% eplchlorohydrln.   Details  regarding
the  dosing  schedule,   numbers  of  animals  and  survival   were  presented  In
Section 6.1.2.2.
    Significantly  Increased  Incidences of  neoplastlc lesions were observed In
the forestomach and  liver  of rats  and  1n the forestomach, urinary bladder  and
lungs of  mice.   Tumor  Incidences  and  the  results of Fischer Exact  Tests  and
Cochran-Armltage Tests  for dose-related  trends are  presented In Table  6-3.
;:n  addition,  the  Incidence  of  adrenal  gland  pheochromocytoma  were  signifi-
cantly  (p=0.029  by life table  and Incidental  tumor tests)  Increased  In male
rats  treated  at  25 mg/kg.   The Incidence of thyroid folllcular  cell  adenomas
6229H                                6-12                            07/25/89

-------
                                  TABLE  6-2

            Incidence  of  Bronchloloalveolar Adenomas  In B6C3F1 Mice
                 Exposed  to  l,3-D1chloropropene  for 24 Months3
 Sex                             Dose   _         .            Tumor Incidence
                                (ppm)


Male                              0                                9/50
                                  5                                6/50
                                 20                               13/50
                                 60                               22/50b

Female                            0                                4/50
                                  5                                3/50
                                 20                                5/50
                                 60                                3/50
                              QUALITY  OF  EVIDENCE

Strengths of study:  Compound  was  administered  by  a  relevant   route   of
                     exposure at  three concentrations.   Adequate  numbers  of
                     animals/group survived to be at risk for late-developing
                     tumors.  Adequate  duration  of  exposure.   Two  species
                     (rats and mice) and both sexes  were used.

Overall adequacy:    Adequate


aSource: Lomax et al., 1989

Statistical  difference  from  control  mean  by  Yate's  x2  palrwlse  test,
 a=0.05  and linear  trend  by  Cochran-Armltage  linear   trend test,  <*=O.Q2,
 two-sided.
5229H                                6-13                            07/25/89

-------
TAB
                                                               -3
                                  Chronic Oral Exposure to Telone n*a,b,c for 2 Years
CD
10
Species/Strain Sex
(No.)
Rat/F344 H (52)
Rat/F344 H (52)
Rat/F344 F (52)
Rat/F334 H (52)
Rat/F334 H (52)
Rat/F344 F (52)
M1ce/B6C3Fl F (50)
H1ce/B6C3Fl F (50)
Dose Target Organ
(rog/kg/day)
0 forestomach
25
50
0 forestomach
25
50
0 liver
25
50
0 forestomach
25
50
0 liver
25
50
0 forestomach
25
50
0 forestomach
25
50
0 urinary bladder
50
100
Tumor Type
squamous-cell
papllloma
squamous-cell
carcinoma
neoplastlc
nodule or
carcinoma
squamous-cell
papllloma or
carcinoma
neoplastlc
nodules
squamous-cell
papllloma
squamous-cell
papllloma or
carcinoma
transitional
cell carcinoma
Tumor Incidence
(p value)
1/52
1/52
9/52
0/52
0/52f
4/52
1/52
6/52
8/52
, 1/52
1/52
13/52
1/52
. 6/52
7/52
0/52
2/52
3/52
0/50
1/50
4/50
0/50
8/50
21/48
0.002d
0.7526
0.008e
0.015d
0.0596
0.015d
D.0566
0.016e
<0.001d
0.7526
<0.001e
0.030d
0.0566
0.030e
0.082d
0.2486
0.1216
0.026d
0.5006
0.0596
<0.001d
0.0036
<0.001e

-------
                                                 TABLE  6-3 (cont.l
V
IV*
ro
Species/Strain Sex
(No.)
M1ce/B6C3Fl F (50)


M1ce/B6C3Fl M (50)



Dose Target Organ
(mg/kg/day)
0 lung
50
100
0 lung
50
100

Tumor Type
alveolar/
bronchlolar
ademona
alveolar/
bronchlolar
adenoma or
carcinoma
Tumor Incidence
(p value)
0/50
2/50
8/50
2/50
4/50
8/50

0.002d
0.12ie
0.0036
0.029d
0.339*
0.046^

                                                QUALITY OF  EVIDENCE
?] Strenghts of study: Two-year study; sufficient number of animals, both sexes, two dose  levels,  two  species
3^                     were used; ancillary studies were Included  (see text).      .    ,
   Weakness of study:  Hale mouse vehicle control had many early deaths from myocarditis.
   Overall adequacy:   Adequate
   aSource: NTP, 1985
   bCorn oil vehicle 1n all studies
   °Pur1ty of compound: 89% ds- and trans-1somers of 1,3 dlchloropropene with 1.0% eplchlorohydrln
   ^Cochran-Armltage Trent Test
   eF1scher Exact Test
   fNo p value 1s presented because no tumors were observed 1n the 25 mg/kg and vehicle control groups.
ro
en
00
us

-------
or  carcinomas  \n  female  rats  showed  a  marginally  significant  (p<0.05)
positive dose-related  trend.   NTP (1985) reported that,  under  the conditions
of  the  study,  there  was  clear  evidence of  cardnogenldty for  male  F344/N
rats and for  female B6C3F1 mice,  and  there  was some  evidence 1n female F344/N
rats.   The  study was  deemed  an  Inadequate  study of carclnogenlclty  In  male
B6C3F1  mice because of  high  mortality  In the  control  group.  Although  the
early deaths  of  the  control  male mice confounded  the  results,  a carcinogenic
effect  of  Telone  II   was  suggested  by  the  tumor  Incidences  of  transi-
tional  cell  carcinomas of  the  urinary bladder, alveolar/bronchlolar neoplasms
and squamous cell paplllomas of the forestomach 1n male mice.
    Results  of  the ancillary  studies   Indicated   that  the  development  of
forestomach  lesions was time-dependent.   Pooling  of  the  tumor  Incidences  from
the ancillary  studies  and  the  2-year study (not  shown  In Table 6-3} enhanced
the statistical significance.
    The  Telone II  used  In the  bloassay  contained 1.0% eplchlorohydrln,  a
known carcinogen,  which may  have Influenced  the development  of  forestomach
lesions.
6.2.3.   Other  Relevant  Information.   A  group of 30  female Ha:ICR mice  was
given weekly subcutaneous Injections  of cls-1,3-d1chloropropene  In trlocta-
noln at a dose  of  3 mg/mouse/week (Van  Duuren et al.,  1979).  After 538 days,
six mice  had local sarcomas (flbrosarcomas)  (6/30;  p<0.0005)  and  no  distant
tumors  were observed.   No tumors developed In untreated  and  vehicle-treated
animals.
    Van  Duuren  et al.   (1979)   also  studied  ds-l,3-d1chloropropene  as  a
tumor-Initiator and as a whole carcinogen when applied  to the  skin of  mice.  A
group of 30  female Ha:ICR  mice  received  a single dermal  application of 122 mg
6229H                                6-16                            09/21/89

-------
1,3-dlchloropropene  In  0.2 mi acetone  followed  by phorbol myrlstate  acetate
In  acetone  at 5  ng, 3  times/week  for  428-576  days.   Controls consisted  of
100 untreated  mice,  90 mice treated  with  0.0025 mg/appllcatlon and 120  mice
treated  with  0.005  rag/application  of  the  tumor  promoter.   No  significant
differences  were  observed  between   the  d1chloropropene-1n1t1ated  mice  and
those  treated with  the  promoter  alone,  with  respect  to local  or  distant
tumors.   When 1,3-dlchloropropene was  tested  as a  whole carcinogen,  three
paplllomas  developed In 3/30  female  mice treated,  with  122 mg/appllcatlon  3
days/week for  <589 days.   Two  of the mice had carcinomas.  Although no  local
tumors  were observed  In  mice  treated  at  41  mg/appllcatlon,  or In acetone-
treated  or   untreated   controls,  the  Incidence   In  high-dose  mice  was  not
significantly different.  The number  of mice with distant  tumors was also not
different from that  In controls.
6.3.   MUTAGENICITY
    Studies  on  the  mutagenlclty  of  1,3-dlchloropropene  are  summarized  In
Table   6-4.    1,3-Dlchloropropene  was   positive  for  reverse  mutation  In
Salmonella  tvphlmuMum  strains   TA100   and   TA1535  both   with and   without
metabolic activation (NTP,  1985;  Stolzenberg  and Mine, 1980;  Haworth  et  al.,
1983).   In   S.  typhlmuMum  strain  TA98,  a  positive  reaction  was obtained
without metabolic activation {NTP, 1985;  Haworth et al. 1983;  VHhayathll  et
al.  1983).    Although   Talcott  and  King  (1984) and  Watson  et  al.   (1987)
demonstrated  that  the  mutagenlclty  to  strain TA100  of  mixtures of els- and
trans-l,3-d1chloropropene  was  abolished  following  removal of  polar  Impuri-
ties,  other  Investigators  (Greedy  et  al.,  1984;   Neudecker  et  al.,  1977;
DeLorenzo et  al.,  1977) found that  both  the ds-1somer and the trans-lsomer
(both  relatively pure) were  mutagenlc  In   strains   TA100,  TA1538,   TA1537,
<»229H                                6-17                            07/25/89

-------
TABLF 6-4
CTv
ro


i
GO


o
-J
to
in
CO
IP


Assay
Reverse
mutation
Reverse
mutation
Reverse
mutation
Reverse
mutation
Reverse
mutation
Reverse
mutation
Reverse
mutation




Indicator
Organism
Salmonella
tyj>h1imir1um
TA 100
TA 1535
TA 1537
TA 98
i-
typhlmurlum
TA 98
S.
typhlmurlum
TA 100
S.
typhlmurlum
TA 1978
TA 1535
TA 100
FyphlmuMum
TA 100
S.
typhlmurlum
TA 1538
TA 1537
TA 1535
lyphlmurlum
TA 100




Compound/
Purity
95. 6X
NR
NR
els- and trans-
Isomers/Nft
ds- and trans-
isomers/98%
cls-lsomer/
99.97X; trans-
1somer/97.46X
mix of ds-
and trans-/
77-95X pure




Application
plate
Incorporation
liquid Incubation
plate
Incorporation
plate
Incorporation
plate
Incorporation
plate
Incorporation
plate
Incorporation




Concentration Activating
or Dose System
0.3333 v8/ » S-9
plate
100 pg/plate none
10. 1, 10-1 i S-9
timol/plate
20. 50, 100 * S-9
MQ/plate
10-200Mg/plate » S-9
0. 0.1. 0.5. 1.0 * S-9
jig/flll
<1 mg/plate none




Response Comment
S-9 mixtures from both rats and
hamsters were used. No
»/* difference was found between
*/+ species. Where a positive re-
-/- sponse was found, the chemical
-/* was cytotoxlc at >333 i»g/plate.
«- NC
NC
»/*
*/+ NC
t/t addition of glutathlone pro-
tected against mutagenlclty.
*/* NC
+ Impurities In the DCP prepa-
ration were removed and the
mutagenlc response was no longer
found. The Impurities them-
selves were mutagenlc.




Reference
NTP, 1985; Haworth
et al., 1983
VHhayatMe et al.,
1983
Stolzenberg and
H1ne, 1980
Oelorenzo et al.,
1977
Creedy et al.,
1984
Neudecker et al.,
1977
Talcott and King,
1984



-------
                                                                            TABLE 6-4 (cont.)
ro
to
X



Assay
Reverse
mutation
Reverse
mutation
Sister
chromatld
exchange
Sex-linked
recessive
Indicator '
Organism
Salmonella
typhlmuMum
TA 100
S.
Yvphlmurlum
TA 100
Chinese
hamster
V79 cell
Drosophlla
melanoqaster
Compound/
Purity
els- Isomer/
99. 7X
els- and
translsomers/
>99.5X
98X
95. 5X
Application
plate
Incorporation
plate
Incorporation
cell culture
feeding
Concentration
or Dose
?5-2000 wg/
plate
NR
3.3, 6.6, 10.0 r
0.5750 ppm
Activating
System Response
* S-9 *
i S-9 */»
m * S-9 -/»
NA *
Comment
the study showed that previously
shown Intrinsic mutagenlclty was
probably due to Impurities and
not 1.3 DCP.
activation was Increased by
greater amounts of and longer
Incubation with S-9.
1.3 OCP was Inactivated by the
S-9 mixture In the V79/SCE assay.
NC
Reference
Watson et al.,
1987
Neudecker and
Henschler, 1986
von der Hude et
al.. 1987
NTP, 19B5; Valencia
et al.. 1985
      lethal

      Redprocol  0.
      trans-      melanoqaster
      locations
95.5X
feeding/Injection  0.5750 ppm
NA
NC
NTP. 1985; Valencia
et al., 1985
o
~J
X.
rv>
      NA =  Not  applicable; NC  * no comment;  NR  * not reported
us

-------
TA1535 and  TA1978.   Neudecker and  Henschler  11986}  found that  the  mutagenl-
clty  of   1,3-dlchloropropene  1n   S.   typhlmurlum  Increased  with  Increasing
levels of  the  S-9 mixture and  with longer Incubation periods.  Greedy  et al.
(1984) also demonstrated  that,  If glutathlone was added  to  the assay system,
the mutagenlcHy of either Isomer  was reduced.
    1,3-Olchloropropene   was  positive   for   sex-linked  recessive   lethal
mutations,  but  negative for  reciprocal  translocatlons 1n Drosophlla  melano-
gaster  (NTP,  1985; Valencia et al., 1985).
6.4.   DEVELOPMENTAL TOXICITY
    Hanley et al. (1987) studied  the effects  of  Inhalation exposure  to 0, 20,
60  or  120 ppm  1,3-dlchloropropene (47.754 c1s- and  42.454 trans-l,3-d1chloro-
propene)   for 6  hours/day during  gestation  days  6-15  In  30  F344 rats  and  on
days 6-18 In 25-31 New  Zealand White rabbits.  Maternal  toxlclty (body weight
gain, liver weight,  kidney  weight, mortality, food and water  consumption and
reproductive  parameters)  and  developmental  toxlclty  (fetal  body  weight,
number of  resorptlons,  external  and skeletal examination and  visceral  exami-
nation) were assessed.  No evidence of developmental  toxlclty  was  observed  In
rats or  rabbits,  but significant  maternal  toxlclty  was  seen  In both  species
of  animals.   Signs  of  maternal  toxlclty  Increased  with Increasing  exposure
concentrations   In  both species.   Maternal  toxlclty  was  evidenced   1n  the
rabbits  by  a decrease  1n weight  gain at  the highest  two  exposure  levels.
Decreases  In  maternal  weight  gain were  observed at  all exposure  levels  1n
rats.  In  rats,  maternal toxlclty  was also  evidenced at all  exposure  levels
by  decreases  1n  food  and   water  consumption and statistically  significant
decreases  In absolute  liver  weights,  and, at  the highest  level, by  statis-
tically  significant  Increases  1n  relative kidney weights.    A  statistically
significant Increase  In the  Incidence  of  one minor  skeletal  variant (delayed


*229H                                6-20                             09/21/89

-------
ossification  of  the  vertebral  centra)  was  observed  among  fetuses of  dams
exposed to  120 ppm 1,3-dlchloropropene,  but  this was  considered  secondary to
the maternal  toxldty.   No adverse  effects  on other  ossification  sites  were
found In the fetal rats.
6.5.   OTHER REPRODUCTIVE EFFECTS
    Venable  et  al.  (1980)  reported a  fertility  study  of  79 male  workers
engaged 1n  the  manufacture of  1,3-dlchloropropene.  Results from  this  study
Indicated no  significant effect  on  fertility frofti  exposure  to 1,3-dlchloro-
propene at levels occurring 1n the work environment.
    Unnett et al.  (1988} exposed  30 male  and 24 female Wlstar  rats to 0. 10,
30 or 90  ppm  D-D  (28.1% cls-1,3-dlchloropropene, 25.6% trans-1,3-dlchloropro-
pene, 25.6% 1,2-dlchloropropane  and  the remainder,  primarily dlchloropropene
Isomers} for 6 hours/day, 5 days/week for  10 weeks.  Treated males  were mated
with untreated females,  and  treated females were mated with  untreated  males.
Libido, fertility and morphology  of  the  reproductive tract  of either sex were
not affected and  no treatment-related dominant lethal effect was observed In
male rats.  Body  weight gain  decreased slightly and  liver  and  kidney  weights
Increased slightly In both sexes at the highest exposure concentration.
    In a U.S. EPA  (1988)  review of an unpublished  experiment (Breslln  et al.,
1987), groups of  30 male and 40  female  F344 rats  were exposed  by  Inhalation
to  Telone  II   (94X  1,3-d1chloropropane,  nearly  equally  divided  between
els and trans Isomers)  at concentrations of  0,  10,  30 or  90 ppm,  6  hours/day,
5 days/week 1n a  mu HI generation  reproduction study.   Exposure  began 10 weeks
before  mating and  was  Increased  to 7 days/week  during  a 2-week  breeding
period.   Exposure  of  the  F,   generation  began  after   weaning  on   the  6
hours/day,  5  days/week  schedule   and continued for 12  weeks.   The  highest
concentration tested  was considered by U.S.  EPA  (1988)  to be  a   NOAEL  for

6229H                                6-21                            09/21/89

-------
reproductive  effects  associated  with  a  slight  decrease  In the  conception
Indices  1n  F,  and  F~  females.   NonreproductWe effects  reported  1n  the  90
ppm  groups  Included hyperplasla  of  the respiratory  epithelium,  degeneration
of olfactory tissue and decreased body weight gain 1n rats of both sexes.
    In  a mouse  sperm  morphology  assay (Osterloh  et al.,  1983),  male  mice
(C57BL/6XC3H,  four  mice/dose  level)  were Injected  1ntraper1toneally for  5
consecutive  days  with  1,3-dlchloropropene  (Telone   II  )   In  0.25  ml  corn
oil  at doses  of 10,   19,  38, 75,  150,-300  and "600  mg/kg/day.   A  negative
control  group  received  only corn oil,  and 90 mg/kg/day  methyl  methanesulfo-
nate was  Injected  as  a  positive  control.   The morphology  of  200 sperm/mouse
was  assessed  35 days  following the  first  Injection.   Testlcular  weights,
total  epldldymal  sperm counts and percentage of  abnormally-shaped  sperm were
averaged  and  compared with  controls  after 35 days.   Methyl  methanesulfonate
produced  a  high percentage  of  abnormally-shaped  sperm (16.4-22.9J4).   At  the
three  highest  dose  levels  (150,  300 and 600  mg/kg/day),  all  mice died before
day  35.   Host  of  the  animals  Injected  with  the  lower  doses   survived  and
exhibited  no  significant  changes  1n   testes  weight,  total  sperm  count  or
percent  of  abnormal  sperm compared  to  vehicle  controls.   Data are  presented
1n  Table 6-5.   Ten  pesticides,   Including  four   known  testlcular toxins  and
three  known mutagens,  were  tested  1n  this  study.    None  of the  pesticides
tested positive.  The authors concluded  that  the  mouse sperm morphology assay
only tested  for damage  at  the spermatic!  stage  of  sperm development  and  was
not a  suitable test for testlcular toxins.
(>.&. SUMMARY
    The  LC5_  for  l,3-d1chloropropene  1n  rats  and  mice  was  4530  mg/m3
(Hlne  et al.,  1953).   Information regarding subchronlc  and  chronic  Inhalation
of  l,3-d1chloropropene  suggests  that damage  to  the  nasal mucosa of  rats  and


6229H                                6-22                            09/21/89

-------
                                   TABLE  6-5
       Testlcular  Weights,  Sperm Counts and Percent Abnormal  Sperm After
               IntraperHoneal  Injection "of 1,3-D1chloropropenea
Testes weight (mg)
Total sperm count
(million/ma)
Percent abnormal
sperm
Methyl methanesul-
fonate (positive
control) percent
abnormal sperm
Control     75 mg/kg   38 mg/kgb    19 mg/kg    10 mg/kgc

203±40      229+14     21U7      218+9      218^9
25.9+8.9    32.0*3.0   32.3+4.5   29.1+6.1    25.8.+Q.6

1.0+0.4     0.9^0.9    0.8*1.0    1.U0.3.    1.8+1.1
16.4f22.9   NA
NA
NA
NA
aSource: Osterloh et al., 1983
bThree of four survived 35 days.
cTwo of four survived 35 days.
NA = Not applicable
6229H
                6-23
                         07/25/89

-------
mice  and  damage  to  the urinary  bladders of  mice may  result from  exposure
(Stott et al., 1988; Torkelson and  Rowe,  1981;  Lomax  et  a!.,  1989).   Evidence
of  damage  to  the liver  and kidneys  was also  found (Parker  et al.,  1982;
Torkelson and Rowe, 1981).
    Oral LD5Q  values 1n  rats  ranged  from  140-740 mg/kg  and.  In mice,  from
300-640 mg/kg {Torkelson and Rowe,  1981;  H1ne  et  al.,  1953;  Toyoshlma et al.,
1978a,b).  Subchronlc  studies  suggested  Increases  1n  the relative weight  of
the  kidneys  1n  rats  treated orally  with 1,3-d1chloropropene  (Torkelson  and
Rowe,  1981).   Chronic  oral  studies  suggest  that  hyperplasla of  the  fore-
stomach and  of  the urinary  bladders  of  rats and mice resulted from  exposure
(NTP, 1985).
    The  only  data available regarding the  carclnogenlcHy  of l,3-d1chloro-
propene  1n humans are three reported  cases  of hematologlc malignancies  that
may have been  the result  of  acute  Inhalation  exposure to 1,3-d1chloropropene
(MarkovHz and   Crosby,  1984).    There 1s  sufficient evidence that  1,3-dl-
chloropropene Is  a carcinogen  In orally  exposed  animals.   NTP  (1985)  found
Increased  Incidences  of  squamous-cell   paplllomas  and  carcinomas   of  the
forestomach and neoplastlc nodules  or  carcinomas  of the  liver  In  rats treated
chronically  with  1,3-dlchloropropene  by  gavage.   Mice  similarly   treated
showed   Increased  Incidences   of   forestomach   tumors,  lung   adenomas   or
carcinomas and transitional  cell  carcinomas of  the  urinary bladder.   There Is
rfeak  evidence  that 1,3-dlchloropropene Is carcinogenic  1n animals exposed by
Inhalation.  Lomax et al.  (1989)  found an Increase 1n  the Incidence  of benign
lung  tumors  (bronchloloalveolar  adenomas)  In male mice treated  chronically
with  1,3-dlchloropropene.  l,3-Q1chloropropene has  been  found  to  be  mutagenlc
'in  various strains of  S.  typhlmurlum  (NTP, 1985;  Stolzenberg  and Hlne,  1980;
Maworth  et  al.,  1983).   l,3-D1chloropropene has  also  been  found  to  be

6229H                                6-24                             09/27/89

-------
positive   for   sex-linked   lethal   mutations,,  but  negative  for  reciprocal
translocatlons  1n  D.  melanoqaster   (NTP,  1985).   l,3-D1chloropropene does not
appear to be a reproductive or a developmental toxicant.
6229H                                6-25                            09/21/89

-------
                     7.   EXISTING GUIDELINES  AND  STANDARDS
7.1.   HUMAN
    The ACGIH  (1986,  1988}  has recommended and adopted a TWA-TLV  of  1  ppm (5
mg/m3)  for  l,3-d1chloropropene.   This  value 1s  based  on  the  findings  of
Torkelson and  Oyen (1977)  that  exposure  to  1 ppm,  7  hours/day for  6  months
resulted  In  no  Injury  to  four  species and  that 3 ppm  resulted  In  slight,
reversible Injury  In one species  (see  Section 6.1.1.2).   A  skin  notation Is
also  listed  by the  ACGIH (1988), wh1ch_ means that appreciable exposure  may
occur through  skin contact  with  the  vapors.   OSHA (1989)  has  also  recommended
and  adopted  a  TWA of  1  ppm  (5  mg/m3}  with a  skin designation  for  l,3-d1-
chloropropene.  The U.S.  EPA  (1987b) verified  a chronic oral  RfD of  3x10"*
mg/kg/day, based  on   Increased organ  weights In  rats  fed  1,3-dlchloropropene
for  90  days  (Til  et  al., 1973).  The U.S. EPA  (1987b)  reported  an oral  slope
factor  for   cardnogenlclty  of  1.8xlO~Vmg/kg/day  and   a   carclnogenlclty
classification of  B2  (probable human  carcinogen); based on  tumors  In  rats  and
mice  In  the  NTP  (1985)   study  (see  Section  6.2.2),   positive mutagenlc
activity, and  structural similarity  to known  oncogens  that  produce  similar
types of  tumors  1n rodents.  IARC (1987) classified 1,3-d1chloropropene as  a
class 28 carcinogen (probable human carcinogen).
7.2.   AQUATIC
     Pertinent  data regarding guidelines for  exposure of aquatic organisms to
1,3-dlchloropropene  were not  located  1n  the available  literature cited  In
Appendix A.
6;?30H                                7-1                             07/25/89

-------
                              8.   RISK  ASSESSMENT

    Statements  concerning  available   literature  1n  this  document  refer  to
published, quotable  sources  and  are  In  no way  meant  to  Imply  that  confi-
dential  business  Information  (CBI),  which this  document could  not  address,
does not  exist.   However,  It was determined that existing  CBI  data  would not
alter the approach to risk  assessment  or  the  risk assessment values  presented
herein.
8.1.   CARCINOGENICITY
8.1.1.   Inhalation.    The  chronic  toxlclty  and  oncogenlclty  of  technical
grade  l,3-d1chloropropene  were  determined  1n  rats  and mice   (see  Sections
6.1.1.2.  and  6.2.1.)  (Lomax et  al.,  1989).   Groups  of rats  and mice  were
exposed  to 0,  5,  20 or 60  ppm {0,  22.7,  90.8 or 272  mg/m3)  1,3-dlchloropro-
pene  (49.5X  ds- and 42.6X trans-l,3-d1chloropropene,  0.7X  1,2-dlchloropro-
pane and  254  epoxldlzed soybean  oil)  6 hours/day,  5  days/week  for  <2  years.
Clinical  signs  of  toxldty  were not observed, and  no  significant differences
In survival were found In  any group of exposed animals.
    No  statistically significant  Increases  In  primary,  benign  or  malignant
tumor  Incidence were found In male  or  female  rats   when  compared  with  the
controls.  The  Incidence  of bronchloloalveolar adenomas  (benign lung  tumors)
was  significantly  Increased 1n male mice  exposed to  60  ppm 1,3-dlchloropro-
pene fop  24 months  (22/50 treated, 9/50 controls).  No  Increase In  Incidence
was  found  In  male mice  exposed to  5 or  20 ppm (see Table  6-2).   No Increase
In primary, benign or malignant  tumors was found 1n the treated female mice.
In  contrast   to  these  results,  NTP  (1985)  found    significantly  Increased
Incidences of neoplastlc  lesions  1n the forestomach and  liver  of rats  and In
the  forestomach,   urinary  bladder  and  lungs  of  mice  1n   a  chronic  gavage

6231H                                8-1                             07/25/89

-------
study.   In both  studies, a  tumorIgenlc  response  was  found  In  the  tissues
through which  the 1,3-dlchloropropene was absorbed,  I.e.,  the forestomach 1n
the gavage study  and  the  lungs  In  the Inhalation study.  In the gavage study,
however, tumors were  also Induced at sites  distant  from the  point  of entry.
Hyperplasla of the  urinary  bladder,  however, was found  1n  animals exposed by
both Inhalation and 1ngest1on.  Lomax et  al.  (1989)  determined that, when the
concentration of  1,3-dlchloropropene  administered by Inhalation  was  converted
to  mg/kg,  the  dose given  In  the 1nhalai1on  study  was 2-3 times  higher  than
the dose given In the oral  study.  A major difference between the studies was
the compound used to  stabilize the 1,3-dkhloropropene mixture.   In the  oral
study,  IX  eplchlorohydrln,   a  compound   that   reportedly  causes  nasal   and
forestomach  tumors  1n  rats  following chronic  Inhalation  and oral  exposure,
respectively, was used  as a stabilizer;  In the  Inhalation  study, a relatively
nontoxlc epoxldlzed soybean oil  stabilizer was  used.  The  levels  of eplchlo-
rohydrln used In  the  gavage study, however,  were about 30-fold lower than the
doses  shown  to be  tumorlgenlc  by 1ngest1on.   The  differing  results,  there-
fore,  are  most likely due to  the differences  In   administration:   repeated
bolus  doses  administered  by  gavage vs. repeated 7-hour  Inhalation exposures.
Another reason for differing results  can  be  differences  In  metabolic pathways
following  oral   vs.   Inhalation   exposures.    Results  from   pharmacoklnetlc
studies  (Fisher.  1988; Fisher  and Kllgore,  1988a)   (see  Section 5.3.)  have
Indicated  that,   following  Inhalation  exposure,   a  substantial  amount  of
1,3-dlchloropropene 1s  metabolized  to the less toxic  glutathlone conjugate,
transported  to  the bloodstream and  Is subsequently  degraded  to  the  mercap-
turlc add form and excreted In the urine.
8.1.2.   Oral.   In the  NTP  (1985)  chronic gavage study, Increased Incidences
of  squamous-cell  paplllomas and  carcinomas of the forestomach and neoplastlc


6231H                                8-2                              09/25/89

-------
nodules or carcinomas  of  the liver were observed  In  rats  treated  with  Telone
II*  (8954  1,3-dlchloropropene,   2.5%   1,2-dlchloropropane,   1.5X   tMchloro-
propene and IX  eplchlorohydrln)  at doses  of 25 and 50 mg/kg/day,  3 days/week
for  2  years.    In  addition,  the  Incidence  of  adrenal gland  pheochromocytoma
Increased significantly  In  male rats treated  at  25 mg/kg, and  the Incidence
of  thyroid  folUcular  cell  adenoma or  carcinoma In  female rats showed  a
significant (p<0.05)  positive dose-related  trend.  Mice  similarly  treated  at
50  and 100 mg/kg/day  had  Increased  Incidences  of  forestomach  tumors,  lung
adenomas  or  carcinomas   and  transitional   cell  carcinomas  of   the urinary
bladder  (see  Table  6-3).   NTP  (1985)  noted  that eplchlorohydrln may  have
Influenced the  development  of  forestomach  lesions, but 1t was concluded  that
there  was  clear   evidence  for  the cardnogenldty  of   Telone  II   In  male
rats and female mice,  some  evidence  In  female  rats  and  Inadequate  evidence  In
male mice, due to high mortality 1n the  male control  group.
8.1.3.    Other Routes.  Weekly subcutaneous  Injection of c1s-l,3-d1chloropro-
pene In  mice at  3 mg/mouse/week  resulted  In  significantly  Increased   Inci-
dences  of  Injection-site fIbrosarcomas.   No significant  differences between
treated mice  and  control  mice were observed when  cls-1,3-d1chloropropene was
tested as a tumor  Initiator or as a whole carcinogen on  the  skin  (Van  Duuren
et al., 1979).
8.1.4.    Weight of Evidence.   The  only  available  data regarding the cardno-
genldty  of  1,3-dlchloropropene  In humans  are   three   reported  cases   of
hematologlc  malignancies   that  may  have  resulted  from  acute   exposure  to
1,3-dlchloropropene (MarkovUz and  Crosby,  1984).   The available  animal  data
Indicate evidence  that  1,3-dlchloropropene  is  carcinogenic by the  oral  route
of exposure and may be carcinogenic  following  Inhalation  exposure  (NTP,  1985;
Lomax  et  al.,  1989).  Hutagenldty  studies   Indicate  that  1,3-dlchloropropene
6231H                                8-3                             09/25/89

-------
1s  mutagenlc  to  various  strains  of  S. typhlmurlum   (NTP,  1985;  Haworth  et
al.,  1983; Stolzenberg  and  Nine,  1980).   According  to  U.S.  EPA  (1986c)
guidelines, 1,3-d1chloropropene  can  be placed  In Group  B2:  probable  human
carcinogen.
8.1.5.   Quantitative Risk Estimates.
    8.1.5.1.   INHALATION  —  The  only  long-term  Inhalation  study available
that  assesses  the  carclnogenlclty  of  1,3-dlchloropropene  Indicates   that
exposure  1s  associated  with  an  Increased  Incidence of  bronchloloalveolar
adenomas  (benign  tumors)   In male  mice exposed  to 60  ppm  (272 mg/m3)  for  2
                                                                  *
years  (Lomax   et   al.,  1989).   (Data  used  to  calculate  the q-j  value  are
presented  In Appendix B.)  Only  benign  tumors  were observed  1n this study and
quantitative  risk  estimate  based  solely  on  benign  tumor  alone  Is  not
routinely  performed;  however,  Incidences  of  lung adenomas  as well as  other
types of  tumors were also Increased following oral exposure.   Therefore,  the
results  from   the Inhalation  study by  Lomax et  al.  (1980)  are  considered
                                                                            '*
relevant  and   a   quantitative  risk estimate  Is   derived.   The value  for  q-j
was  calculated using  the linearized  multistage  model  developed  by  Kenneth
Crump  and adopted by  U.S. EPA.   The  conversion  factor used  to  adjust  for
spec1es-to-spec1es  extrapolation  was   the  cube  root  of  the  ratio  of  the
average body weight  of  a  man  (assumed to be 70  kg) to the body weight of the
                                                             *
experimental  animal  (Appendix  B).   The   value  for   the  q-j  In  humans  1s
calculated  to be 1.3xlO-1 (mg/kg/day)"1.   Assuming   a  reference  human  body
weight of  70  kg  and a  respiratory rate of 20 mVday,  ambient  air  concentra-
tions  of   2.7xlO~*,  2.7xlO~s  and   2.7xlO~*  mg/m3  are   associated   with
Increased cancer  risks of IxlO"5, IxlO"8 and IxlO"7, respectively.
    8.1.5.2.   ORAL  — The only long-term  study available  that assesses  the
carclnogenlclty  of  1,3-dlchloropropene  following  chronic  oral  exposure  1s


6231H                                8-4                             09/27/89

-------
that by NTP  (1985).  This  study  Indicates  that chronic exposure Is associated
with  Increased  Incidences of  squamous-cell  paplllomas and  carcinomas  of the
forestomach, neoplastlc  nodules  or carcinomas of  the  liver, possibly adrenal
and thyroid  tumors  1n rats,  and  Increased Incidences  of  forestomach tumors,
lung adenomas  or  carcinomas and  transitional  cell carcinomas  of  the urinary
bladder  In  mice.   Because  of  the  demonstrated  carclnogenlclty of  Telone
!!•,  H  Is  appropriate  to  derive  a  q,*  for  1,3-dlchloropropene.   The
value   for   q,*  was  calculated   using  the   linearized   multistage   model
developed  by Kenneth  Crump  and  adopted by  U.S. EPA.  The  conversion  factor
used to adjust  for  spec1es-to-spec1es extrapolation was the cube  root  of the
ratio of  the average  body weight  of  a  man (assumed to be 70  kg)  to  the body
weight  of   the  experimental  animal   (Appendix  B).    A   q,*  of  l.SxlO"1/
mg/kg/day  Is calculated  based on  the  combined  Incidences  of tumors  In the
forestomach  and liver and  pheochromocytoma  In  the adrenals  of male rats.  The
concentrations of  1,3-dlchloropropene In drinking  water associated with risk
levels   of   10~5,    10~6   and    10~7   are   2xl(T3,   2xlO"«   and   2xlO~s
mg/a, respectively.
8.2.   SYSTEMIC TOXICITY
8.2.1.   Inhalation Exposure.
    8.2.1.1.   LESS THAN  LIFETIME EXPOSURE   (SUBCHRONIC)  --  Stott  et  al.
(1988)  exposed  F344 rats  and B6C3F1  mice to 0,  10,  30,   90  or  150  ppm  of
technical-grade 1,3-dlchloropropene  (90X 1,3-dlchloropropene)  6 hours/day,  5
days/week  for  13  weeks.   Degenerative  or  hyperplastlc  changes In the  nasal
mucosa were  observed In  both  sexes of  rats  and mice exposed to >90 ppm and  1n
2/10  male  rats  exposed  to   30  ppm.   Hyperplasla of  the  urinary  bladder
transitional epithelium  was  found  In  female mice exposed to 90 or 150  ppm  of
the  vapor.   No  treatment-related effects  were  observed   In  rats  or  mice


6231H                                8-5                             09/27/89

-------
exposed  to 10  ppm  1,3-d1ch1oropropene. A  NOEL of  10  ppm  (45.4  mg/m3)  (rec
#2)  and  a LOAEL  of 30  ppm  (136.2 mg/m3}  (rec #13} for  respiratory effects
In  rats   were   Identified.   This   study  will  be  used  as  the  basis  for  the
subchronlc RfD,  since a higher percentage  of  the  vapor administered 1n this
study consisted of  1,3-dlchloropropene  compared with the  Parker et al. (1982)
study below.
     Parker et  al.  (1982)  exposed  mice and  rats  to 0,  5, 15  or 50  ppm  of  a
mixture  of D-D  (52X cls-and  trans-1,3-dlchloropr.opene and 29% !,2-d1chloro
propane)  6 hours/day,  5 days/week  for 6  or  12 weeks.   Slight  to moderate
diffuse  hepatocytlc  enlargement was  found  In male  and  female  mice exposed to
50 ppm for 12 weeks.   Increased mean I1ver-to-body  weight  ratios of male rats
and  Increased mean  kidney-to-body weight ratios  of female  rats were seen at
the  50 ppm level.   No  compound-related  effects  were found  at lower levels, so
15  ppm   (68 mg/m3)  can  be defined  as  the  NOAEL   (rec  #25) and 50  ppm  (227
mg/m3} can  be  defined as  the  LOAEL (rec #26}  for  liver  effects  1n rats  and
mice.  Although a higher LOEL  value  Is  Identified  In the  Parker et al. (1982)
study than 1n the Stott  et al.  (1988)  study (15 ppm vs. 10 ppm}, the Stott et
al.  (1988) study  will  be used as  the basis  for the Inhalation RfD, since the
vapor used In this  study was  90X  1,3-dlchloropropene, while  the vapor used In
the  Parker et al. (1982) study was only 52X.
     Coate et al.  (1979)  reported  that  rats  and mice exposed to 93 ppm Telone
II   for   13  weeks  had  reduced   body  weight  gain   (rec  #20-24).   Tor kelson
and  Oyen  (1977)  reported a  Dow  Chemical   study  1n which  liver   and  kidney
necrosis  was  found  In  rats  and  guinea  pigs  exposed  to >11  ppm  (rec  #33,
34).   Neither  of  these studies  will be used  as  the basis  for the subchronlc
Inhalation RfD,  since  the  former  study reports a NOAEL higher than the LOAEL
In the Stott et al. (1988) study  and the latter  study  was a pilot consisting

6231H                                8-6                             09/27/89

-------
of very  few animals.  Torkelson  and  Oyen  (1977)  reported a slight, apparently
reversible cloudy  swelling  of  the renal epithelium  In  male  rats  exposed to 3
ppm, but not  to  1  ppm,  of  l,3-d1chloropropene (99% 1,3-d1chloropropene) for 4
or 7 hours/day,  5  days/week for 6 months.   The  renal  effect  was  not substan-
tiated In  a  study In which  50 rats/sex/group were  exposed  to <60  ppm for 2
years, or  10  rats/sex/group were exposed  to  <60 ppm for 6 or  12 months.   No
compound-related  effects  were  found  following  exposure  of  rabbits,  guinea
pigs or  dogs  to  1  or 3 ppm  1,3-d1chloropropene  for  6  months.   It Is reasona-
ble, therefore,  to consider the 3  ppm level In  the  study  by Torkelson  and
Oyen (1977) as a NOAEL (rec #5).
    The  subchronlc Inhalation   RfD  Is  calculated  by  adjusting  10  ppm (45.4
mg/m3)   from  the  Stott  et  al.  (1988)  study  for  Intermittent  exposure,
multiplying by the RGDR and dividing by an  uncertainty  factor  of 100 (10  for
Interspecles  extrapolation  and  10 to protect  the  most  sensitive  Individual).
The RGDR 1s the  ratio of  (rat  ventilation  rate/the extrathoraclc  surface area
of  the  rat)  to  (human  ventilation  rate/extrathoraclc  surface  area  of  the
human)   [(0.223   mVday/11.6 m*)/(20   mVday/177  m*)J   (Jarabek,   1988).
Therefore,  the   calculated   subchronlc   Inhalation   RfD   Is    0.01   mg/m3.
Confidence In the  key  study used to  derive the  RfD  Is  high;  the  study  was
well conducted  and extensive  hlstopathologlcal  examinations  of   the  animals
were done.  Confidence  In the data base 1s medium, since several  studies were
conducted, two of  which were  of high  quality,  but effects  seen In  a lower
quality  study   were   not   substantiated.    Therefore,  confidence   In  the
subchronlc Inhalation RfD Is medium.
    8.2.1.2.    CHRONIC EXPOSURE — Lomax et al.  (1989)  determined the chronic
toxldty of Inhaled l,3-d1chloropropene  (93X  l,3-d1chloropropene) In rats  and
mice exposed  to  5, 20 or 60 ppm  for  6 hours/day,  5 days/week for <2 years.


6231H                                8-7                             09/27/89

-------
Examinations  of hematologlcal,  biochemical  and  urlnalysls  data  1n  treated
animals   did   not   Indicate   toxlclty  from   l,3-d1chloropropene   exposure.
Hlstopathologlcal  examination  of  rats revealed  exposure-related  effects  In
the nasal tissue of  male and female  rats  exposed  to 60 ppm for 24 months, but
not after exposure for 6 or 12  months.  Hlstopathologlcal  examination of mice
revealed  exposure-related  morphological changes  In  the  urinary bladder  and
lung  of  both sexes.   Significant  Increases  1n  the  Incidence  of  hyperplasla
and  Inflammation  of the transitional  epithelium .of  the urinary bladder  was
found  In male mice exposed  to 60 ppm for  24 months and In female mice exposed
to  20 and 60 ppm  for  24 months.  Significant  Increases In  the  Incidence  of
hyperplasla of  the  respiratory  and  olfactory epithelium  were found  1n male
mice  exposed  to 60 ppm for 24 months  and In  female mice exposed  to 20 and  60
ppm  for  24 months.  Therefore,  a  NOEL of  5  ppm  (22.7 mg/m3)  {rec  #5)  and a
LOAEL  of  20  ppm (90.8 mg/ma)  (rec #6)  1s  defined  for the  respiratory  and
bladder  effects of  1,3-dlchloropropene  In  mice.   A  NOEL  of  20   ppm  (90.8
mg/m3}  (rec  #3)  and  a  LOAEL  of  60  ppm  (272  mg/m3)  (rec  #4)  are  defined
for the respiratory  effects In  rats.   Although  the  exposure  level of 5 ppm 1n
mice  Is  a NOEL for  respiratory  and  bladder  effects,  the  respiratory effects
cannot  be  considered  In   the   derivation  of  the   RfO  because  values  for
respiratory tract  surface  areas are not  yet  available  for  B6C3F1  mice.  The
bladder effects,  however,  are  systemic effects for which  methodology exists.
A  chronic  Inhalation  RfD  of  0.04  mg/m3  could  be  calculated by  adjusting
22.7  mg/m3  (5  ppm)  for Intermittent  exposure to  4.1 mg/m3,  multiplying  by
the  ratio  of  the   blood/gas  partition  coefficient   for  animals/humans  (no
Information available, so the default  value of  1  Is used), and dividing by  an
uncertainty  factor  of 100  (10  for  Interspedes  extrapolation  and   10  to
protect  the  most sensitive Individual).   The pharmacoklnetlc  study by  Stott

6231H                                8-8                             09/27/89

-------
and  Kastl  (1986)  suggests  that  a  steady  state  of  1,3-dlchloropropene was
reached In  the  blood  within  the duration period of the dally exposures.  This
RfD,  however,  1s greater  than the  subchronlc  Inhalation RfD  of  0.01 mg/m3,
based on  a  NOEL of 10 ppm for  respiratory  effects  In rats.   The I GAEL 1n the
subchronlc  study was  30 ppm,  at  which 2/10 rats  had degenerative changes In
the  nasal mucosa.   Only 2/50 rats exposed  to 20  ppm 1n the chronic study had
nasal  tissue lesions; the  Increased Incidence  Is  not  statistically signifi-
cant  when compared with the  Incidence  (0/50)   1n .the controls.  Furthermore,
20  ppm  Is a chronic  LOAEL  In mice  and  Is  higher than the NOEL of  10 ppm 1n
rats  In  the subchronlc  study  used as  the basis  for  the  subchronlc  RfD.
Therefore,  the  Inhalation  RfD  of  0.01  mg/m3  1s  adopted   as  the  chronic
Inhalation  RfD.  As  discussed  In   Section  8.2.1.1., confidence  In  the key
study  1s  high   and  In  the  data  base,  medium.    Overall  confidence  In the
chronic Inhalation  RfD  1s  medium because H protects for  the critical effect
of  respiratory  effects  In   rats,   but   1t  may  not  be   protective   for  the
respiratory effects 1n mice.
8.2.2.   Oral Exposure.
8.2.2.1. LESS  THAN LIFETIME   EXPOSURE   (SUBCHRONIC)  —  T11   et   al.   (1973)
administered  1,3-d1chloropropene  (Telone  II  )  1n  propylene glycol  to  10
Albino  rats/sex/dose  to  0,   1,  3,  10  or  30  mg/kg/day,   6  days/week  for  90
days.  No significant  differences  between the  groups were  found  In the means
of body weight  and  food  consumption.  No biologically significant  differences
1n hematology or clinical  chemistry parameters were found, and no compound-
related  abnormalities  were   seen upon   gross  autopsy.   Increased  relative
kidney weights,  however,  were found In  male rats at 10 and  30 mg/kg/day and
1n  female rats  at  30 mg/kg/day.   Therefore, a NOEL  for  kidney effects  of  3
mg/kg/day  (rec  #1) and  a  LOAEL  of  10 mg/kg/day  (rec  #7} were  Identified.


6231H                                8-9                             09/27/89

-------
This  study  will  be used as  the  basis  for the subchronlc  oral  RfD.  since the
only  other  subchronlc  oral  studies are  abstracts  of  Russian  studies  which
lack  experimental  details  (Strusevlch  and  Ekshtat,  1974;  Strusevlch  and
Sadovnlk, 1975).
    The  subchronlc  oral RfD Is  calculated  by taking the  NOEL  of 3 mg/kg/day
from  the  Til  et  al. (1973)  study,  adjusting for  Intermittent  exposure to 2.6
mg/kg/day and  dividing  by  an uncertainty factor  of  1000  (10 for Interspedes
extrapolation, 10 to protect the most  sensitive  Individuals  and an additional
modifying  factor of  10  for  the  deficient  data  base).   An  RfO of  3xlO~3
mg/kg/day  1s  calculated.   Confidence  In  the key study that 1s  the  basis for
the  subchronlc RfD  1s  low  because  the study  Is  of  poor  quality.  Confidence
1n  the data  base  Is  low  since   few subchronlc  oral studies  exist.   Overall
confidence 1n the subchronlc oral RfD 1s low.
    8.2.2.2.   CHRONIC  EXPOSURES  --   NTP   (1985)   determined   the  chronic
toxlclty  of 1,3-d.1chloropropene  1n  rats given 0, 25 or  50 mg/kg/day  and mice
given  0,  50  or  100  mg/kg/day  Telone  II   (89J4  1,3-dlchloropropene)  by
gavage  ^n corn oil 3 days/week   for 104  weeks.   No effects on  survival  were
found  1n  male and female rats.   Basal  cell  hyperplasla  of the forestomach was
observed  In  Increased  Incidences  In  both sexes  of  treated  rats  In  the  high
dose  group; edema  of  the  submucosa of the  urinary  bladder  Increased  1n  high
dose male and female rats.   Increased  Incidences  of  nephropathy were  found In
both  the  high and low dose  female rats.   In  mice, the survival of the control
male  mice was  significantly  reduced  due to  myocarditis (not  treatment-re-
lated).   Survival  of  the  high dose female  mice was significantly less  than
controls.  Increased  Incidences   of epithelial   hyperplasla  of  the  urinary
bladder  were  found In  both dose groups  of both sexes  of mice.   High-dose
female mice also had Increased   Incidences  of  epithelial  hyperplasla of  the


6231H                                8-10                            09/27/89

-------
forestomach and of hydronephrosls.  An  AEL  of  25 mg/kg was defined for kidney
neuropathy In female rats  (rec  #2)  and  hyperplasla of the forestomach In male
rats  (rec  #4);  an AEL  of  50 mg/kg  was  defined  for hyperplasla of the urinary
bladder  In  both male and  female  mice (rec  #5,  6).   Consequently,  the T11 et
al.  (1973)  study  described In  Section  8.2.2.1., which was  the  basis  for the
subchronlc oral  RfD,  Is used as  the  basis  for  the chronic  oral  RfD.   In the
90-day  gavage  study by  T11  et al.  (1973),  kidney weights  Increased  In male
rats  given 10 mg/kg/day and  In female rats given 30 mg/kg/day.  The  RfD Is
calculated by adjusting  the NOEL  of 3 mg/kg/day for Intermittent exposure and
dividing  by  an  uncertainty factor  of 10,000 (10  for  Interspedes  extrapola-
tion,  10  to  protect  the  most sensitive  Individuals, 10  for  the  use  of  a
subchronlc study  and  an additional modifying  factor  of  10  for  the  deficient
data  base).   A chronic  oral  RfD  of  3xlO~*  mg/kg/day Is calculated and this
value has  been  verified  (U.S.  EPA,  1987b).   As  discussed  In Section 8.2.2.1.,
confidence In the key  study used  as the basis  for the chronic oral  RfD 1s low
because  of  Us  poor quality and  Us  short  duration.  Confidence In  the data
base  Is  low,  as  the  chronic  NTP (1985)  study  was  not  designed  to  study
chronic  toxlclty  and  does not  define a  NOAEL.   Overall  confidence  In  the
chronic oral RfD Is low.
6231H                                8-11                            09/27/89

-------
                         9.  REPORTABLE QUANTITIES
9.1.   BASED ON SYSTEMIC TOXICITY
    The  available  data  on the  effects of  long-term administration  of 1,3-
dichloropropene in  animals were  discussed  in detail  in Chapter  6.   Studies
that  provide  dose-response  data  are  summarized  in  Table 9-1.   Subchronic
studies are  included  In  Table  9-1 because effects of  subchronic  exposure are
similar  to  those  of  chronic  exposure  and  occur  at doses  and  exposure
concentrations  not  appreciably  different than-  those given   in  the  chronic
studies.   Por  this  reason, no uncertainty factors  were applied  to  doses  in
subchronic studies.
    Several  studies   discussed  in Chapter 6  are not  included in  Table 9-1.
Torkelson and  Oyen  (1977)  reported that, at  exposures of  50 ppm  (227 mg/m3)
1,3-dichloropropene  (19  exposures in  28 days)  or  11  ppm  (50  mg/m3)  1,3-
dichloropropene  (27   exposures  in 39  days),   liver  and  kidney  necrosis  was
found  in rats.  The  only effect  observed  among rats,  guinea pigs,  dogs  or
rabbits  exposed  by   inhalation  to  1,3-dichloropropene  <7   hours/day,   5
days/week for  6 months was cloudy swelling of  the  renal tubule epithelium of
male rats  (13.6 mg/m3, 4  or  7 hours/day).   These  studies were  not   included
in  Table  9-1   because  the  composition  of   the  1,3-dichloropropene  was  not
specified  and the  reported  effects  have  not  been  substantiated  in  other
studies  using  higher  exposure   levels  of  1,3-dichloropropene  of  >891. for
longer durations.
    Parker et  al.  (1982) found increased relative liver and kidney weights 1n
rats and  hepatocellular  hypertrophy  in mice  exposed by  inhalation to 50 ppm
of  the  D-D  mixture  (521  1,3-dichloropropene,  29X   1,2-dichloropropane). This
study is  not included in  Table  9-1  since the concentration  of  1,2-dichloro-
propane  in  the D-D  mixture  was  very high.   Similarly,  Linnett et al.  (1988)
6232H                                9-1                              06/19/89

-------
                                                                          TABLE  9-1
                                                           Toxicity  Summary  for  1,3-Oichloropropene
Species/
Route Strain Sex
Inhalation rat/F344 M



Inhalation rat/F344 M
F



..hd-ldtion rat/F344 M
F

•o
IVJ
inhalation mouse/ M
B6C3F1 F



inhalation mouse/ F
CD-I



inhalation mouse/ F
B6C3F1


Average Vehicle/
Number Body Physical Transformed
at Start Weight State Purity Exposure Animal Oose
(kg) (mg/kg/day)
10 0.26" air 90.9% 30 ppm (136 mg/ 17. lc
m3) 6 hours/
day, 5 days/week
for 13 weeks
10 0.235" air 92% 93 ppm (422 mg/ 64. Oc
10 0.160 m3) 7 hours/ 72. 5C
day, 5 days/
week for 13
weeks
50 0.380" air 92.1% 60 ppm (272 mg/ 30. 2C
50 0.230 m3) 6 hours/ 35.7
day. 5 days/
week for 2
years
10 0.027" air 90.9% 90 ppm (409 mg/ 97. 4C
10 0.022 m3) 6 hours/ 106.2
day, 5 days/
week for 13
weeks
10 0.031" air 92% 93 ppm (422 mg/ 1133
m3) 7 hours/
day, 5 days/
week for 13
weeks
50 0.03d air 92.1% 20 ppm (90.8 mg/ 21.1"
m3 ) 6 hours/
day, 5 days/
week for 2 years
Equivalent
Human Dose* Response
(rog/kg/day)
2.6 degenerative changes in
nasal nucosa


9.6 reduced body weight gain




5.3 decreased body weight gain;
degeneration of nasal
mucosa
i

7.1 degenerative changes in
nasal mucosa (both sexes);
hyperplasia of urinary bladder
epithelium (females)
•
8.6 reduced body weight gain




1.6 hyperplasia of respiratory
mucosa and urinary bladder
epithel ium

Reference
Stott et al . ,
1988


Coate et «1 . ,
1979



Lomax et al . ,
1989



Stott et al.,
1988-



Coate et al . ,
1979



Lomax et al . ,
1989


(>139H
                                                                                                                                                     06/29/89

-------
                                                                     TABLE 9-1 (cent.)


Route

Oral


»r«l


Oral


Oral

to
i

Species/
Strain

rat/
albino

rat/F344


rat/F334


mouse/
B6C3F1


Average
Number Body
Sex at Start Weight
(kg)
M 10 0.221"


F 50 0.25"


M 50 0.425"
F 50 0.25

F 50 0.028



Vehicle/
Physical
State Purity

propylene 78.5%
glycol

corn oil 89%


corn oil 89%


corn oil 89%





Exposure

10 mg/ kg/day, 6
days/week for
13 weeks
25 mg/kg/day
3 days/week
for 104 weeks
50 mg/kg/day
3 days/week
for 104 weeks
100 mg/kg/day,
3 days/week
for 104 weeks


Transformed
Animal Dose
(mg/kg/day)
8.6e


10. 7"


21.4"


42. 9e




Equivalent
Human Dose"
(mg/kg/day)
1.3


1.6


3.9
3.3

3.2





Response Reference

increased relative kidney Til et al . .
weight 1973

increased incidence of NTP. 1985
nephropathy

edema of submucosa of NTP, 1985
urinary bladder

reduced survival NTP, 1985



"Calculated by multiplying the transformed animal dose by the cube root of the ratio of the animal body weight to the human body weight (70 kg)
"Estimated from data in the study
'Calculated by expanding exposure concentration in ntg/m3 from intermittent to continuous, multiplying by the animal inhalation rate (U.S. EPA, I980a)
 and dividing by the animal body weight
"Reference body weight (U.S. EPA. 1980a)
''Calculated by expanding dose over a 7-day week
6139H
06/26/89

-------
found a  decrease In body weight  and  an Increase 1n  liver  and  kidney weights
In male  and  female  rats exposed  to 90  ppm  D-D  In  a  reproduction study.  This
also will not  be used  as a basis  for  an RQ value because  of  the composition
of the D-D mixture (53.7% 1,3-dlchloropropene).
    The  effects  of  exposure  to  1,3-dlchloropropene  Include  degenerative
changes  In  the  nasal  mucosa,  hyperplastlc  changes   In  the urinary  bladder,
reduced  body  weight gain.  Increased  kidney weights, nephropathy  and reduced
survival.  The  lowest  doses resulting  Vn  each  of'these effects  were used to
calculate CSs  (Table 9-2).   The  highest  CS (20) was obtained  In  the chronic
oral study by  NTP (1985) In which mice  treated  with  10  mg/kg/day had reduced
survival.  The corresponding RQ Is 100  pounds and  Is  recommended as the basis
for the RQ for chronic toxldty to 1,3-dlchloropropene (Table 9-3).
9.2.   BASED ON CARCINOGENICITY
    The NTP (1985) reports clear  evidence  of  carclnogenldty In rats  and mice
following  oral  exposure to  Telone  II   (1,3-dlchloropropene}  (Table  6-3).
Squamous  cell  paplllomas  and  carcinomas   of  the forestomach  and  Increased
Incidence  of   neoplastlc  nodules   of  the  liver were observed  1n male  F344
rats.  Squamous-cell paplllomas were found  In female  F344  rats.   In addition,
the  Incidence  of adrenal gland pheochromocytoma were significantly Increased
1n  male  rats  treated  at 25 mg/kg,  and the  Incidence  of  thyroid  folllcular
cell adenoma  or  carcinoma  In  female  rats  showed  a marginally  significant
(p<0.05)  positive  dose-related  trend.  In  female   B6C3F1  mice.  Increased
Incidences of  transitional-cell carcinomas  of the urinary  bladder  were found
as  well  as   alveolar/bronchlolar adenomas  of  the  lung  and  squamous-cell
paplllomas or  carcinomas of  the   forestomach.   Results  1n  male B6C3F1  mice
were not  clear because  of  high mortality 1n  the control  group.   Dose-related
Increased Incidences of  transitional-cell  carcinomas of the urinary  bladder,


6232H                                9-4                             09/21/89

-------
                                                                         TABLE 9-2



                                                       Oral Composite Scores for  1,3-Dichloropropene
Animal
Koutf Species Dose
(mg/kg/day)
I nlMlat ion rat 17. 1
initiation rat 30.2

; .iiid"lal ion mouse 21.1
l
U1
liul rat 8.6
<>,,,! rat 10.7

Oral rat 21.4
Ordl mouse 42.9
Chronic
Human MED
(mg/day)
182
371

112
91
112

231
224
RVd
2,1
1.6

2.4
2.6
2.4

2.0
2.0
Effect
degenerative changes in
nasal mucosa
reduced body weight
gain
hyperplasia of respiratory
mucosa and urinary bladder
epi thleum
increased kidney weight
increased incidence of
nephropathy
edema of urinary bladder
reduced survival
RVe
6
4

4
4
7

5
10
cs
12.6
6.4

9.6
10.4
16.8

40.0
20.0
RQ
1000
1000

1000
1000
1000

1000
100
Reference
Stott et al
Lomax et al

Lomax et al
Til et al. ,
NTP, 1985

NTP, 1985
NTP, 1985
., 1988
., 1989

., 1989
1973
m



6I39H
06/29/89

-------
                                  TABLE  9-3
                             1,3-Dichloropropene
         Minimum  Effective Dose  (MED) and Reportable  Quantity  
-------
squamous-cell paplllomas of  the  forestomach  and alveolar/bronchlolar  adenomas
and  carcinomas  of the lung,  however,  were found  1n  the male mice.  Lomax  et
al.  (1989)  found  no  statistically significant Increase  In  tumor  Incidence  1n
F344 rats treated with 1,3-dUhloropropene by  Inhalation.   In  B6C3F1  mice,  an
Increased Incidence of a benign  lung  tumors  (bronchloloalveolar  adenomas) was
found  In male mice  exposed to 60 ppm  1,3-d1chloropropene.  Van  Duuren  et al.
(1979)  also  observed sarcomas   In  Swiss mice  Injected  with  1,3-d1chloro-
propene.   MarkovUz   and   Crosby  (1984), found  some  evidence  for  a  causal
relationship between  acute exposure of humans  to  l,3-d1chloropropene and the
development of hematologlc  malignancies.
    l,3-D1chloropropene 1s  given a  cancer classification  of  B2, a  probable
human  carcinogen, by  U.S.  EPA  (1987b)  and  28,  as  a   chemical  or  group  of
chemicals that Is probably  carcinogenic for humans, by IARC (1987).
    Data used to  calculate  the  potency  factors (F or 1/ED,Q)  for  Inhalation
and oral exposure are  summarized  In Table 9-4  and Table  9-5.   Fs were derived
using  the linearized  multistage  model  developed by Kenneth Crump and adopted
by  the U.S.  EPA.   For the  Inhalation data,  the unadjusted I/ED-,-  obtained
from  the animal  data  (4.8xl(TVmg/kg/day)   was  corrected  for  Interspecles
extrapolation by  multiplying the cube root  of  the weight of a  human (70 kg)
by  the  weight  of  the animal,   and  the  resultant  F   Is  6.4xlO~1/mg/kg/day
(Table 9-4)  (Lomax et al., 1989).  For the  oral  data, equivalent human doses
and  combined Incidences of  forestomach  and  liver tumors  and adrenal   pheo-
chromocytoma  In  male  rats  (U.S. EPA,  1987b)  were  used  (Table  9-5).  The
resultant  F  for  oral  data  Is   g^xlO'Ving/kg/day.   Since  the F  for oral
exposure 1s  <1,  l,3-d1chloropropene Is placed  1n Potency Group 3; since the
chemical  Is  In  group  B2,  l,3-d1chloropropene  has  a  Low  Hazard  Ranking,
according  to  the Hazard   Ranking  Scheme  for  Reportable  Quantities   under
CERCLA.  The RQ associated  with Medium Hazard ranking  1s  100.
6232H                                9-7                             09/28/89

-------
                                  TABLE 9-4
          Derivation of Potency Factor (FJ for Inhalation Exposure to
                       1,3 Dlchloropropene  (Telone  II*)
Exposure route:
Species:
Strain:
Sex:
Vehicle or physical  state:
Body weight:
Duration of treatment:
Duration of study:
Llfespan of animal:
Target organ:
Tumor type:
Experimental doses/
exposure:
(mg/m3. 6 hours/
day, 5 days/week)
Transformed doses
(mg/kg/day):
Tumor Incidence:
Unadjusted 1/ED10
(F)
Adjusted I/ED™
(F)
Reference:
aReported
Estimated
Inhalation
mouse
B6C3Fi
male
vapor
0.0303
2 years
2 years
2 yearsb
lung
benign adenoma
0          22.7
0
9/50
5.3
6/50
           90.8
            272.0
21.2
13/50
63.1
22/50
4.8 x 10~2/mg/kg/day
6.4 x 10~Vmg/kg/day
Lomax et al., 1989
6232H
        9-8
                             09/21/89

-------
                                  TABLE 9-5
             Derivation of Potency Factor (F) for Oral Exposure to
                       1,3 Dlchloropropene  (Telone  II*)
Exposure route:
Species:
Strain:
Sex:
Vehicle or physical state:
Body weight:
Duration of treatment:
Duration of study:
Llfespan of animal:
Target organ:
Tumor type:
Experimental doses/
exposure:
(mg/kg/day, 3 days/week)
Transformed doses(human)
(mg/kg/day):
Tumor Incidence:
VEDIO (f factor)
Reference:
oral, gavage
rat
F344
male
corn oil
0.42 kgb
104 weeks
104 weeks
104 weeks3
forestomach, liver
paplllomas, carcinomas,  neoplastlc  nodules,
pheochromocytomas, folUcular  cell  adenoma/
carcinoma

0          50         100

024
4/52       13/52      23/52
9.6xlO~Vmg/kg/day
NTP, 1985
Estimated
Reported
6232H
        9-9
09/28/89

-------
                                10.  REFERENCES
Ab1vard1, C.   1970.   Occurrence of  paratylenchus  hamatus on  citrus In  Iran
and  Us  sensitivity  to two  nematlddes  under laboratory conditions.   Plant.
D1s. Rep.  54(12): 1085-1088.

ACGIH  (American  Conference  of  Governmental  Industrial  Hyglenlsts).   1986.
Documentation of  the  Threshold Limit  Values and Biological Exposure Indices.
5th ed.  ACGIH, Cincinnati, OH.  p.  189.-

ACGIH  (American  Conference  of  Governmental  Industrial  Hyglenlsts).   1988.
Threshold limit Values and Biological Exposure Indices  for 1988-1989.   ACGIH,
Cincinnati,  OH.  p. 18.

Albrecht, N.N.  1987a.   Toxicology  and hazard assessment of 1,3-dlchloropro-
pene.  Arch. Env.  Health  42: 292-296.

Albrecht, W.N.  1987b.   Occupational  exposure to  1,3-dlchloropropene (lelone
II  ) In Hawaiian pineapple culture.   Arch.  Env.  Health.   42: 286-291.

Albrecht, W.N.  and K. Chenchln.  1985.  Dissipation of  1,2-d1bromo-3-chloro-
propane  (DBCP), ds-l,3-d1chloropropene  (1,3-DCP), and dUhloropropenes  from
soil to atmosphere.  Bull. Env. Contain.  Toxlcol.  34: 824-831.

Applegate, V.C.,  J.H.  Howell,  A.E.  Hall,  Jr.  and  M.A. Smith.   1957.   Toxlc-
Ity  of  4346  chemicals to  larval  lampreys  and fishes.   Spec.  Scl. Rep. Fish.
No. 207, U.S. Dept. Interior,  Fish Wildlife Service, Washington,  DC.  p.  1-3,
8-9. 108-109.


6233H                                10-1                             07/25/89

-------
Ben-Yephet, Y., D.  Letham  and  G.  Evans.   1981.   Toxlclty of 1,2-dibromoethane
and  1,3-dichloropropene  to microsclerotia of  verticilllum dahliae.   Pestic.
Sci.  12(2): 170-174.

Blackmon,  C.W.  and H.L.  Musen.    1974.   Controls  of  the Columbia  dance)
nematode Hoplolaimus columbus or soybeans.   Plant.  Dis.  Rep.  58(7): 641-645.

Breslin, W.J., H.D. Kirk,  C.M. Streeter,  J.F.  Quast and O.R.  Szabo.   1987.
Telone  II® soil  fumigant:  Two-generation  inhalation  reproduction study  in
Fischer  344  rats.   Prepared  by  Health  and   Environmental   Sciences  USA.
Submitted by Oow  Chemical  Co.,  Midland MI.   MRID 403124.  (Cited in U.S. EPA,
1988).

Brodzinsky. R.  and H.B.   Singh.   1982.   Volatile  organic  chemicals   in  the
atmosphere: An assessment of available data.   EPA-600/S3-83-021.   p. 155.

Buccafusco,  R.J.,  S.J.  Ells  and  G.A.   LeBlanc.   1981.   Acute toxicity  of
priority  pollutants  to  bluegill  (Lepomis  machrochlrus).   Bull.  Environ.
Contam. Toxicol.   26(4): 446-452.

Carreon,   R.E.  and  O.M.   Wall.    1983.    Telone   IIs:   Skin  sensitization
potential  in   the  guinea  pig.   Office  of  Pesticide  Programs,  U.S.  EPA,
Washington, DC.  TSCAT fiche # OTS0515850.

Castro,  C.E.  and  N.O.  Belser.   1966.  Hydrolysis  of cis-  and  trans-1,3-di-
chloropropene 1n  wet soil.   J.  Agric.  Food Chem.  14: 69-70.
6233H                                10-2                             06/19/89

-------
C11m1e,   I.J.G.,   D.H.  Hutson.   B.J.  Morrison   and   G.   Sioydln.    1979.
Glutathlone  conjugation 1n  the  detoxlcatlon  of   (Z)-l,3-d1chloropropene  {a
component of the nematoclde D-D) 1n the rat,   Xenoblotlca.   9: 149-156.

Coate,  W.B.,  D.L.   Keenan,  R.  Voelker  and  R.J.  Hardy.   1978.   Subacute
Inhalation    toxlclty    study     In    rats   and    mice   of   Telone    II
(1,3-dlchloropropene).   TSCAT flche # OTS0515834.

Coate,  W.B.,  D.L.   Keenan,  R.W.  Voelker  and  R.J.  Hardy.   1979.   90-Day
Inhalation  study  1n rats  and  mice  -  Telone II   {Final Report).    Office  of
Pesticide Programs,  U.S. EPA, Washington,  DC.  TSCAT flche  # OTS0515855.

Cohen,   D.B.    1986.    Groundwater   contamination   by   toxic   substances.   A
California  assessment.  in:   ACS.  Symp.  Ser.  315  (Eval.  Pestle.  Ground
Water): Amer. Chem.  Soc.  29: 499-529.

Cole,  R.H.,  R.E.  Frederick,  R. P.  Healy  and R.G.  Rolan.   1984.   Preliminary
findings of  the priority pollutant monitoring project of the  Nationwide  Urban
Runoff Program.  J.  Water Pollut.  Control  Fed.  56:  898-908.

Cook,  R.J.,  J.W.  Sltton and W.A.  Haglund.   1987.   Influence of  soil  treat-
ments  on growth and yield  of  wheat and  Implications  for  control  of  pythlum
root rot.  Phytopathology.   77(8):  1192-1198.

Costante, J.F., W.F. Ma1,  J. Aleong and R.M. Klein.  1987.   Effects of  apple
rootstocks  and  nematlcldes  on  Pratylenchus  penetrans  populations  and  apple
tree growth.  J. Am. Soc. Hortlc.  Sc1.   112(3):  441-444.


6233H                                10-3                             07/25/89

-------
Greedy, C.L.,  T.M.  Brooks, B.J.  Dean,  D.H.  Hutson  and  A.S.  Nright.   1984.
The protective action of  glutathione  on the microbial mutagenicity  of the Z-
and E-lsomers of 1,3-dichloropropene.   Chem.  81ol.  Interact.   50:  39-48.

Crockett,   P.M.,  B.  Killan,  K.S.  Crump and  R.B.  Howe.   1985.   Descriptive
Methods   for   Using   Data   from   Dissimilar  Experiments   to    Locate   a
No-Adverse-Toxic-Effects Region in the dose-duration plane.  Prepared  by K.S.
Crump  and  Co., Inc.. under  Contract No. 6807-007 for  Environmental Criteria
and Assessment Office, U.S. EPA, Cincinnati,  OH.

Daft,  J.L.   1988.   Rapid  determination  of fumigant  and   industrial  chemical
residues in food.   J. Assoc.  Off. Anal.  Chem.   71(4):  748-760.

Dean, J.A.,  Ed.   1985.   Lange's Handbook of Chemistry.   13th ed.   McGrawHill
Book Co.,  New York, NY.   p. 7-294.

DeBenedictis,  A.   1979.   Chlorocarbons, hydrocarbons  (allyl  chloride).-  ITK
Klrk-Othmer  Encyclopedia  of  Chemical Technology.   Vol.   5,  3rd  ed., Grayson,
M. and D.  Eckroth, Eds.   John Wiley and Sons,  Inc., New York.   p.  766-767.

DeLorenzo,  F., S.  Degl'Innocenti,  A.  Ruocco,  L. Silengo  and  R.  Cortese.
1977.   Mutagenicity  of  pesticides   containing  1,3-dichloropropene.   Cancer
Res.  37:  1915-1917.
6233H                                10-4                            06/19/89

-------
D1etz,  F.K.,   E.A.  Hermann,  P.E.  Kastl,  D.A.  OHtenber  and  J.C.  Ramsey.
1985.   1,3-Olchloropropene:   Pharmacok1net1c  effects  on  tissue  non-protein
sulfhydryls and  macromolecular  binding  In  Fischer 344  rats  and  B6C3F1  mice
following oral administration.  TSCAT flche # OTS0515836.

Dllllng, W.I.   1977.   Interphase  transfer  processes.    II. Evaporation  rates
of  chloromethanes,  ethanes,   ethylenes,  propanes  and  propylenes  from  dilute
aqueous  solutions.    Comparisons   with  -theoretical  predictions.   Env.  Sd.
Tech.  11:  405-409.

Oowty,  B., D.  Carlisle,  J.L.  Laseter  and  3.  Storer.   1975.   Halogenated
hydrocarbons  In  New Orleans  drinking water and blood plasma.   Science.   187:
75-77.

Durkln,  P. and  W.  Meylan.   1988.   Users  guide  for  D2PLOT:  A  program  for
dose/duration  graphs.   Prepared   by  Chemical   Hazard   Assessment  Division,
Syracuse  Research  Corp.   under   Contract  No.  68-C8-0004  for  Environmental
Criteria and Assessment Office,  U.S. EPA, Cincinnati,  OH.

Edwards, C.A.  and  D.  Relchle.   1969.    Experimental   manipulation  of  soil
Invertebrate populations for  trophic studies.   Ecology.   50(3):  495-498.

Fisher,  G.D.    1988.    The  disposition  of  1,3-dlchloropropene   In  the  rat
following acute Inhalation exposure.  Dlss. Abstr.  Int.   48:  3537-B.

Fisher,  G.D.  and  W.W.   Kllgore.    1988a.   Tissue  levels   of  glutathlone
following  acute  Inhalation of 1,3-dlchloropropene.  J. Tox. Env. Health.   23:
171-182.

6233H                                10-5                            07/25/89

-------
Fisher, G.D.  and H.W. Kllgore.   1988b.   Mercapturlc add  excretion by  rats
following  Inhalation  exposure  to  1,3-d1chloropropene.   Fundam.  Appl.   Tox.
11: 300-307.

Gosselln   R.,   H.    Hodge,    R.    Smith    and    M.   Gleason    III.     1976.
Dlchloropropenes.  In.:   Clinical  Toxicology of  Commercial  Products, 4th ed.
Williams and Wllklns,  Baltimore.  MD.  p.  119-121.
                                                  •
Great Lakes Water Quality  Board.   1983.   An Inventory of chemical  substances
Identified  In  the Great  Lakes  ecosystem.   Report  to the  Great Lakes  Water
Quality Board.  Windsor,  Ontario,  Canada.   Vol.  1, Summary,  p. 64.

Hanley, T.R.  Jr.,  J.A.  John-Greene, J. T.  Young, L.L.  Calhoun and K.S.  Rao.
1987.     Evaluation    of   the    effects    of   Inhalation    exposure   to
1,3-dlchloropropene  on fetal  development  In rats and rabbits.  Fundam.  App.
Tox.  8: 562-570.

Haworth,  S.,   T. Lawlor,  K.  Mortelmans,   W.   Speck  and  E.   Zelger.    1983.
Salmonella  mutagenldty   test  results  for 250  chemicals.   Env.  Mutagen.
Suppl.  1: 3-142.

Heltntuller, P.T., T.A. HolHster  and  P.R.  Parrlsh.   1981.   Acute toxlclty of
54  Industrial  chemicals  to  sheepshead minnow  cyprlnodon  varlegatus.    Bull.
Environ. Contam. Toxlcol.  27(5):  596-604.
6233H                                10-6                            07/25/89

-------
Hermens,  J.,   F.  Busser,  P.  Leeuwanch  and  A.  Musch.   1985.   Quantitative
correlation studies between  the  acute  lethal  toxicity of 15 organic  halldes
to   the  guppy   (PoeciHa  reticulata)   and  chemical   reactivity   towards
4-nitrobenzylpyridine.  Toxicol.  Environ. Chem.   9(3):  219-236.

H1ne, C.H., et al.   1953.   Toxicology  and sage handling  of  CBP-55  (technical
l-chloro-3-bromopropene-1>.  Am.  Med.  Assoc.  Arch. Ind.   Hyg. Occup. Med.   7:
118. (Cited In U.S.  EPA, 1980)

Hutson, D.H.,  J.A.  Moss and B.A.  Pickering.   1971.   Excretion  and  retention
of  components of  the  soil  fumigant  D-D and  their  metabolites in the  rat.
Food Cosmet. Tox.  9: 677-680.

IARC.   1987.   IARC  monographs  on the  evaluation of  carcinogenic  risks  to
humans.  Supp. 7.  p.62.

Oarabek, A.   1988.   U.S.  EPA,  Research Triangle Park.  Telephone conversation
with Gary Diamond, Syracuse Research Corporation,  Syracuse,  NY.   December  20,
1988.

Jeffrey,  M.M.,   D.J.   Schuetz  and  L.G.  Lomax.   1987.   Telone  II®  Soil
Fumigant: Acute  Dermal  Toxlcity  Study  in  New Zealand White  Rabbits.   Office
Of  Pesticide  Programs,  U.S. EPA, Washington, DC.  TSCAT fiche # OTS0515820.

Johnson,  W.W.  and  M.T.  Fin ley.   1980.   Handbook  of  acute  toxicity  of
chemicals  to  fish  and  aquatic   Invertebrates.   U.S.  Department   of  the
Interior, Fish Wildlife Service, Washington, DC.  Resource Publ.  137.
6233H                                10-7                            06/26/89

-------
Jones  J.R.   and  T.A.   Collier.    1986.   .Telone   II®:  OECD  40!  acute  oral
toxidty test In the rat.   TSCAT  fiche  »  OTS0515823.

Kenaga,  E.E.   1980.   Predicted  bioconcentratlon  factors  and  soil   sorption
coefficients of pesticides  and other  chemicals.   Ecotoxicol.  Env.  Safety.   4:
26-38.

Kotcon,  J.B.  and  R. Loria.   1987. "Fall  fumigation  of potato  with  1,3-di-
chloropropene:  Efficacy  against   Pratylenchus  crenatus.  yield  response  and
groundwater contamination potential.   Plant Dis.   71(12):  1122-1124.

Krijgsheld,  K.R. and A. van der Gen.   1986.   Assessment of the  impact  of  the
emission  of  certain   organochlorine  compounds  on  the aquatic  environment.
Part  II: Allylchloride,   1,3-  and  2,3-dichloropropene.    Chemoshpere.   15:
861-880.

Lao, R.C.,  R.S.  Thomas,   P.  Bastien,  R.A. Halman  and  J.A.  Lockwood.   1982.
Analysis  of organic  priority and  non-priority  pollutants  In  environmental
samples   by   GC/MS/computer   systems.    In:    Analytical   Techniques   in
Environmental  Chemistry  II.   Albaiges,  J.,  Ed.    Pergamon  Press  LTD.,  New
York, NY.  p. 107-118.

LeBlanc,  G.A.   1980.    Acute  toxicity  of  priority  pollutants to  water flea.
(daphnia maqna).  Bull. Environ.  Contam.  Toxlcol.   24: 684-691.

LeBlanc,  G.A.   1984.     Interspecies  relationships  in   acute   toxicity  of
chemicals to aquatic organisms.  Environ. Toxicol. Chem.  3(1): 47-60.
6233H                                10-8                            06/19/89

-------
Leistra,  M.   1970.  Distribution  of 1,3-dichloropropene over  the phases  in
soil.   J.  Agrk.  Food Chem.   18:  1124-1126.

Llnnett,  S.L., D.G.  Clark,   D.  Blair  and  S.L.  Cassidy.   1988.   Effects  of
subchronic  inhalation  of  D-D  (1,3-dichloropropene/l,2-dichloropropane)   on
reproduction in male  and female rats.  Fund.  Appl.  Tox.   10:  214-223.
                                               •

Lomax, L.G.,  W.T. Stott,  K.A.  Johnson,  L.L.  Calhoun,   B.L.  Yano  and  J.F.
Quast.  1989.   The  chronic  toxicity  and  oncogenicity  of  inhaled  technical
grade 1,3  dichloropropene in rats and mice.   Fund.  Appl.  Tox.  12:  418-431.

Mabey, N.R.,  J.H.  Smith, R.T.,  H.L.  Johnson, et  al.    1981.   Aquatic  fate
process data  for organic priority pollutants.  EPA-440/4-81-014.   U.S.  EPA,
Washington, DC.  p. 434.

Maddy, K.T., H.R.  Fong,  J.A.  Lowe, D.W.  Conrad  and  A.S. Fredrickson,   1982.
A  study  of  well   water  in   selected California communities for  residues  of
1,3-dich1oropropene,    chloroallyl    alcohol    and    49    organophosphate   or
chlorinated hydrocarbon pesticides.  Bull.  Env. Contam.  Toxicol.   29:  354-359.

Mantel,  N.  and   M.A.  Schneiderman.   1975.   Estimating  "safe"  levels,   a
hazardous  undertaking.  Cancer Res.  35:  1379-1386.

Markovitz,  A.  and N.H.  Crosby.   1984.   Chemical  carcinogenesis.   A -soil
fumlgant,     1,3-dichloropropene,     as    possible    cause   of    hematologic
malignancies.  Arch.  Intern. Med.  144: 1409-1411.
6233H                                10-9                            06/19/89

-------
Mathur, S.P., H.A.  Hamilton  and T.C. Vraln.  1980.   Influence  of  some field-
applied nematlcldes  on  mlcroflora and mineral  nutrients  In an organic  soil.
J. Environ. Sc1. Health.  815(1): 61-76.

Mazurek, H.A. and B.R.T.  Slmonettl.   1986.  Organic  components  In bulk  and
wet-only precipitation.   Critical Review  Env.  Control.  16:  27.

HcCall,  P.J.   1987.    Hydrolysis  of  lJ3-d1chloropropene   In  dilute  aqueous
solution.  Pestle. Scl.   19:  235-242.

Munnecke,  O.E.  and  S.O.  Van Gundy.   1979.  Movement  of  fumlgants In  soil,
dosage  responses  and   differential  effects.    Annu.   Rev.  Phytopathol.    17:
405-429.

Nater,  3.P.  and  V.H.J.  Gooskens.   1976.   Occupational dermatosls  due  to  a
soil fumlgant.  Contact  Dermatitis.  2: 227-229.

Neudecker,  T. and  D.  Henschler.  1986.  HutagenlcHy of chloroolefIns In  the
Salmonella/mammalian  mlcrosome  test.    III.    Metabolic   activation  of-  the
allyllc  chloropropenes  allyl  chloride,  1,3-dlchloropropene,  2,3-dlchloro-l-
propene, 1,2,3-tMchlorpropene,  1,l,2,3-tetrachloro-2-propene and  hexachloro-
propene by S9 mix  via  two different  metabolic pathways.   Mutal.   Res.  170:
1-9.

Neudecker,  T.,  A.  Stefanl  and  D. Henschler.  1977.   lin vitro mutagenlclty  of
the soil nematlclde l,3-d1chloropropene.   Enperlantla.  33:  1084-1085.
6233H                                10-10                           07/25/89

-------
NTP  (National   Toxicology  Program).    1985.   Toxicology  and  carcinogenesis
studies of  Telone  IT  in  F344/N rats  and  B6C3F1 mice.   U.S.  Department  of
Health and Human Services.   NTP TR 269.   NIH Publication No.  85-2525.

OSHA   (Occupational    Safety   and    Health   Administration).    1989.    Air
contaminants: Final rule.  29 CFR Part 1910.  54:  2933.

Osterloh, 0., G. Letz,  S.  Pond and C.  Becker.    1983.   An assessment of  the
potential   testicular   toxicity  of  10  pesticides  using   the   mouse-sperm
morphology assay.  Mutat. Res.  116: 407-415.

Osterloh,  O.D.,  B.S.  Cohen,   W.  Popendorf  and   S.M.   Pond.   1984.   Urinary
excretion  of the  N-acetyl  cysteine  conjugate  of cis-1,3-dichloroporpene  by
exposed individuals.   Arch.  Env. Health.  39: 271-275.  '

Otson, R.   1987.   Purgeable organics  in  Great  Lakes  raw and  treated water.
Intern. J. Environ. Anal. Chem.  31: 41-53.

Parker,  C.M.,   W.B.  Coate  and  R.W.  Voelker.   1982.   Subchronic  inhalation
toxicity  of 1,3-dichloropropene/l,2-dichloropropane   (D-D)  in mice and  rats.
J. Tox. Env. Health.   9: 899-910.

Pellizzari,  E.D,  M.D.  Erlckson and  R.A.  Zweidinger.   1979.   Formulation of
preliminary  assessment  of   halogenated   organic   compounds   in   man   and
environmental  media.    EPA/560/13-79-006.   U.S.  EPA, Research  Triangle  Park,
NC.  p. 469.
6233H                                 10-11                            06/19/89

-------
Refff, B.   1978.   The acute toxicity of 1,3-dichloropropene to  the  golen orfe
(Idus Idus melanotus).  Shell  Oil  Company.   NTIS OT 50515717.

Roberts,  T.R.  and  G. Stoydin.   1976.   The degradation  of (Z)- and  (E)-l,3
dlchloropropenes  and 1,2-dichloropropane in soil.  Pestic. Scl.   7:  325-335.
                                              •*
Rogers, S.E.,  D.L.  Peterson   and  w7c.  Lauer.    1987.   Organic  contaminants
removal for potable reuse.  J. Wat. Pollut. Con. Fed.  59: 722-732.

Sabel, G.V. and  T.P.  Clark.   1984.  Volatile organic  compounds as  indicators
of  municipal  solid  waste  leachate  contamination.    Waste Manag.  Res.   2:
119-130.

SANSS   (Structure   and    Nomenclature   Search   System).   1989.    Chemical
Information System (CIS computer database).

Schneider, B.A.   1979.  Toxicology Handbook.  Mammalian and Aquatic Data Book
1.   Toxicology   Data.   OPP,  U.S.  EPA,  Washington,  DC.    EPA  540/9-79-003A.
NTIS PB 80-196876.

Scott, C.R. and   P.A.  Wolf.   1962.   The antibacterial  activity  of a series of
quaternaries  prepared   from  hexatnethylenetetramine   and  halohydrocarbons.
Appl. Microbiol.   10: 211-216.

Shackelford,  W.M.  and  L.H.   Keith.   1976.   Frequency of organic compounds
Identified in water.  EPA-600/4-76-062.  U.S. EPA., Athens, GA.  p.  208.
6233H                                10-12                           06/19/89

-------
SRI 
-------
Tabak, H.H.,  S.A.  Quave,  c.I.  Mashni  and E.F. Barth.   1981.   BiodegradabiHty
studies with  organic  priority pollutant  compounds.   J. Water  Pollut.  Contr.
Fed.   53:  1503-1518.

Talcott,  R.E.  and  J.  King.   1984.   Mutagenk  impurities  in  1,3-dichloro-
propene preparations.   J. Natl.  Cancer Inst.   72:  1113-1116.

Thomas, I.J.  and  M.V.  McKenry.   1974.  Part  1.   Movement and fate  as affected
by various conditions  in several  soils.   Hilgardia.   42: 393-421.

Thomas, R.G.   1982.   Volatilization  from  water.   In:   Handbook  of  Chemical
Property  Estimation  Methods,  Lyman,  W.J.,  N.F,  Reehl  and  D.H.  Rosenblatt,
Eds.   McGraw Hill  Book Co.,  Inc.   New York, NY.   p.  15-1-15-34.

Til,   H.P., M.T. Spanjers, V.J.  Fernon  and P.J.G.  Reuzel.   1973.   Subchronic
(90-day)  toxicity  study   with   Telone  II®  in  albino  rats.    Office  of
Pesticide Programs, U.S. EPA, Washington, DC.  TSCAT fiche # OTS0515825.

Torkelson, T.R. and F.  Oyen.   1977.   The  toxicity  of  1,3-dichloropropene  as
determined by  repeated  exposure  of laboratory animals.  Am.  Ind.  Hyg.  Assoc.
J.  38: 217-223.

Torkelson, T.R.  and V.K. Rowe.    1981.   Halogenated alephatlc  hydrocarbons.
In:  Patty's   Industrial  Hygiene  and  Toxicology.   3rd  ed.  G.D.  Clayton and
F.E.  Clayton, Eds.  John Wiley and Sons, Inc., New York, NY.   IIB:  3573-3577.

6233H                                 10-14                           06/19/89

-------
Toyoshlma,  S.t  R.  Sato and  S.  Sato.   1978a.   The acute  toxlclty test  of
Telone II* 1n rats.  TSCAT flche # OTS0515832.

Toyoshlma,  S.,  R.  Sato and  S.  Sato.   1978b.   The acute  toxlclty test  of
Telone  II  In  mice.    Office  of  PesUdde  Programs,  U.S.  EPA,  Washington,
DC.  TSCAT flche* OTS0515833.

Tuazon, E.C.  R.  Atkinson,  A.M. Winer and  J.N.  Pitts.  1984.  A study  of  the
atmospheric   reactions   of     l,3-d1chloropropene    and   other    selected
organochlorlne compounds.  Arch. Env. Contam.  Toxlcol.  13:  691-700.

U.S.  EPA.   1977.   Computer printout  of  nonconfIdentlal production  data  from
TSCA production file for 1977.   Washington, DC.

U.S.  EPA.   1978.   In-depth   Studies  on   Health  Environmental   Impacts   of
Selected Water Pollutants.  U.S.  EPA  Contract No.  68-01-4646.   (CHed  1n  U.S.
EPA, 1980b)

U.S.  EPA.  1980a.   Guidelines and  Methodology  Used  In the  Preparation  of
Health  Effect  Assessment  Chapters  of  the  Consent Decree  Water  Criteria.
Federal Register.   45(231): 79347-79357.

U.S.  EPA.  1980b.   Ambient  Water  Quality Criteria  for Dlchloropropane  and
Dlchloropropene.   Prepared  by  the  Office  of  Health   and   Environmental
Assessment, Environmental  Criteria and  Assessment Office, Cincinnati,  OH  for
the Office  of Water  Regulations and Standards Criteria, Washington, DC.   EPA
440/5-80-043.  NTIS PB81-117541.
6233H                                10-15                           09/28/89

-------
U.S. EPA.   1984.   Methodology and  Guidelines,for  Ranking Chemicals  Based on
Chronic Toxlclty  Data.   Prepared  by  the Office  of Health  and  Environmental
Assessment, Environmental  Criteria and Assessment  Office, Cincinnati,  OH for
the Office of Emergency and Remedial Response, Washington, DC.

U.S. EPA.   1985.   Health and Environmental Effects  Profile  for  1,3-D1chloro-
propene.   Prepared  by  the  Office of  Health  and  Environmental  Assessment,
Environmental  Criteria  and Assessment  Office,  Cincinnati,  OH for  the  Office
of  Solid   Waste  and  Emergency  Response.  Washington,  DC.   EPA/600/X-85/399.
NTIS PB88-174594.

U.S. EPA.   1986a.   Methodology  for Evaluating Reportable Quantity Adjustments
Pursuant to CERCLA  Section 102.   Prepared  by  the  Carcinogen  Assessment  Group,
Office of  Health  and Environmental Assessment, Washington, DC for  the  Office
of Emergency and Remedial Response, Washington, DC.

U.S. EPA.   1986b.  Exams II computer model.  Athens, GA.   Version 2.91.

U.S.  EPA.   1986c.   Guidelines  for   Carcinogen   Risk  Assessment. " Federal
Register.   51: 33992-34003.

U.S. EPA.   1987a.   Graphical  exposure modeling  system  (GEMS).   PC  Version,
April,  1987.  CLOGP.  Computer program.

U.S. EPA.   1987b.   Integrated Risk Information System  (IRIS).   Reference Dose
(RfD) for  Oral Exposure for  1,3-dlchloropropene.   Online.   (Verification date
04/15/87.)   Office  of   Health  and Environmental  Assessment,  Environmental
Criteria and Assessment Office.   Cincinnati, OH.

6233H                                10-16                           09/28/89

-------
U.S.  EPA.   1988.  Health  Advisory  for 1,3-D1chloropropene.   Prepared  by the
Office of Drinking Water, Washington, DC.

U.S.  EPA/OWRS.   1986.   Guidelines  for   Deriving  Numerical  National  Water
Quality  Criteria for  the  Protection  of  Aquatic  Organisms  and Their  Uses.
U.S. EPA, Washington, DC.  p. 22-58, 98.  NTIS PB85-227049/XAB.

Valencia  R.,  J.H. Mason,  R.C.  Woodruff- and  S.  Zlmmerlng.   1985.   Chemical
mutagenesls  testing   In drosophlla.    III.   Results  of  48   coded  compounds
tested for the National Toxicology Program.  Env. Mutagen.  7: 325-348.

van  der  Pas,  L.J.T.  and M.  Lelstra.   1987.   Movement  and  transformation  of
1,3-dlchloropropene  In  the soil  of flower bulb  fields.  Arch.  Env.  Contam.
Toxlcol.  16:  417-422.

Van   Duuren,   B.L.,   B.M.   Goldschmldt,   G.   Lowengart,   et  al.    1979.
Carclnogenlclty  of  halogenated  oleflnlc and  aliphatic  hydrocarbons  In  mice.
J. Natl. Cancer  Inst.  63: 1433-1440.

Varanka, I.  1979.   Effect  of  some  pesticides  on the  rhythmic adductor  muscle
activity of freshwater mussel larvae.  Symp. B1ol.  Hung.  19: 177-196.

Venable,  J.R.,  C.D.  McCllmans,  R.E.  Flake  and  D.B.  Dlmlck.   1980.   A
fertility  study  of male  employees  engaged In  the manufacture  of  glycerine.
J. Occup. Med.   22(2): 87-91.
6233H                                10-17                           09/28/89

-------
Vlthayathll, A.J.,  C.  McClure and  J.W.  Meyers.   1983.   Salmonella/mlcrosome
multiple Indicator mutagen1c1ty test.  Muta.  Res.   121:  33-37.

von  der  Hude,   H.,  M.  Scheutwlnkel,  U.  Gramllch  and  B.  Flssler.   1987.
Geontoxldty of  three  carbon  compounds  evaluated 1n the  SCE  test in  vitro.
Env. Mutagenesls.  9: 401-410.

Watson,  M.P.,  T.M.  Brooks,  K.R.  Huckle,  D.H.   Hutson,  K.L.  Lang  and  R.J.
Smith.   1987.   Nlcroblal mutagenlclty  studies with  (2)-l,3-d1chloropropene.
Chem. Blol. Interact.  61:  17-30.

Wlndholz,  M.,  Ed.  1983.   The Merck Index.    10th ed.   Merck  and Co.,  Inc.,
Rahway, NJ.  p  446.

Worthing,  C.R. and  S.B.  Walker.  1987.  The  Pesticide  Manual.  8th  ed.   The
British Crop Protection Council,  Croydon, England, p. 4410,  4420.

Yang, R.S.H.  1986.   1,3-d1chloropropene.  Res. Rev.   97:  19-35.
6233H                                10-18                           09/28/89

-------
                                  APPENDIX A  .

    This  HEED  Is  based  on  data  Identified  by  computerized  literature

searches of:

                   CHEMLINE
                   TSCATS
                   CASR online (U.S.  EPA Chemical Activities Status Report)
                   TOXLINE
                   TOXLIT
                   TOXLIT 65
                   RTECS
                   OHM TADS
                   STORET
                   SRC Environmental  Fate Data Bases
                   SANSS
                   AQUIRE
                   TSCAPP
                   NTIS
                   Federal Register
                   CAS ONLINE (Chemistry and Aquatic}
                   HSDB
                   SCISEARCH
                   Federal Research In Progress
These  searches  were conducted  In  March, 1989,  and  the  following  secondary

sources were reviewed:
       ACGIH  (American  Conference  of  Governmental  Industrial  Hyglenlsts).
       1986.   Documentation  of  the  Threshold  Limit  Values  and  Biological
       Exposure Indices.  5th ed.  Cincinnati, OH.

       ACGIH  (American  Conference  of  Governmental  Industrial  Hyglenlsts).
       1987.   TLVs:  Threshold Limit  Values  for Chemical  Substances  1n  the
       Work   Environment   adopted  by  ACGIH  with   Intended   Changes   for
       1987-1988.  Cincinnati, OH.  114 p.

       Clayton,  G.D.  and  F.E.   Clayton,  Ed.    1981.   Patty's  Industrial
       Hygiene and Toxicology.   3rd rev.  ed.  Vol.  2A.  John  Wiley and Sons,
       NY.  2878 p.

       Clayton,  G.O.  and  F.E.   Clayton,  Ed.    1981.   Patty's  Industrial
       Hygiene and Toxicology.   3rd rev.  ed.  Vol.  28.  John  Wiley and Sons,
       NY.  2879-3816 p.

       Clayton,  G.D.  and  F.E.   Clayton,  Ed.    1982.   Patty's  Industrial
       Hygiene and Toxicology.   3rd rev.  ed.  Vol.  2C.  John  Wiley and Sons,
       NY.  3817-5112 p.
6140H                                A-l                            07/25/89

-------
       Grayson, M.  and 0.  Eckroth,  Ed.  1978-84.   Klrk-Othmer  Encyclopedia
       of Chemical Technology, 3rd ed.  John Wiley and Sons, NY.   23 Volumes.

       Hamilton,  A.   and  H.L.  Hardy.   1974.    Industrial  Toxicology.   3rd
       edition.  Publishing Sciences Group,  Inc.,  HA.  575 p.

       IARC  (International  Agency for Research  on  Cancer).   IARC Monographs
       on the Evaluation of Carcinogenic Risk  of Chemicals  to Humans.   IARC,
       Lyons, France: WHO.

       Jaber,  H.M.,  W.R.  Mabey,  A.T.  L1eu,  T.W.  Chou  and  H.L.  Johnson.
       1984.    Data   acquisition   for   environmental  transport   and   fate
       screening  for  compounds  of  Interest to  the  Office  of Solid  Waste.
       EPA-600/6-84-010.   (NTIS  PB84-243906)  Henlo  Park,   CA:  SRI  Inter-
       national.

       NTP  (National  Toxicology  Program).   1988.   Toxicology Research  and
       Testing Program.  Chemicals on Standard  Protocol.   Management Status.

       Ouellette,   R.P.  and  J.A.  King.   1977.   Chemical  Week  Pesticide
       Register.  McGraw-Hill  Book Co., NY.

       Sax,  I.N.   1984.   Dangerous  Properties of  Industrial  Materials.   6th
       ed.  Van Nostrand Relnhold Co., NY.

       SRI  (Stanford  Research  Institute).    1987.    Directory  of  Chemical
       Producers.   Stanford, CA.

       U.S.  EPA.   1986.   Report  on  Status  Report  1n   the  Special  Review
       Program,  Registration   Standards   Program  and   the   Data   Call   In
       Programs.   Registration  Standards  and   the  Data  Call  In  Programs.
       Office of Pesticide Programs, Washington,  DC.

       USITC   (United  States   International    Irade  Commission).    1986.
       Synthetic Organic  Chemicals.   U.S.  Production  and Sales,  1985,  USITC
       Publication 1892.  Washington, DC.

       Verschueren,  K.   1983.   Handbook of  Environmental  Data  on  Organic
       Chemicals.   2nd ed.  Van Nostrand Relnhold Co., NY.

       Worthing,  C.R.  and  S.6. Walker,  Ed.   1983.   The Pesticide  Manual.
       British Crop Protection Council.  695 p.

       Wlndholz, M.  Ed.   1983.  The  Merck  Index.   10th   ed.   Merck  and  Co.,
       Inc., Rahway, NJ.
6140H                                A-2                            07/25/89

-------
    In addition,  approximately 30 compendia  of aquatic  toxicity data  were

reviewed, including the following:


       Battelle's Columbus Laboratories.   1971.   Water  Quality Criteria Data
       Book.  Volume  3.   Effects  of Chemicals  on  Aquatic  Life.   Selected
       Data  from the  Literature  through  1968.   Prepared for the U.S.  EPA
       under Contract No. 68-01-0007.  Washington,  DC.

       Johnson,  W.W.  and  M.T.  Finley.   1980.   Handbook of Acute  Toxicity of
       Chemicals  to  Fish and  Aquatic  Invertebrates.  Summaries  of  Toxicity
       Tests Conducted  at Columbia  National  Fisheries  Research  Laboratory.
       1965-1978.   United States  Dept.  Interior,  Fish  and  Wildlife  Serv.
       Res. Publ. 137, Washington,  DC.

       McKee, J.E. and  H.W.  Wolf.   1963.   Water  Quality  Criteria.   2nd  ed.
       Prepared  for  the  Resources  Agency of California,  State Water  Quality
       Control  Board.  Publ.  No. 3-A.

       Pimental, D.   1971.   Ecological  Effects  of  Pesticides  on Non-Target
       Species.   Prepared for the U.S.  EPA, Washington,  DC.   PB-269605.

       Schneider,  8.A.   1979.   Toxicology  Handbook.  Mammalian  and  Aquatic
       Data.  Book 1:  Toxicology  Data.   Offi'ce  of  Pesticide  Programs,  U.S.
       EPA, Washington, DC.   EPA 540/9-79-003.   NTIS PB 80-196876.
6140H                                A-3                            06/16/89

-------
                                 APPENDIX 6

                 Cancer Data Sheet for Derivation of q! for
                             Inhalation  Exposure
Compound:  1,3-dlchloropropene

Reference:  lomax et al.,  1989

Specles/straln/sex:  mouse, B6C3F1,  male

Body weight = 0.030 kg (measured)

Length of exposure  = 24 months

Length of experiment (Le)  - 24 months

Llfespan of animal (L) * 24 months

Tumor site and type:  lung, benign adenoma
Experimental Doses or
     Exposures

-------
                                                                           APPENDIX C

                                                              Summary Table for  1,3-Olchloropropene

Species
Exposure
Effect
RfO or qj*
Reference
Inhalation exposure
Subchronlc
Chronic
Carclnogenlclty
Oral exposure
Subchronlc
Chronic
Cardnogenlclty
rat
rat
mouse

rat
rat
rat
10 ppm (45.4 mg/m») 6
hours/day. 5 days/week for
13 weeks (HEC. 1.4 mg/m')
10 ppm (45.4 mg/m») 6
hours/day, 5 days/week for
13 weeks (HEC. 1.4 mg/m»)
5, 20. 60 ppm (22.7, 90.6.
272 mg/m*} 6 hours/day, S
days/week for 2 years

3 mg/kg/day, 6 days/week
for 90 days
3 mg/kg/day, 6 days/week
for 90 days
0. 25, 50 mg/kg/day,
3 days/week for 104 weeks
degenerative changes 1n nasal
mucosa at higher doses
degenerative changes In nasal
mucosa at higher doses
benign lung tumors

Increased kidney weight at
higher doses
Increased kidney weight at
higher doses
forestomach, liver
0.01 mg/m*
0.01 mg/m»
1.3 x 10~l
( mg/kg/day T1

3 x 10~»
(mg/kg/day }
3 x 10~«
(mg/kg/day)
1.8 x 10'»
(mg/kg/day)"1
Stott et al.. 1982
Stott et al., 1988
Umax et al.. 1989

T11 et al., 1973
Til et al., 1973
NTP. 1985
»EPO)>T*BLE QUANTITIES
Based on chronic
toxlclty:
Based on care Inogenl city:
100
100






CD
CD
10

-------
                                 APPENDIX D
               DOSE-DURATION RESPONSE GRAPHS FOR EXPOSURE TO
                            1,3-DICHLOROPROPENE
D.I.   DISCUSSION
    Dose-duration response  graphs  for  inhalation  and oral exposure  to 1,3-
dlchloropropene generated by the method  of Crockett et al. (1985)  using  the
computer  software  by Durkin and  Meylan (1988) developed  under contract  to
ECAO-Clndnnatl are presented In Figures  D-l  to D-6.  Data used to generate
these graphs are presented  in  Section D.2.  In generation of  these figures,
all responses  are classified as  adverse (PEL,  AEL  or LOAEL)  or' non-adverse
(NOEL  or  NOAEL)  for  plotting.    For   Inhalation  exposure,   the  ordinate
expresses concentration in either of  two  ways.   In Figures D-l  and  D-2,  the
experimental concentration  expressed as  mg/m3 was  multiplied  by  the  time
parameters of  the exposure  protocol  (e.g., hours/day  and  days/week) and  is
presented  as   expanded  experimental  concentration  (mg/m3).   In Figures  D-3
and D-4,  the expanded  experimental  concentration  was multiplied by  the cube
root  of  the  ratio of  the animal ihuman  body  weight  to adjust for  species
differences  In  basal  metabolic  rate  (Mantel  and  Schnelderman,  1975)  to
estimate  an equivalent   human  or  scaled  concentration  (mg/m3).    For  oral
exposure,  the  ordinate expresses dosage  as human  equivalent  dose  (Figures
D-5 and  D-6).  The  animal dosage in mg/kg/day  Is  multiplied by the cube root
of  the  ratio  of  the  animal .'human  body  weight  to  adjust  for  species
differences  in basal  metabolic  rate (Mantel  and  Schnelderman, 1976).   The
result  is then multiplied  by  70 kg,  the  reference human body  weight,  to
express the human equivalent dose as mg/day for a  70 kg human.
    The  Boundary for  Adverse  Effects (solid line)  1s  drawn  to  identify  the
lowest  adverse effect  dose or  concentration  at   the  shortest duration  of
6234H                                D-l                            06/16/89

-------
0


N
9

V
X
U

B
U
B

i
0.
X
U
    iieeei
     10001 • r
       IBM
          B.0001
           Exposure)
0.001             0.01              0.1

  HUNAN EQUIU DURATION  (fraction  tifespan)

             ENVELOP METHOD
                                          Figure  D-l


                  Dose/Duration - Response Graph  for  Inhalation  Exposure  to
           1,3-01chloropropene: Expanded Experimental  Concentration,  Envelop  Method
             Key:       N - NOEL
                        n - NOAEL
                        L « LOAEL
                        A » AEL
                        F « FEL


         Solid Line - Adverse Effects Boundary


         Dotted Line » No Adverse Effects Boundary
         6234H
                   0-2
                                                                             06/16/89

-------
P]
x;
ui
i
A,

bj
     100000
      loeoo •-
       1000 - -
        100 •-
10--
          i--
        e.i
                      A41

                      F40
                                                         n24
                                                                        L4   1

                                                                        n3
                                                              NJL2

          B •8881
< Inhat at i on Exposure )
                 t   |  j f j i III.
                   0.001            0.01              0.1
                     HUNAN EQUIU DURATION (fraction lifespan)

                           CENSORED DATA METHOD
                                                      1    2
                                        Figure D-2

                 Dose/Duration - Response Graph for Inhalation Exposure to
                         1,3 Dichloropropene: Expanded Experimental
                            Concentration, Censored Data Method
            Key:
              N
              n
              L
              A
              F
NOEL
NOAEL
LOAEL
AEL
FEL
        Solid  Line  »  Adverse  Effects  Boundary

        Dotted Line - No  Adverse  Effects Boundary
        6234H
                                    0-3
                                                 06/16/89

-------

e
hi
3
       e.ei
          010001.
(Inhalat ion Exposure >
0.001            0.01              e.i
  HUMAN EQUIV DURATION (Fraction lifespan)
             ENMELOP METHOD
                                       Figure D-3

               Dose/Duration - Response Graph for Inhalation Exposure to
                1,3 Dkhloropropene:  Scaled Concentration,  Envelop  Method
           Key:       N - NOEL
                     n - NOAEL
                     L » LOAEL
                     A . AEL
                     F . FEL

       Solid Line - Adverse Effects Boundary

       Dotted Line » No Adverse Effects Boundary
      6234H
               0-4
06/16/89

-------
 n
 A
 U
 •J
W
        0.1--
       0.01
          0.0001

-------
I
\
i
          e.eei

           B.81                  6.1
       HUMAN EQUIV DURATION  (fraction Ufespan)

                  ENUELOP METHOD
                                        Figure D-5

                   Dose/Duration - Response  Graph for Oral Exposure to
                1,3 DUhloropropene:  Human Equivalent Dose, Envelop Method
           Key:
N
L
A
F
NOEL
LOAEL
AEL
FEL
       Solid Line - Adverse Effects Boundary

       Dotted Line « No Adverse Effects Boundary
       6234H
                                            D-6
                                                                           06/16/89

-------
 ft
 *.*
 t\
 If
bl
fl
w
S1
2:
       1M0
         18 T
        0.1
            :  ]'13
           8,881

-------
exposure at which  an  adverse  effect occurred.  From  this  point,  an infinite
line is extended upward,  parallel  to the dose axis.   The  starting  point  is
then connected  to  the lowest  adverse  effect dose or concentration  at  the
next  longer  duration  of  exposure  that  has  an  adverse  effect  dose  or
concentration equal  to  or lower  than  the  previous   one.   This  process  is
continued  to  the   lowest  adverse  effect  dose  or  concentration.   From  this
point,  a  line  Is  extended to the right, parallel  to the duration axis.  This
Region of Adverse Effects lies above the Adverse  Effects Boundary.
    Using  the  envelope method,  the  Boundary for No  Adverse  Effects (dashed
line)  is   drawn  by  identifying  the  highest no adverse  effects  dose  or
concentration.  From   this  point,  a  line parallel  to the duration axis  is
extended  to the  dose  or  concentration  axis.  The   starting  point is  then
connected  to  the next  lower or equal no adverse  effect dose or concentration
at  a longer  duration of  exposure.   When  this  process  can  no longer  be
continued,  a  line  is  dropped  parallel  to the dose or concentration axis  to
the  duration  axis.   The  Region  of  No  Adverse   Effects lies  below  the  No
Adverse Effects  Boundary.   At  either ends  of the graph between  the Adverse
Effects and No Adverse  Effects Boundaries   are   Regions of Ambiguity.   The
area (if   any)  resulting  from Intersection  of   the  Adverse Effects  and  No
Adverse Effects Boundaries is defined as the Region of Contradiction.
    In the  censored data method,  all no adverse effect points located in the
Region of Contradiction are  dropped from consideration and the  No Adverse
Effect Boundary is redrawn so that  it does  not intersect the Adverse Effects
Boundary  and  no Region of Contradiction  1s  generated.  This  method results
1n the most conservative definition of the No Adverse  Effects Region.
6234K                                D-8                            06/16/89

-------
    In the graphs  depicting  the  Inhalation  data (Figures  D-l  to D-4),   no
one species,  effect  or  study  figures  predominantly In defining  the  Adverse
Effects Boundary.   The  LOAELs  for  the primary  Inflection  of  the  Adverse
Effects Boundary  (rec  #35  and  36),   «0.004-0.007  llfespan  of  the  human
equivalent durations, reflect toxic  maternal  effects (decreased  body  weight
gain)   In  rats and rabbits  1n  a  teratogenlclty  study (Hanley et  al.  1987).
The AELs   (rec  #33  and  34)  found  at  =0.02-0.05  Hfespan  of  the  human
equivalent durations  reflect kidney- and  liver necrosis  in rats  and  guinea
pigs (Torkelson and Oyen, 1977).   The Region of Contradiction  Is  quite large
and  is   contained   within   the   0.003-1.0   llfespan  region  of  the  human
equivalent duration.  This region is not characterized  by any one  species,
effect or study,  and probably  reflects differences  in  study  protocol  and
quality.   The chronic  and  subchronic inhalation  RfO of  0.01  mg/m3  is based
on  a  NOEL  for  degenerative changes in the  nasal  mucosa  of rats  (rec  #1)
(Stott et  al. 1988).  The Inhalation  RfDs are  well  below  the  Boundary  for No
Adverse Effects.
    In the  graphs depicting the  oral  data  (Figure  D-5  and  0-6), the  data
points concentrated  at  sO.0015   lifespan of  the  human  equivalent  duration
reflect oral  LDsos for  rats  and mice (rec  #10,  13,  16,   17).  The LOAEL  for
the  primary  Inflection   point   (rec   #7,   *0.15   lifespan   of   the  human
equivalent duration,  in  the  Adverse  Effect  Boundary reflects  an  Increase In
kidney weights  in  male  rats  (Til  et  al., 1973).   The Adverse Effect  Boundary
is  nearly  without  slope  at   human  equivalent  durations  =0.1  lifespan,
suggesting  little  difference between the subchronic and  chronic  toxldty of
l,3-d1chloropropene.   This conclusion,  however,  cannot be  drawn due  to  the
small   number of  oral studies  available.   The  Region  of Contradiction  is
quite  small,  reflecting the small  number   of oral  studies  available.   The
6234H                                D-9                            06/26/89

-------
chronic and  subchronic oral  RfOs  of 3  x 10""  and  3  x  10~3,  respectively,

are based on a NOEL for kidney effects In  the  T11  et al. study  (rec  #1) and

are well below the boundary for No Adverse Effects.



D.2.   DATA USED TO GENERATE DOSE/DURATION-RESPONSE GRAPHS



D.2.1.   INHALATION EXPOSURE
Chemical Name:
CAS Number:
Document Title:

Document Number:
Document Date:
Document Type:
1,3-dlchloropropene
542-75-6
Health and Environmental  Effects Document on
1,3-Dichloropropene
FOltO-106
5/16/89
HEED
RECORD #1 :








Species: Rats
Sex: Male
Effect: NOEL
Route: Inhalation
Number Exposed:
Number Responses:
Type of Effect:
Site of Effect:
Severity Effect:
Dose: 8.
Duration
Duration

10
0
DEGEN
NASAL
6
100
Exposure: 13
Observation:







.0 Weeks
13.0 Weeks






                  Comment:     Concentrations given: 0, 10, 30, 90, 150 ppm,
                               6 hours/day, 5 days/week.  Basis of subchronic
                               and chronic RfD.  Degeneration of the nasal
                               mucosa seen In all rats  at 90 and 150 ppm
                               and in male rats at 30 ppm.

                  Citation:    Stott et al., 1988
6234H
                   D-10
06/26/89

-------
RECORD #2:
RECORD #3:
Species:
Sex:
Effect:
Route:
Rats
Male
NOEL
Inhalation
                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
Dose: 0.500
Duration Exposure: 6.0  Months
Duration Observation: 6.0 Months
                          11
                          0
                          HYPRT
                          KIDNY
                          3
                  Comment:   Concentrations given:  1, 3 ppm 4 or 7 hours/
                             day, 5 days/week.   Slight reversible cloudy
                             swelling of the renal   epithelium at 3 ppm.
                             Composition of test material  not specified.

                  Citation:  Torkelson and Oyen, 1977
Species:
Sex:
Effect:
Route:
Rats
Both
NOAEL
Inhalation
                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
Dose: 16.200
Duration Exposure: 24.0  Months
Duration Observation: 24.0 Months
                          100
                          1.
                          DEGEN
                          NASAL
                          6
                  Comment:   Concentrations given:   0, 5, 20, 60 ppm. Degen-
                             eration of the nasal tissues seen at high Inci-
                             dence in one male and females at 60 ppm and in
                             one male at 20 ppm at 24, but not at 6 or 12
                             months.

                  Citation:  Lomax et al., 1989
RECORD #4:
Species:
Sex:
Effect:
Route:
Rats
Both
LOAEL
Inhalation
Dose: 48.600
Duration Exposure: 24.0 Months
Duration Observation: 24.0 Months
                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          100
                          35
                          DEGEN
                          NASAL
                          6
                  Comment:   Concentrations given: 0. 5, 20, 60 ppm 6 hours/
                             day, 5 days/week.  Degeneration of the nasal
                             tissues seen at high Incidence in male and fe-
                             male at 60 ppm at 24, but not at 6 or 12 months

                  Citation:  Lomax et al,, 1989
6234H
                   0-11
                                       06/26/89

-------
RECORD #5:
Species:
Sex:
Effect:
Route:
Mice
Female
LOAEL
Inhalation
Dose: 16.200
Duration Exposure: 24.0  Months
Duration Observation: 24.0 Months
                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          0
                          21
                          HYPRP
                          OTHER
                          3
                                    50
                                    28
                                    HYPRP
                                    NASAL
                                    3
                  Comment:     Concentrations given: 0, 5, 20, 60 ppm 6
                               hours/day, 5 days/week.   Hyperplasia of the
                               urinary bladder and the  nasal epithelium were
                               found at 20 arid 60 ppm.

                  Citation:    Lomax et al. 1989
RECORD #6:



Species:
Sex:
Effect:
Route:
Mice
Female
NOAEL
Inhalation
Dose: 4.000
Duration Exposure: 24.0 Months
Duration Observation: 24.0 Months

                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          46
                          4
                          HYPRP
                          OTHER
                          3
                                    50
                                    4
                                    HYPRP
                                    NASAL
                                    3
                  Comment:     Concentrations given: 0, 5, 20, 60 ppm,
                               Hyperplasia of the urinary bladder and nasal
                               epithelium were found at 20 ppm and greater.

                  Citation:    Lomax et al., 1989
RECORD #7:



Species:
Sex:
Effect:
Route :
Mice
Male
NOAEL
Inhalation
Dose: 16.200
Duration Exposure: 24.0 Months
Duration Observation: 24.0 Months

                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          48
                          11
                          HYPRP
                          OTHER
                          3
                                    50
                                    4
                                    HYPRP
                                    NASAL
                                    3
                  Comment:     Concentrations given: 0, 5, 20, 60 ppm.
                               Hyperplasia of the urinary bladder and nasal
                               epithelium were found at 60 ppm.

                  Citation:    Lomax et al., 1989
6234H
                   D-12
                                      06/26/89

-------
RECORD #8:
Species:
Sex:.
Effect:
Route:
Mice
Male
AEL
Inhalation
Dose: 48.600
Duration Exposure: 24.0 Months
Duration Observation: 24.0 Months
                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          47
                          37
                          HYPRP
                          OTHER
                          3
                                    50
                                    48
                                    HYPRP
                                    NASAL
                                    3
                  Comment:     Concentrations given:  0, 5, 20, 60 ppm.
                               Hyperplasla of the urinary bladder and nasal
                               epithelium were found at 60 ppm.
                  Citation:    Lomax et al.,  1989
RECORD #9:



Species:
Sex:
Effect:
Route:
Rats
Male
LOAEL
Inhalation
Dose: 2.800
Duration Exposure: 6.0
Duration Observation: 6


Months
.0 Months

                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          9
                          NR
                          HYPRT
                          KIDNY
                          3
                  Comment:     Concentrations given:  1, 3 ppm.  Slight,
                               reversible cloudy swelling of the renal
                               epithelium at 3 ppm.  Composition of test
                               material not specified.

                  Citation:    Torkelson and Oyen, 1977
RECORD #10:
Species:
Sex:
Effect:
Route:
Dogs
Both
NOEL
Inhalation
                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
Dose: 2.800
Duration Exposure: 6.0  Months
Duration Observation: 6.0 Months
                          2
                          0
                          TOXSL
                          BODY
                          2
                  Comment:     Concentrations given:  1, 3 ppm.
                               histological effects found.

                  Citation:    Torkelson and Oyen, 1977
                                               No
6234H
                   D-13
                                     06/26/89

-------
RECORD #11
Species:
Sex:
Effect:
Route:
Rabbits
Both
NOEL
Inhalation
                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
Dose: 2.800
Duration Exposure: 6.0 Months
Duration Observation: 6.0 Months
                          5
                          0
                          TOXSL
                          BODY
                          2
                  Comment:      Concentrations given:  1,  3 ppm.
                               histologlcal  effects seen.

                  Citation:     Torlcelson and Oyen,  1977
                                              No
RECORD #12:



Species:
Sex:
Effect:
Route:
Guinea Pigs
Both
NOEL
Inhalation
Dose: 2.800
Duration Exposure: 6
Duration Observation


.0 Months
: 6.0 Months

                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          18
                          0
                          TOXSL
                          BODY
                          2
                  Comment:      Concentrations given: 1, 3 ppm.
                               histologlcal effects seen.

                  Citation:    Torkelson and Oyen, 1977
                                              No
RECORD #13:



Species:
Sex:
Effect:
Route:
Rats
Male
LOAEL
Inhalation
Dose: 24
Duration
Duration

.300
Exposure: 13
Observation:


.0
13


Neeks
.0 Weeks

                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          10
                          2
                          DEGEN
                          NASAL
                          6
                  Comment:     Concentrations given:  0, 10, 30, 90, 150 ppm
                               6 hours/day, 5 days/week. Degeneration of
                               nasal epithelium seen at 30 ppm.

                  Citation:    Stott et al., 1988
6234H
                   D-14
                                      06/16/89

-------
RECORD #14:
Species:
Sex:
Effect:
Route:
Rats
Female
NOEL
Inhalation
                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
Dose: 24.300
Duration Exposure: 13.0  Neeks
Duration Observation: 13.0 Heeks
                          10
                          0
                          DEGEN
                          NASAL
                          6
                  Comment:      Concentrations given:  0, 10,  30,  90, 150 ppm
                               Degeneration of nasal  epithelium seen at >

                  Citation:     Stott. et al., 1-988
RECORD #15:








Species: Rats
Sex: Female
Effect: LOAEL
Route: Inhalation
Number Exposed:
Number Responses:
Type of Effect:
Site of Effect:
Severity Effect:
Dose: 73.000
Duration Exposure: 13.0
Duration Observation: 13

10
10
DEGEN
NASAL
6

Weeks
.0 Neeks






                  Comment:     Concentrations given: 0, 10, 30, 90, 150 ppm.
                               Degeneration of the nasal epithelium seen at
                               _>90 ppm.

                  Citation:    Stott et  al., 1988
RECORD #16:



Species:
Sex:
Effect:
Route:
Mice
Female
NOAEL
Inhalation
Dose: 24.300
Duration Exposure: 13
Duration Observation:


.0 Neeks
13.0 Neeks

                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          9
                          0
                          HYPRP
                          OTHER
                          3
                                    9
                                    0
                                    DEGEN
                                    NASAL
                                    6
                  Comment:     Concentrations given: 0, 10, 30, 90, 150 ppm.
                               Hyperplasia of the urinary bladder and nasal
                               degeneration seen at >9Q ppm.

                  Citation:    Stott et al., 1988
6234H
                   D-15
                                     06/16/89

-------
RECORD #17:
Species:
Sex: '
Effect:
Route:
Mice
Fema1e
LOAEL
Inhalation
Dose: 73.000
Duration Exposure: 13.0  Weeks
Duration Observation: 13.0 Weeks
                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          9
                          7
                          HYPRP
                          OTHER
                          3
                                    9
                                    9
                                    DEGEN
                                    NASAL
                                    6
                  Comment:     Concentrations given:  0, 10, 30, 90, 150 ppm.
                               Degeneration of the urinary bladder and nasal
                               degeneration seen at ^90 ppm.

                  Citation:    Stott et al.. 1988
RECORD #18:



Species:
Sex:
Effect:
Route:
Mice
Male
NOEL
Inhalation
Dose: 24
Duration
Duration

.300
Exposure: 13
Observation:


.0
13


Weeks
.0 Weeks

                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          10
                          0
                          DEGEN
                          NASAL
                          6
                  Comment:     Concentrations given: 0, 10, 30, 90, 150 ppm.
                               Nasal degeneration found at ,>90 ppm.

                  Citation:    Stott et al., 1988
RECORD #19:



Species:
Sex:
Effect:
Route :
Mice
Male
LOAEL
Inhalation
Dose: 73
Duration
Duration

.000
Exposure: 13
Observation:


.0
13


Weeks
.0 Weeks

                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          10
                          10
                          DEGEN
                          NASAL
                          6
                  Comment:     Concentrations given: 0, 10, 30, 90, 150 ppm.
                               Nasal degeneration seen at >9Q ppm.

                  Citation:    Stott et al., 1988
6234H
                   D-16
                                      06/26/89

-------
RECORD #20:
Species:
Sex:
Effect:
Route:
Rats
Both
NOAEL
Inhalation
                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
Dose: 30.300
Duration Exposure: 13.0  Neeks
Duration Observation: 13.0 Weeks
                          NR
                          NR
                          WGTDC
                          BODY
                          4
                  Comment:     Concentrations given: 0, 12, 32, 93 ppm.
                               Decreased body weight gain at 93 ppm.

                  Citation:    Coate et al.,-1979
RECORD #21:



Species:
Sex:
Effect:
Route :
Rats
Both
LOAEL
Inhalation
Dose: 88
Duration
Duration

.000
Exposure:

1

3
Observation:




.0
13


Weeks
.0 Weeks

                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          NR
                          NR
                          WGTDC
                          BODY
                          4
                  Comment:     Concentrations given: 0, 12, 32, 93 ppm.
                               Decreased body weight gain at 93 ppm.

                  Citation:    Coate et al., 1979
RECORD #22:



Species:
Sex:
Effect:
Route:
Mice
Female
NOAEL
Inhalation
Dose: 30
Duration
Duration

.300
Exposure: 13
Observation:


.0
13


Weeks
.0 Weeks

                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          NR
                          NR
                          WGTDC
                          BODY
                          4
                  Comment:     Concentrations given: 0,  12, 32,  93  ppm.
                               Decreased body weight gain at 93  ppm.

                  Citation:    Coate et al., 1979
6234H
                   0-17
                                      06/16/89

-------
RECORD #23;
Species:
Sex:
Effect:
Route:
Mice
Female
LOAEL
Inhalation
                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
Dose: 88.000
Duration Exposure: 13.0  Weeks
Duration Observation: 13.0 Weeks
                          NR
                          NR
                          WGTDC
                          BODY
                          4
                  Comment:     Concentrations given: 0, 12, 32, 93 ppm.
                               Decreased body weight gain at 93 ppm.

                  Citation:    Coate,etal., V979
RECORD #24:



Species:
Sex:
Effect:
Route:
Mice
Male
NOAEL
Inhalation
Dose: 88
Duration
Duration

.000
Exposure: 13
Observation:


.0
13


Weeks
.0 Weeks

                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          NR
                          NR
                          WGTDC
                          BODY
                          4
                  Comment:     Concentrations given: 0, 12, 32, 93 ppm.
                               Decreased body weight gain at 93 ppm.

                  Citation:    Coate et al., 1979
RECORD #25:



Species:
Sex:
Effect:
Route:
Rats
Both
NOAEL
Inhalation
Dose: 12
Duration
Duration

.200
Exposure: 12
Observation:


.0
12


Weeks
.0 Weeks

                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          18
                          NR
                          WGTIN
                          BODY
                          4
                  Comment:     Concentrations given: 0, 5, 15, 50 ppm.
                               Increased liver-to-body weight seen in males
                               and increased kidney-to-body weight seen In
                               females at 50 ppm.

                  Citation:    Parker et al., 1982
6234H
                   D-18
                                      06/16/89

-------
RECORD #26:
Species:
Sex:
Effect:
Route:
Rats
Both
LOAEL
Inhalation
                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
Dose: 40.500
Duration Exposure: 12.0  Weeks
Duration Observation: 12.0 Weeks
                          18
                          NR
                          WGTIN
                          BODY
                          4
                  Comment:      Concentrations  given:  0,  5,  15,  50 ppm.
                               Increased liver-to-body weight  In  males  and
                               Increased kidney-to-body weight  In females  at
                               50 ppm.

                  Citation:     Parker et al.,  1982
RECORD #27:



Species:
Sex:
Effect:
Route:
Mice
Male
LOAEL
Inhalation
Dose: 40.500
Duration Exposure: 12.0 Weeks
Duration Observation: 12.0 Weeks

                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          Zl
                          12
                          HYPRT
                          LIVER
                          3
                  Comment:      Concentrations given:  0, 5,  15,  50 ppm.
                               Hepatocytlc enlargement seen at  50 ppm.

                  Citation:     Parker et al., 1982
RECORD #28:



Species:
Sex:
Effect:
Route:
Mice
Male
NOAEL
Inhalation
Dose: 12.200
Duration Exposure: 12.0 Weeks
Duration Observation: 12.0 Weeks

                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          NR
                          NR
                          HYPRT
                          LIVER
                          3
                  Comment:     Concentrations given: 0, 5, 15, 50 ppm.
                               Hepatocytic enlargement seen at 50 ppm.

                  Citation:    Parker et al., 1982
6234H
                   D-19
                                     06/16/89

-------
RECORD #29:
Species:
Sex:
Effect:
Route:
Mice
Female
NOAEL
Inhalation
                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
Dose: 12.200
Duration Exposure: 12.0  Weeks
Duration Observation: 12.0 Weeks
                          18
                          NR
                          HYPRT
                          LIVER
                          3
                  Comment:      Concentrations given:  0,  5,  15,  50 ppm.
                               Nepatocytic enlargement seen at  50 ppm.

                  Citation:     Parker et al./1982
RECORD #30:



Species:
Sex:
Effect:
Route:
Mice
Female
LOAEL
Inhalation
Dose: 40.500
Duration Exposure: 12
Duration Observation:


.0 Neeks
12.0 Weeks

                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          18
                          6
                          HYPRT
                          LIVER
                          3
                  Comment:
             Concentrations given: 0, 5, 15, 50 ppm.
             Hepatocytic enlargement seen at 50 ppny;
                  Citation:    Parker et al.,  1982
RECORD #31 :



Species:
Sex:
Effect:
Route:
Rats
Both
NOEL
Inhalation
Dose: 24.300
Duration Exposure: 10.0 Weeks
Duration Observation: 10.0 Weeks

                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          30
                          NR
                          WGTDC
                          BODY
                          3
                       30
                       NR
                       WGTIN
                       KIDNY
                       4
                     30
                     NR
                     WGTIN
                     LIVER
                     4
                  Comment:     Concentrations given: 0, 10, 30, 90 ppm.
                               Small decrease In body weight gain and slight
                               increases in liver and kidney weights were
                               found at 90 ppm in this reproduction study.

                  Citation:    Llnnett et al., 1988
6234H
                   D-20
                                     06/16/89

-------
RECORD #32;
Species:
Sex:
Effect:
Route:
Rats
Both
LOAEL
Inhalation
Dose: 73.000
Duration Exposure: 10.0  Weeks
Duration Observation: 10.0 Weeks
                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          30
                          NR
                          WGTDC
                          BODY
                          3
                      30
                      NR
                      WGTIN
                      KIDNY
                      4
                      30
                      NR
                      WGTIN
                      LIVER
                      4
                  Comment:     Concentrations given:  0, TO, 30, 90 ppm.
                               Small decrease 1n body weight gain and slight
                               Increase In liver and  kidney weights at 90 ppm
                               In this reproduction study.

                  Citation:    Llnnett et al., 1988
RECORD #33:








Species: Rats
Sex: N.S.
Effect: AEL
Route: Inhalation
Number Exposed:
Number Responses:
Type of Effect:
Site of Effect:
Severity Effect: ,
Dose: 10.100
Duration Exposure: 39
Duration Observation:

NR
NR
NECRO
KIDNY
6

.0 Days
39.0 Days

NR
NR
NECRO
LIVER
6
                  Comment:     Concentrations given:  11, 50 ppm.

                  Citation:    Torkelson and Oyen, 1977
RECORD #34:
Species:     Guinea P1gs  Dose: 10.100
Sex:         N.S.         Duration Exposure: 39.0  Days
Effect:      AEL          Duration Observation: 39.0 Days
Route:       Inhalation
                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          NR
                          NR
                          NECRO
                          KIDNY
                          6
                                    NR
                                    NR
                                    NECRO
                                    LIVER
                                    6
                  Comment:     Concentrations given: 11, 50 ppm.

                  Citation:    Torkelson and Oyen, 1977
6234H
                   0-21
                                     06/16/89

-------
RECORD #35:
Species:
Sex: •
Effect:
Route:
Rats
Female
LOAEL
Inhalation
                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
Dose: 22.700
Duration Exposure: 6.0  Days
Duration Observation: 15.0 Days
                          30
                          NR
                          WGTDC
                          BODY
                          4
                  Comment:     Concentrations given:  0,  20, 60, 120 ppm.
                               No teratogeniclty found but maternal toxlcity
                               seen at >20 ppm.

                  Citation:    Hanley et al., 1987
RECORD #36:



Species:
Sex:
Effect:
Route:
Rabbits
Female
LOAEL
Inhalation
Dose: 22,700
Duration Exposure: 12.0 Days
Duration Observation: 23.0 Days

                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          25
                          NR
                          WGTDC
                          BODY
                          4
                  Comment:     Concentrations given: 0, 20, 60, 120 ppm.
                               No teratogenicity seen but maternal toxlcity
                               found at _>20 ppm.

                  Citation:    Hanley et al., 1987
RECORD #37:



Species:
Sex:
Effect:
Route :
Rats
N.S.
FEL
Inhalation
Dose: 4530.000
Duration Exposure: 1 .0
Duration Observation: 1


Days
.0 Days

                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          NR
                          NR
                          DEATH
                          BODY
                          10
                  Comment:     4530 mg/m3 was an

                  Citation:    Hlne et al., 1953
6234H
                   D-22
                                      06/16/89

-------
RECORD #38:
Species:
Sex:
Effect:
Route:
Mice
N.S.
FEL
Inhalation
                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
Dose: 4530.000
Duration-Exposure: 1.0  Days
Duration Observation: 1.0 Days
                          NR
                          NR
                          DEATH
                          BODY
                          10
                  Comment:     4530 mg/m3 was the LC50.

                  Citation:    Mine et al., 1953
RECORD #39:



RECORD #40:
Species: Guinea P1gs Dose: 1800.000
Sex: N.S. Duration Exposure: 1.0
Effect: FEL Duration Observation: 1
Route: Inhalation
Number Exposed: NR
Number Responses: NR
Type of Effect: DEATH
Site of Effect: BODY
Severity Effect: 10
Comment: Concentration given: 400 ppm. Death
after 7-hour exposure.
Citation: Torkelson and Oyen, 1977
Species: Rats Dose: 4500.000
Sex: N.S. Duration Exposure: 1.0
Effect: FEL Duration Observation: 1
Route: Inhalation
Days
.0 Days

seen

Days
.0 Days
                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          NR
                          NR
                          DEATH
                          BODY
                          10
                  Comment:     1000 ppm was the LC50.

                  Citation:    Torkelson and Oyen, 1977
6234H
                   D-23
                                      06/16/89

-------
RECORD #41
Species:
Sex:
Effect:
Route:
Rats
N.S.
AEL
Inhalation
Dose:  12000.000
Duration Exposure: 1.0  Days
Duration Observation: 1.0 Days
                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          NR
                          NR
                          IRRIT
                          MMBRN
                          3
                      NR
                      NR
                      TOXDF
                      KIDNY
                      6
                      NR
                      NR
                      TOXDF
                      LIVER
                      6
                  Comment:      Concentration given:  2700 ppm 1,3-DCP was a
                               mucous membrane Irritant and caused injury to
                               lung,  kidney, liver and nasal  area.

                  Citation:    Torkelson and Oyen, 1977
RECORD #42:



Species:
Sex:
Effect:
Route:
Rats
Both
LOAEL
Inhalation
Dose: 72.900
Duration Exposure: 15.0 Weeks
Duration Observation: 15.0 Weeks

                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          70
                          NR
                          DEGEN
                          LUNG
                          6
                                    70
                                    NR
                                    WGTDC
                                    BODY
                                    4
                  Comment:     90 ppm (range 0, 10, 30, 90 ppm) 6 hours/day,
                               5 days/week 1n multigeneration repro study.
                               NOAEL for repro (slight reduction in female
                               conception indices); respiratory epithelial
                               lesions, body weight loss.

                  Citation:    Breslin et al., 1987
RECORD #43:



Species:
Sex:
Effect:
Route:
Rats
Both
NOAEL
Inhalation
Dose: 24
Duration
Duration

.300
Exposure: 15
Observation:


.0
15


Weeks
.0 Weeks

                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          70
                          NR
                          DEGEN
                          LUNG
                          6
                                    70
                                    NR
                                    WGTDC
                                    BODY
                                    4
                  Comment:     30 ppm 
-------
D.2.2.  ORAL EXPOSURE
Chemical Name:
CAS Number:
Document Title:

Document Number:
Document Date:
Document Type:
1,3-d1chloropropene
542-75-6
Health and Environmental
1,3-01chloropropene
F0110-106
5/16/89
HEED
Effects Document on
RECORD #1 :



Species:
Sex:
Effect:
Route:
Rats
Male
NOEL
Gavage-
Dose: 2.600
Duration Exposure: 13.0 Keeks
Duration Observation: 13.0 Weeks
*
                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          NR
                          NR
                          WGTIN
                          KIDNY
                          4
                  Comment:     Doses given:  0,  1,  3,  10,  30 mg/kg.  Used as
                               the basis for the chronic  and subchronlc
                               oral RfD.  A higher relative kidney weight was
                               seen 1n male rats at 210 mg/kg.

                  Citation:    T11 et al.. 1973
RECORD #2:



Species:
Sex:
Effect:
Route:
Rats
Female
AEL
Gavage
Dose: 10.700
Duration Exposure: 2.0
Duration Observation: 2


Years
.0 Years

                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          52
                          24
                          NEURP
                          KIDNY
                          6
                  Comment:     Doses given:  0. 25. 50 mg/kg 15/52 control,
                               24/52 low dose and 22/52 high dose.

                  Citation:    NTP, 1985
6234H
                   D-25
                         06/27/89

-------
RECORD #3:
Species:
Sex:
Effect:
Route:
Rats
Male
NOAEL
Gavage
                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
Dose: 10.700
Duration Exposure: 2.0  Years
Duration Observation: 2.0 Years
                          52
                          5
                          HYPRP
                          OTHER
                          3
Comment: Doses given: 0, 25, 50 mg/kg. Hyperplasia of
the forestomach seen at 50 mg/kg.
Citation: NTP,~1985
RECORD #4: Species: Rats
Sex: Male
Effect: AEL
Route: Gavage
Number Exposed:
Number Responses:
Type of Effect:
Site of Effect:
Severity Effect:

Dose: 21
Duration
Duration
52
13
HYPRP
OTHER
3

.400
Exposure: 2.0 Years
Observation: 2.0 Years

                  Comment:     Doses given:  0, 25, 50 mg/kg.  Hyperplasia of
                               the forestomach seen at 50 mg/kg.

                  Citation:    NTP, 1985
RECORD #5:



Species:
Sex:
Effect:
Route:
Mice
Female
AEL
Gavage
Dose: 21.400
Duration Exposure: 2.0
Duration Observation: 2


Years
.0 Years

                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          50
                          15
                          HYPRP
                          OTHER
                          3
                  Comment:     Doses given: 0, 25, 50 mg/kg. Hyperplasia of
                               the urinary bladder was found at 50 mg/kg.

                  Citation:    NTP, 1985
6234H
                   D-26
                                      06/27/89

-------
RECORD #6:
Species:
Sex:
Effect:
Route:
Mice
Male
AEL
Gavage
                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
Dose: 21.400
Duration Exposure: 2.0  Years
Duration Observation: 2.0 Years
                          50
                          9
                          HYPRP
                          OTHER
                          3
                  Comment:     Doses given: 0, 50, 100 mg/kg. Hyperplasla of
                               the urinary bladder found at 50 mg/kg.

                  Citation:    NTP,-1985
RECORD #7 :



Spedes:
Sex:
Effect:
Route:
Rats
Male
LOAEL
Gavage
Dose: 8.600
Duration Exposure: 13
Duration Observation:


.0
13


Weeks
.0 Weeks

                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          NR
                          NR
                          WGTIN
                          KIDNY
                          4
                  Comment:     Doses given: 0, 1, 3, 10, 30 mg/kg. Increase
                               1n kidney weight was found in male rats
                               treated with ^10 mg/kg. The NOAEL 2.6 mg/kg
                               is basis for chronic and subchronic RfD.

                  Citation:    Til et al., 1973
RECORD #8:



Species:
Sex:
Effect:
Route:
Rats
Female
NOEL
Gavage
Dose: 8.600
Duration Exposure: 13.0 Weeks
Duration Observation: 13.0 Weeks

                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          NR
                          NR
                          WGTIN
                          KIONY
                          4
                  Comment:     Doses given: 0,  1, 3, 10, 30 mg/kg.

                  Citation:    Til et al., 1973
6234H
                   D-27
                                      06/27/89

-------
RECORD #9:
Species:
Sex: '
Effect:
Route:
Rats
Female
LOAEL
Gavage
                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  SUe of Effect:
                  Severity Effect:
Dose: 25,700
Duration Exposure: 13.0  Weeks
Duration Observation: 13.0 Weeks
                          NR
                          NR
                          WGTIN
                          KIDNY
                          4
                  Comment:      Doses given:  0,  1,  3,  10,  30 mg/kg

                  Citation:     Til  et al.t  1973
RECORD #10:



RECORD #1 1 :
Species: Rats
Sex: Male
Effect: FEL
Route: Oral, NOS
Number Exposed:
Number Responses:
Type of Effect:
Site of Effect:
Severity Effect:
Comment: LD50 was
Citation: Torkelson
Species: Rats
Sex: Female
Effect: FEL
Route: Oral, NOS
Dose: 710.000
Duration Exposure: 1.0
Duration Observation: 1
NR
NR
DEATH
BODY
10
710 mg/kg.
and Rowe, 1981
Dose: 470.000
Duration Exposure: 1 .0
Duration Observation: 1
Days
.0 Days



Days
.0 Days
                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          NR
                          NR
                          DEATH
                          BODY
                          10
                  Comment:     LD50 was 470 mg/kg.

                  Citation:    Torkelson and Rowe, 1981
6234H
                   D-28
                                     06/27/89

-------
RECORD #12:
Species:
Sex:
Effect:
Route:
Rats
Male
PEL
Oral, NOS
                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
Dose: 560.000
Duration Exposure: 1.0  Days
Duration Observation: 1.0 Days
                          NR
                          NR
                          DEATH
                          BODY
                          10
                  Comment:      LD5o  was  560 mg/kg  (95% confidence  limits
                               were  452-695).

                  Citation:     ToyosMma et al.",  1978a
RECORD #13:



Species:
Sex:
Effect:
Route:
Rats
Female
PEL
Oral, NOS
Dose: 510.000
Duration Exposure: 1.0
Duration Observation: 1


Days
.0 Days

                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          NR
                          NR
                          DEATH
                          BODY
                          10
                  Comment:      LD50 was 510 mg/kg (951 confidence limits
                               were 480-726)

                  Citation:    Toyoshlma et al.,  1978a
RECORD #14:



Species:
Sex:
Effect:
Route :
Rats
N.S.
PEL
Oral, NOS
Dose: 140.000
Duration Exposure: 1.0
Duration Observation: 1


Days
.0 Days

                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          NR
                          NR
                          DEATH
                          BODY
                          10
                  Comment:     LDSQ was 140 +/- 25 mg/kg.

                  Citation:    Mine et al., 1953
6234H
                   D-29
                                     06/16/89

-------
RECORD #15;
RECORD #16:
Species:
Sex:
Effect:
Route:
Rats
N.S.
PEL
Oral,
                                     NOS
                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
Dose: 150.000
Duration Exposure: 1.0  Days
Duration Observation: 1.0 Days
                          NR
                          NR
                          DEATH
                          BODY
                          10
                  Comment:      LDSO was  150 mg/kg (95X confidence limits
                               were 130-170) LDSO for males was 130 mg/kg
                               and the LD,0 for females was between 110
                               and 250 mg/kg.  *

                  Citation:     Jones and Collier, 1986
Species:
Sex:
Effect:
Route:
Mice
N.S.
PEL
Oral,
                                     NOS
                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
Dose: 300.000
Duration Exposure: 1.0  Days
Duration Observation: 1.0 Days
                          NR
                          NR
                          DEATH
                          BODY
                          10
                  Comment:     LD5a was 300 W- 37 mg/kg.

                  Citation:    Hine et al.,  1953
RECORD #17:



Species:
Sex:
Effect:
Route :
Mice
Both
PEL
Oral, NOS
Dose: 640.000
Duration Exposure: 1 .0
Duration Observation: 1


Days
.0 Days

                  Number Exposed:
                  Number Responses:
                  Type of Effect:
                  Site of Effect:
                  Severity Effect:
                          NR
                          NR
                          DEATH
                          BODY
                          10
                  Comment:     LD,0 for both males and females was 640
                               mg/kg.

                  Citation:    Toyoshima et al., 1978b
6234H
                   D-30
                                      06/16/89

-------